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The morbidity associated with diabetes mellitus is increasing worldwide; 
within the UK alone it now affects approximately 1.3 million people. It is a leading 
cause of cardiovascular mortality, the leading cause of blindness and the single 
largest cause of end-stage renal failure. The non-obese diabetic (NOD) mouse has 
become the best characterised animal model for autoimmune diabetes which 
accounts for approximately 15% of all human cases. In recent years there has been an 
increased interest in the importance of macrophages (M!) in the pathogenesis of 
diabetes in NOD mice as well as the complications of diabetes. Recent studies of 
NOD M! have indicated impaired phagocytosis of apoptotic cells (AC) whilst there 
is conflicting data regarding the inflammatory phenotype of NOD M! in vitro.   
This study set out to examine the phagocytic capacity of NOD M! in vitro 
and in vivo and identify the molecular nature of the defect involved in the previously 
reported impaired uptake of AC. In addition, the inflammatory nature of different 
populations of NOD-derived M! was determined in vitro and their responses to 
inflammatory stimuli in vivo comprehensively assessed. 
Robust in vitro phagocytosis assays, using either microscopy or flow 
cytometry were developed and adapted to evaluate phagocytosis of a wide range of 
particles including AC, latex beads and pneumococci. NOD derived M! exhibited a 
marked in vitro phagocytic defect for AC and latex beads but not pneumococci 
opsonised with IgG. A peritoneal phagocytosis assay was then used to examine 
phagocytosis of AC and latex beads in vivo. Mathematical modelling of AC and 
peritoneal M! (PM!) numbers indicated that PM! from NOD mice took twice as 
long to ingest an AC in vivo compared to control C57BL/6 PM!. Study of peritoneal 
AC clearance in various NOD congenic strains strongly suggested that the gene(s) 
responsible for the phagocytic defect were located on idd 18 on chromosome 3. This 
locus contains the exciting candidate gene Vav3 that is involved in the intracellular 
regulation of M! phagocytosis.  
The inflammatory phenotypes of bone marrow derived macrophages 
(BMDM!), PM! and pleural M! (PLM!) were then compared. In vitro studies 
indicated that BMDM! were hyper-inflammatory whilst resident M! were hypo-
responsive to the same stimuli compared to control C57BL/6 M!. M! dependent and 
independent models of inflammation were employed to examine the behaviour of 
NOD M! in vivo. NOD mice recruited fewer leukocytes in both thioglycollate 
 
 iii 
peritonitis and carrageenan pleurisy but no differences in chemokine levels were 
evident. In contrast to the diminished leukocyte recruitment evident in M! dependent 
models of inflammation, NOD mice were able to mount an extremely vigorous 
immune response associated with prominent leukocyte infiltration in delayed-type 
hypersensitivity pleurisy. Thus, although it is relatively straightforward to examine 
M! function in vitro, the analysis of the role of M! as co-ordinators of inflammatory 
response in vivo is much more complex and the mechanisms underlying the 
diminished leukocyte response of NOD mice in M! dependent models of 
inflammation remain unclear. 
This study examined the phagocytic defect of NOD M! with congenic 
studies suggesting the involvement of the Vav3 gene in idd 18. BMDM! and resident 
M! of NOD mice exhibit opposite responses to inflammatory stimuli in vitro. In 
addition, NOD mice exhibit diminished responses in vivo in M! dependent models 
















First and foremost, I would like to thank my supervisor Dr. Jeremy Hughes, 
his endless enthusiasm and support has been an inspiration.   
The team Jeremy brought together, and I was lucky enough to join in 2003, 
has been a continual source of intellectual advice, practical help and emotional 
support. I wish to express my gratitude and appreciation to all my colleagues, past 
and present, who have helped me during this work. In particular I wish to 
acknowledge Dr Tiina Kipari who taught me many of my laboratory skills and who 
gave so freely of her own time. I would like to thank Simon Watson, Jean-Fraincois 
Cailhier, David Ferenbach, David Walbaum, Agnes Coutinho and Anya Adair for 
their intellectual stimulation and practical assistance when required. I have several 
people to thank within the Centre for Inflammation Research including Professor 
John Savill for his excellent guidance, experimental surgeon Spike Clay for 
assistance with in vivo procedures, Dr Debbie Sawatzky for her expertise with 
models of murine pleurisy, Shonna Johnston for help with flow cytometry and 
confocal-microscopy, Dr. Paul Hartley for much of the fluorescent microscopy but in 
particular the beautiful 3-dimensional images of phagocytosed apoptotic cells, Aili 
Zhang for assistance with Real-Time PCR, Katherine Miles for help and advice with  
ELISA technology  and Dr Mohini Gray who first gave me access to NOD mice in 
Edinburgh. 
Special thanks are also due to Dr Susan Wong of Bristol University for 
introducing me to the NOD mouse, Professor Linda Wicker of Cambridge University 
for her invaluable insights and expertise with congenic NOD mice and Professor 
Jonathon Sherrat of  Herriot-Watt University for his mathematical insights. 
Finally this thesis could not have been completed without the support, 





I, Kristian Anthony Niels Houlberg, declare that this thesis was composed myself 
and the work contained herein is my own and was done by myself with the technical 
help of people I have acknowledged in the appropriate section, and this work has not 
















Table of Contents 
Abstract....................................................................................................................ii 
Dedication............................................................................................................... iv 
Acknowledgements .................................................................................................. v 
Declaration..............................................................................................................vi 
Table of Contents ...................................................................................................vii 
Index of Figures ....................................................................................................xiii 
Index of Tables ..................................................................................................... xvi 
Abbreviations........................................................................................................ xix 
 
Chapter 1. Introduction........................................................................................... 1 
 
1.1 DIABETES MELLITUS ................................................................................ 2 
1.2 THE NON-OBESE-DIABETIC MOUSE ....................................................... 3 
1.2.1 Background to the NOD mouse strain ...................................................... 4 
1.2.2 Diabetes susceptibility loci in NOD mice................................................. 7 
1.2.3 Is the NOD mouse a good model for human T1DM?.............................. 11 
1.2.4 The evidence for lymphocytes in the pathogenesis of autoimmune diabetes 
in NOD mice .................................................................................................. 13 
1.2.5 Evidence that M! are important in the pathogenesis of autoimmune 
diabetes in NOD mice..................................................................................... 13 
1.3 THE MACROPHAGE.................................................................................. 16 
1.3.1 Opposing M! actions explained by different M! Phenotypes................. 18 
1.3.2 Abnormalities in M! function apparent in NOD mice............................ 21 
1.4 PHAGOCYTOSIS........................................................................................ 23 
1.4.1 Receptors and ligands involved in phagocytosis..................................... 23 
1.4.2 Downstream signalling events................................................................ 26 
1.5 APOPTOSIS ................................................................................................ 31 
1.5.1 Apoptotic Pathways ............................................................................... 32 
1.5.2 Failure to clear AC contributes to autoimmunity .................................... 35 
1.6 IN VIVO MODELS OF INFLAMMATION.................................................. 37 
1.6.1 Key cells involved in peritoneal and pleural inflammation ..................... 38 
1.6.2 Cytokines............................................................................................... 43 
1.6.3 Chemokines ........................................................................................... 45 
1.6.4 Additional inflammatory mediators........................................................ 48 
1.6.5 TG peritonitis......................................................................................... 50 
1.6.6 CG pleurisy............................................................................................ 50 
1.6.7 Delayed Type Hypersensitivity Pleurisy................................................. 51 
 
 viii 
1.7 AIMS OF THE STUDY ............................................................................... 54 
 
Chapter 2. Methods ............................................................................................... 55 
 
2.1 EXPERIMENTAL ANIMALS..................................................................... 56 
2.1.1 Non Obese Diabetic Mice ...................................................................... 56 
2.1.2 C57BL/6 Mice ....................................................................................... 56 
2.1.3 NOD.H2I
7 
Congenic Mice ..................................................................... 56 
2.1.4 NOD.R320, NOD.R20, NOD.1591 and NOD.R905 Congenic Strains.... 56 
2.2 CELLS ......................................................................................................... 57 
2.2.1 Resident Peritoneal Macrophages........................................................... 57 
2.2.2 RESIDENT PLEURAL MACROPHAGES ........................................... 58 
2.2.3 Bone Marrow Derived Macrophages...................................................... 60 
2.2.4 Apoptotic Cells ...................................................................................... 64 
2.2.5 Pneumococci.......................................................................................... 69 
2.3 IN VITRO PHAGOCTOSIS ASSAYS .......................................................... 69 
2.3.1 In vitro phagocytosis assay using microscopic analysis .......................... 69 
2.3.2 In vitro phagocytosis assay using flow cytometric analysis .................... 75 
2.4 IN VIVO PHAGOCYTOSIS ASSAY............................................................ 79 
2.4.1 Performing the in vivo phagocytosis assay ............................................. 79 
2.4.2 Analysis of the in vivo phagocytosis assay following injection of apoptotic 
cells ................................................................................................................ 80 
2.4.3 Analysis of the in vivo phagocytosis assay with beads............................ 87 
2.4.4 Rationale for excluding samples from analysis....................................... 89 
2.5 MEASURING MESSENGER RNA LEVELS WITHIN MACROPHAGES...... 93 
2.5.1 Exracting mRNA using Trizol................................................................ 93 
2.5.2 Reverse Transcription and Real Time PCR ............................................ 94 
2.5.3 Data Analysis......................................................................................... 94 
2.6 MEASURING CELL SURFACE EXPRESSION OF PROTEINS.............. 100 
2.7 MEASURING IN VITRO PRODUCTION OF CHEMOKINES AND 
CYTOKINES................................................................................................... 103 
2.8 IN VIVO MODELS OF INFLAMMATION................................................ 104 
2.8.1 Thioglycollate peritonitis ..................................................................... 104 
2.8.2 Carageenan pleurisy............................................................................. 114 
2.8.3 Delayed-Type Hypersensitivity Pleurisy .............................................. 119 
 
 ix 
2.9 ANALYSIS OF CIRCULATING LEUKOCYTES..................................... 121 
2.10 STATISTICAL ANALYSIS..................................................................... 124 
 
 
Chapter 3. NOD Macrophages Exhibit Reduced Phagocytic Clearance In Vitro
............................................................................................................................. 125 
 
3.1 INTRODUCTION...................................................................................... 126 
3.2 RESULTS .................................................................................................. 127 
3.2.1 NOD and H-2
i7 
PM! demonstrate reduced phagocytic clearance of AC and 
latex beads in vitro........................................................................................ 127 
3.2.2 NOD M! in vitro do not exhibit reduced clearance of opsonised 
pneumococci ................................................................................................ 129 
3.2.3 Both BMDM! and PM! from 15-week-old female NOD mice exhibit a 
marked in vitro phagocytic defect for AC ..................................................... 132 
3.2.4 The phagocytic defect for AC is clearly apparent with both 30 and 60 
minute feed times ......................................................................................... 134 
3.3 SUMMARY ............................................................................................... 136 
 
Chapter 4. NOD Macrophages Exhibit Reduced Phagocytic Clearance of 
Apoptotic Cells In Vivo ...................................................................................... 137 
 
4.1 INTRODUCTION...................................................................................... 138 
4.2 RESULTS .................................................................................................. 139 
4.2.1 Similar numbers of AC are recovered from NOD and C57BL/6 mice, 
despite increased numbers of resident PM! present in the peritonea of NOD 
mice ............................................................................................................. 139 
4.2.2 Adjusting clearance of free AC for numbers of resident PM! unmasks a 
marked in vivo phagocytic defect within NOD mice ..................................... 140 
4.2.3 Relating the numbers of free AC recovered to the numbers of resident 
PM! recovered at each time point................................................................. 145 
4.2.4 NOD mice exhibit reduced in vivo phagocytosis of beads..................... 146 




Chapter 5. The in vivo phagocytic defect of NOD mice localises to idd18 & Vav3
............................................................................................................................. 151 
 
5.1 INTRODUCTION...................................................................................... 152 
5.2 RESULTS .................................................................................................. 153 
5.2.1 No consistent differences were identified between NOD and C57BL/6 M! 
in the production of mRNA for several key phagocytic receptors.................. 153 
5.2.2 No real differences were identified between NOD and C57BL/6 PM! in 
the surface expression of several key phagocytic receptors ........................... 157 
5.2.3 Using congenic NOD strains, the in vivo phagocytic defect is localised 
first to idd 3/10/18 and subsequently to idd 18.............................................. 164 
5.3 SUMMARY ............................................................................................... 174 
 
Chapter 6. In vitro analysis of the inflammatory phenotype of NOD macrophages
............................................................................................................................. 175 
 
6.1 INTRODUCTION...................................................................................... 176 
6.2 RESULTS: BMDM! .................................................................................. 177 
6.2.1 BMDM! derived from NOD and C57BL/6 mice are comparable......... 177 
6.2.2 NOD BMDM! exhibit a marked hyper-inflammatory response ........... 180 
6.3 RESULTS: RESIDENT PLM!................................................................... 192 
6.3.1 NOD PLM! are strikingly hypo-responsive compared to C57BL/6 PLM!
..................................................................................................................... 192 
6.4 RESULTS: RESIDENT PM! ..................................................................... 202 
6.4.1 NOD PM! are hypo-responsive compared to C57BL/6........................ 202 
6.4.2 NOD PM! are hyporesponsive compared to C57BL/6 PM! ................ 210 
6.5 SUMMARY ............................................................................................... 216 
 
Chapter 7. Analysis of the NOD inflammatory response in vivo........................ 217 
 
7.1 INTRODUCTION...................................................................................... 218 
7.2 THIOGLYCOLLATE PERITONITIS ........................................................ 218 
7.2.1 NOD mice recruit fewer leukocytes in thioglycollate peritonitis........... 219 




7.2.3 NOD and C57BL/6 mice exhibit comparable levels of chemokines and 
cytokines ...................................................................................................... 227 
7.2.4 Defective recruitment of leukocytes did not localise to idd18............... 227 
7.3 CARRAGEENAN PLEURISY................................................................... 231 
7.3.1 Male NOD mice exhibit reduced leukocyte recruitment during CG 
pleurisy......................................................................................................... 231 
7.3.2 Female NOD mice exhibit reduced recruitment of M! and PMN 24 hours 
after initiation of CG pleurisy ....................................................................... 232 
7.3.3 NOD mice produce significantly less MCP-1 during CG pleurisy ........ 233 
7.4 CIRCULATING LEUKOCYTES............................................................... 242 
7.4.1 Circulating leukocyte numbers are comparable between NOD and 
C57BL/6 mice .............................................................................................. 242 
7.5 DELAYED-TYPE HYPERSENSITIVITY MODEL OF PLEURISY......... 245 
7.5.1 NOD mice exhibit a vigorous inflammatory response during DTH pleurisy
..................................................................................................................... 245 
7.6 SUMMARY ............................................................................................... 249 
 
Chapter 8. Discussion .......................................................................................... 250 
 
8.1 M! FROM NOD MICE EXHIBIT DEFECTIVE PHAGOCYTOSIS ......... 251 
8.1.1 NOD mice exhibit a phagocytic defect for apoptotic cells and latex beads 
but not IgG opsonised pneumococci in vitro ................................................. 251 
8.1.2 NOD mice exhibit a phagocytic defect for apoptotic cells and latex beads 
in vivo........................................................................................................... 252 
8.1.3 The mechanism underlying the phagocytic defect appears consistent with 
dysfunction of the Vav3 gene........................................................................ 253 
8.1.4 Further work ........................................................................................ 256 
8.2 BMDM! AND RESIDENT M! FROM NOD MICE EXHIBIT DIVERGENT 
PHENOTYPES IN VITRO................................................................................ 257 
8.2.1 Further work ........................................................................................ 258 
8.3 NOD MICE EXHIBIT DEFECTIVE RECRUITMENT OF LEUKOCYTES 
IN M!-DEPENDENT MODELS OF INFLAMMATION ................................ 259 
8.3.1 NOD mice recruit fewer leukocytes to TG peritonitis........................... 259 
8.3.2 NOD mice recruit fewer leukocytes to CG pleurisy.............................. 261 
8.3.3 NOD mice exhibit a vigorous inflammatory response to DTH pleurisy 261 
 
 xii 
8.4 POTENTIAL MECHANISMS FOR IMPAIRED LEUKOCYTE 
RECRUITMENT IN TG PERITONITIS AND CG PLEURISY ....................... 262 
8.4.1 Chemokine and cytokine levels............................................................ 262 
8.4.2 Migratory capabilities of NOD leukocytes ........................................... 263 
8.4.3 Circulating numbers of NOD leukocytes.............................................. 264 
8.4.4 Complement component C5a ............................................................... 265 
8.4.5 Further work ........................................................................................ 267 






Index of Figures 
 
Figure 1- 1 Schematic diagram contrasting and comparing the functions of 
 classically and alternatively activated M!. ...................................... 20 
Figure 1- 2 Schematic diagram showing the activation / deactivation of the Rho 
 family of small GTPases ................................................................. 29 
Figure 1- 3 Schematic diagram of the down-stream phagocytic signaling events 30 
Figure 1- 4 Schematic diagram of apoptotic pathways ....................................... 34 
Figure 1- 5 Complement Pathways .................................................................... 49 
Figure 1- 6 Delayed-Type Hypersensitivity Pleurisy.......................................... 53 
Figure 2- 1 Analysis of resident peritoneal macrophages purified by adhesion... 59 
Figure 2- 2 Photomicrographs of typical cytospins of day 7 BMDM! ............... 62 
Figure 2- 3 Flow cytometric analysis of BMDM! ............................................. 63 
Figure 2- 4 Assessing the proportion of pyknotic nuclei by Hoescht 33342 ....... 67 
Figure 2- 5 Flow cytometric analysis of apoptotic thymocytes........................... 68 
Figure 2- 6 Photomicrographs of PM! and AC in the process of phagocytosis .. 72 
Figure 2- 7 Three dimensional analysis of PM! following interaction with AC . 73 
Figure 2- 8 Setting up gates to assess phagocytosis............................................ 77 
Figure 2- 9 Calculation of the percentage of M! exhibiting phagocytosis by flow 
 cytometry........................................................................................ 78 
Figure 2- 10 Cytospin analysis of peritoneal M! following an ip injection of 
 apoptotic cells ................................................................................. 81 
Figure 2- 11 Counting and gating out Flowcheck™ beads by flow cytometry...... 85 
Figure 2- 12 Flow cytometric analysis of lavage fluid following an ip injection of 
 AC .................................................................................................. 86 
Figure 2- 13 Flow cytometric analysis of lavage fluid following an injection of l
 atex beads ....................................................................................... 88 
Figure 2- 14 No evidence of apoptotic cells in lavage fluid.................................. 90 
Figure 2- 15 Heavily blood stained lavage fluid................................................... 90 
Figure 2- 16 Using analysis of lymphocyte numbers to assess partial loss of pellet..
 ........................................................................................................ 91 
Figure 2- 17 Inexplicable smears......................................................................... 92 
Figure 2- 18 Schematic diagram of Thioglycollate peritonitis studies ................ 107 
Figure 2- 19 Forward and side scatter plots of peritoneal cells during TG peritonitis
 ...................................................................................................... 109 
 
 xiv 
Figure 2- 20 Analysis of M! and neutrophil kinetics during TG peritonitis ....... 110 
Figure 2- 21 Analysis of B and T lymphocyte numbers during TG peritonitis.... 111 
Figure 2- 22 Forward and side scatter profiles of leukocytes during TG peritonitis..
 ...................................................................................................... 112 
Figure 2- 23 Analysis of M! and neutrophil kinetics during TG peritonitis ....... 113 
Figure 2- 24 Schematic diagram of Carrageenan pleurisy .................................. 116 
Figure 2- 25 Analysis of leukocytes recruited to CG pleurisy ............................ 117 
Figure 2- 26 Analysis of dendritic cells in CG pleurisy...................................... 118 
Figure 2- 27 Schematic diagram of Delayed Hypersensitivity pleurisy .............. 120 
Figure 2- 28 Analysis of circulating monocytes and PMN ................................. 122 
Figure 2- 29 Analysis of circulating lymphocytes.............................................. 123 
Figure 3- 1 Analysis of phagocytosis of AC and 3µm latex beads in vitro........ 128 
Figure 3- 2 Analysis of in vitro phagocytosis of opsonised pneumococci......... 131 
Figure 3- 3 Analysis of in vitro phagocytosis by PM! from 15 week old NOD 
 mice and BMDM! from the same mice......................................... 133 
Figure 3- 4 Analysis of the effect of incubation time on in vitro phagocytosis . 135 
Figure 4- 1 Analysis of free AC and PM! numbers recovered ......................... 141 
Figure 4- 2 Analysis of AC phagocytosis, adjusted for baseline numbers of PM!..
 ...................................................................................................... 143 
Figure 4- 3   Analysis of in vivo phagocytosis following ip administration of  
  10 x 10
6
 AC………………………………………………………...144 
Figure 4- 4 Explanation of the meaning behind constant k3.............................. 147 
Figure 4- 5 Illustrations of the ‘best fit’ lines used to analyse experimental data ....
 ...................................................................................................... 148 
Figure 4- 6 NOD mice exhibit defective clearance of latex beads in vivo ......... 149 
Figure 5- 1 mRNA expression by NOD and C57BL/6 BMDM!...................... 155 
Figure 5- 2 mRNA production by NOD and C57BL/6 PM! ............................ 156 
Figure 5- 3 Representative histograms of CD14 expression of PM! ................ 159 
Figure 5- 4 Representative histograms of CD36 expression of PM! ................ 160 
Figure 5- 5 Representative histograms of SRA expression of PM! .................. 161 
Figure 5- 6 Representative histograms of CD61 expression of by PM! ........... 162 
Figure 5- 7 Representative histograms of CD51 expression of PM! ................ 163 
Figure 5- 8 Analysis of the numbers of resident PM! recovered...................... 167 
Figure 5- 9 Analysis of AC numbers recovered by different strains of mice..... 168 
Figure 5- 10 Analysis of AC clearance by different strains of mice.................... 169 
 
 xv 
Figure 5- 11 Analysis of resident PM! numbers recovered................................ 171 
Figure 5- 12 Analysis of AC numbers recovered by different strains of mice..... 172 
Figure 5- 13 Analysis of AC clearance by different strains of mice.................... 173 
 
Figure 6- 1 M! derived from the bone marrow of NOD and C57BL/6 mice 
 exhibit comparable surface expression of macrophage markers ..... 179 
Figure 6- 2 Chemokine levels produced by BMDM! stimulated with LPS ...... 185 
Figure 6- 3 Cytokine levels produced by BMDM! stimulated with LPS.......... 186 
Figure 6- 4 Chemokine levels produced by BMDM! stimulated with CG ....... 188 
Figure 6- 5 Cytokine levels produced by BMDM! stimulated with CG........... 189 
Figure 6- 6 Chemokine levels produced by BMDM! stimulated with TG........ 190 
Figure 6- 7 Cytokine levels produced by BMDM! stimulated with TG ........... 191 
Figure 6- 8 Chemokine levels produced by PLM! after 4 hours stimulation with 
 LPS............................................................................................... 197 
Figure 6- 9 Cytokine levels produced by PLM! after 4 hours stimulation with 
 LPS............................................................................................... 198 
Figure 6- 10 Chemokine levels produced by PLM! after 4 hours stimulation with 
 CG ................................................................................................ 199 
Figure 6- 11 Cytokine levels produced by PLM! after 4 hours stimulation with CG
 ...................................................................................................... 200 
Figure 6- 12 Chemokine production by PM! after 24 hours of LPS stimulation 208 
Figure 6- 13 Cytokine production by PM! after 24 hours of LPS stimulation.... 209 
Figure 6- 14 Chemokine production by PM! after 4 hours of LPS stimulation .. 212 
Figure 6- 15 Cytokine production by PM! after 4 hours of LPS stimulation...... 213 
Figure 6- 16 Chemokine production by PM! after 4 hours of TG stimulation.... 214 
Figure 6- 17 Cytokine production by PM! after 4 hours of TG stimulation ....... 215 
Figure 7- 1 NOD mice recruit fewer leukocytes during thioglycollate peritonitis ...
 ...................................................................................................... 220 
Figure 7- 2 NOD mice recruit fewer lymphocytes during thioglycollate peritonitis
 ...................................................................................................... 221 
Figure 7- 3 Analysis of leukocyte numbers during TG peritonitis .................... 223 
Figure 7- 4 Comparable leukocyte infiltration at 24 hours in male administered 
 1ml of 3% TG and female mice administered 0.5ml of 10% TG.... 224 
Figure 7- 5 Analysis of infiltrating monocytes/macrophages and mature 
 macrophages during the first 24 hours of TG peritonitis. ............... 225 
 
 xvi 
Figure 7- 6 Analysis of PMN recruitment during TG peritonitis ...................... 226 
Figure 7- 7 Analysis of chemokine and cytokine levels during TG peritonitis.. 229 
Figure 7- 8 Analysis of leukocyte numbers 24 hours after the initiation of TG 
 peritonitis in C57BL/6, NOD and 4 congenic strains of NOD mice 
 ...................................................................................................... 230 
Figure 7- 9 Analysis of volumes of recovered pleural lavage fluid................... 235 
Figure 7- 10 Analysis of leukocyte numbers in CG pleurisy .............................. 236 
Figure 7- 11 Analysis of DC numbers and comparison to M! numbers in CG 
 pleurisy ......................................................................................... 237 
Figure 7- 12 Analysis of leukocyte numbers in CG pleurisy in female mice at 24 
 hours ............................................................................................. 238 
Figure 7- 13 Analysis of MCP-1 levels during CG pleurisy ............................... 239 
Figure 7- 14 Analysis of KC levels during CG pleurisy ..................................... 240 
Figure 7- 15 Analysis of circulating monocytes numbers................................... 243 
Figure 7- 16 Analysis of circulating PMN numbers per ml of whole blood........ 244 
Figure 7- 17 Analysis of pleural lavage volumes during DTH pleurisy .............. 247 




 Index of Tables 
Table 1- 1 Autoimmune conditions to which NOD mice are prone..................... 6 
Table 1- 2 idd loci and candidate genes.............................................................. 8 
Table 1- 3 Comparison of clinical features present at the onset of autoimmune 
 diabetes in humans and NOD mice.................................................. 12 
Table 1- 4 Stages of insulitis observed in NOD or BALB/c pancreata as 
 described by Annemarie Jansen (Jansen et al., 1994). ...................... 15 
Table 1- 5 Receptors and molecules implicated in phagocytosis of AC ............ 25 
Table 1- 6  Properties of selected CXC chemokines ......................................... 46 
Table 1- 7  Properties of selected CC chemokines ............................................. 47 
Table 2- 1 Reagents and quantities used for Reverse Transcription PCR .......... 96 
Table 2- 2 Temperatures and times used for Reverse Transcription .................. 97 
Table 2- 3 Reagents and volumes used for Real Time PCR .............................. 98 
Table 2- 4 Times and temperatures used for Real Time PCR............................ 99 
Table 2- 5 List of antibodies used to target surface proteins involved in 
 phagocytosis ................................................................................. 102 
Table 2- 6 Monoclonal antibodies and isotypes used for flow cytometric analysis 
 of leukocytes................................................................................. 108 
Table 5- 1 Summary of NOD congenic strains used and the presence or absence 
 of an apoptotic cell phagocytosis defect......................................... 166 
Table 6- 1 Chemokine and cytokine production by quiescent non-activated 
 BMDM! after 24 hours................................................................. 182 
Table 6- 2 Negligible interferon " production by BMDM! stimulated with either 
 LPS, CG or TG ............................................................................. 183 
Table 6- 3 Chemokine and cytokine production by stimulated BMDM! after 1 
 hour .............................................................................................. 184 
Table 6- 4 Chemokine and cytokine levels produced by quiescent PLM! after 24 
 hours ............................................................................................. 194 
Table 6- 5 Negligible amount of interferon " levels are produced by PLM! ... 195 
Table 6- 6 Chemokine and cytokine production by PLM! after 1 hour of 
 stimulation .................................................................................... 196 
Table 6- 7 Chemokine and cytokine levels produced by PLM! after 24 hours 
 stimulation .................................................................................... 201 
Table 6- 8 Chemokine and cytokine levels produced by quiescent PM! after 24 
 hours ............................................................................................. 203 
 
 xviii 
Table 6- 9 Negligible interferon " levels produced by PM!............................ 205 
Table 6- 10 Chemokine and cytokine production by PM! after 24 hours TG 
 stimulation .................................................................................... 206 
Table 6- 11 Chemokine and cytokine production by PM! after 1 or 4 hours LPS 
 stimulation .................................................................................... 207 
Table 6- 12 Chemokine and cytokine production by quiescent PM! ................ 211 
Table 7- 1 Analysis of cytokine and chemokine levels 24 hours after initiation of 





% : percentage 
°C  : degrees Celsius 
7-AAD : 7 aminoactinomycin 
AC : apoptotic cell 
AGE : advanced glycation end-products 
AIF : apoptosis inducing factor 
ANOVA : analysis of variance 
Apaf-1 : apoptosis protease activating factor 1 
APC : allophycocyanin  
BB : bio-breeding 
BMDM! : bone marrow derived macrophage 
CBA : cytometric bead array 
CD40L : CD40 ligand 
CG : carrageenan 
CO2  : carbon dioxide 
CR : complement receptor 
CSF-1 : colony stimulating factor 1 
ctla-4 : cytotoxic T lymphocyte-associated antigen 4 
DC : dendritic cell 
DIABLO : 
direct inhibitor of apoptosis binding protein with a low isoelectric 
point 
DMEM/F12  : dulbecco’s modified eagle medium with F12  
DTH : delayed type hypersensitivity 
ELISA : enzyme linked immuno sorbant assay 
FACS : fluorescence-activated cell sorter 
FasL : fas ligand 
FBS : foetal bovine serum 
FcR : Fc receptor 
FITC : fluorescein isothiocyanate 
GAD : glutamic acid decarboxylase 
GEF : guanidine exchange factors 
H2O2 : hydrogen peroxide 
HBSS : hanks balanced salt solution  
HSP-60 : heat shock protein 60 
ip : intraperitoneally 
ipl : intrapleurally 
IA-2 : insulinoma associated protein 2 
IAP : inhibitor of apoptosis protein 
idd : insulin dependent diabetes  
IFN" : interferon gamma 
Ig : immunoglobulin  
IGIF : IFN! inducing factor 
IL : interleukin 
 
 xx 
iNOS : inducible nitric oxide synthase 
ITAM : immunoreceptor tyrosine-based activation motif 
KC : keratinocyte chemoattractant 
KO : knockout 
LPS : lipopolysaccharide 
MCP-1 : monocyte chemoattractant protein l 
MEGF : multiple epidermal growth factor-like domains 
MDR : M! disappearance reaction 
M# : macrophage 
MHC : major histocompatibility complex  
MIP-1$ : M#-inflammatory protein 1 alpha  
MIP-2 : M#-inflammatory protein 2  
MODY : maturity onset diabetes of the young 
NHS : National Health Service 
NK : natural killer 
NO : nitric oxide 
NOD : non-obese diabetic 
NON : non-obese non-diabetic 
O2- : superoxide anion 
PBS : phosphate buffered saline without calcium and magnesium 
pdcd-1 : programmed cell death 1 
PE : phycoerythrin 
PLM! : pleural M! 
PMN : polymorphonuclear cell  (or neutrophil) 
PM" : peritoneal M! 
PS : phosphatidylserine 
RAGE : AGE receptor  
RANTES : regulated upon activation normal T cell expressed and secreted 
rbc : red blood cells 
RPMI : Roswell Park Memorial Institute 1640 media 
SLE : systemic lupus erythematosis  
smac : second mitochondria-derived activator of caspase 
SRA : scavenger receptor A 
SREC : scavenger receptor expressed by endothelial cells 
T1DM : type 1 diabetes mellitus 
T2DM : type 2 diabetes mellitus 
Tc  : cytotoxic T cell 
TCR : T cell receptor 
TG : thioglycollate 
TGF-% : transforming growth factor beta  
Th : T helper cells 
TLR : toll like receptor 
TNF$ : tumour necrosis factor alpha  
TNFR : tumour necrosis factor receptor  
Treg : regulatory T cells 
TSP : thrombospondin 
 
 xxi 
WHO : World Health Organisation 
























Chapter 1. Introduction 




1.1 DIABETES MELLITUS 
Diabetes mellitus is a complex metabolic disease characterised by elevated blood 
glucose levels. It continues to be defined by the World Health Organisation (WHO) 
as a fasting plasma glucose level greater than 7.0mmol/l or plasma glucose of greater 
than 11.0mmol/l, 2 hours after a glucose load (WHO, 2006). Type 1 diabetes mellitus 
(T1DM) results from autoimmune destruction of the insulin producing # cells in the 
islets of Langerhan within the pancreas and invariably requires treatment with daily 
injections of insulin. Type 2 diabetes mellitus (T2DM) is a syndrome resulting from 
a variable combination of increased peripheral insulin resistance (primarily in the 
liver, muscle and adipose tissue) and a relative lack of insulin secretion. T2DM is 
usually managed by a combination of diet, oral hypoglycaemic agents and sometimes 
insulin. Together T1DM and T2DM account for the vast majority of cases of 
diabetes mellitus although additional, rarer classifications exist such as gestational 
diabetes when hormones produced during pregnancy reduce a woman's sensitivity to 
insulin or Maturity Onset Diabetes of the Young (MODY) used to describe 
dominantly inherited, monogenic defects of insulin secretion, excluding T2DM, 
occurring at any age, (Fajans et al., 2001) . 
Around 1.3 million people in England are known to have diabetes, of which T1DM 
accounts for approximately 15% (DoH, 2001); while T2DM accounts for most of the 
remaining 85% of diabetic patients. The incidence of diabetes mellitus is increasing 
globally with projections suggesting that 366 million people will be affected by 2030 
compared with 171 million in the year 2000 (Wild et al., 2004); Indeed it is estimated 
that 3 million people will be affected by the year 2010 within the UK (Amos et al., 
1997). The current estimated prevalence of T1DM in the UK is one per 700 to 1,000 
children, yielding a total population with T1DM aged under 25 years in the UK of 
approximately 25,000 (DoH, 2007). Whilst increased obesity and decreased physical 
activity can explain the increased incidence of T2DM, the factors underlying the 3 to 
4% increased incidence in T1DM witnessed across Europe (Eurodiab, 2000), 
including the UK (Gardner et al., 1997) and especially in young children, are poorly 
understood. 
Diabetes mellitus carries an enormous cost: morbidity to the patient and financial to 
the Nation Health Service (NHS). The risks to diabetics from coronary heart disease 
and stroke are up to 5 and 3 times higher than in the general population respectively.  




It is the leading cause of blindness in people under the age of 60 and the largest 
single cause of end stage renal failure. Excluding accidents, diabetes is the biggest 
cause of lower limb amputation. The life expectancy of UK patients with T1DM is 
reduced by 20 years compared to the general population whilst those with T2DM 
suffer a 10 year reduction in life expectancy. It is estimated that the treatment of 
people with diabetes mellitus accounts at least 5% of the total NHS budget and 10% 
of hospital in-patient resources. In addition, 1 in 20 diabetic patients require care 
from the social services because of disability (DoH, 2001).  
Although the management and treatment of T1DM has improved immeasurably in 
the last 100 years, from a rapidly fatal condition to a treatable disease, clearly the 
burden on patients and the health service remains tremendous. Unsurprisingly 
therefore, research into diabetes was the subject of a major review by the Department 
of Health in October 2002 to focus future areas of research. It was understood that 
“genetic and immunological contributions have been identified in part” but further 
work on the factors underlying the aetiology of diabetes was warranted, in particular 
“characterisation of the genes involved, environmental triggers and immunological 
events” (DoH, 2002). 
 
1.2 THE NON-OBESE-DIABETIC MOUSE 
It is generally recognised that T1DM is an autoimmune disease with a protracted and 
unpredictable onset. Whilst the appearance of autoantibodies carries a high 
prognostic value, they can predate the onset of symptoms by several years and do not 
exactly predict whether or when disease will occur. The pancreas is a difficult organ 
to study in humans, as it is difficult to image and not amenable to biopsy. 
Experimental animal models are tools that enable researchers to study the aetiology 
and pathogenesis of complex diseases and interventions in vivo and in vitro, in ways 
not possible in humans. They do however remain an approximation of the human 
disease and insights gained from animal models ultimately have to be tested against 
the human condition.  
The Non-Obese Diabetic (NOD) mouse is one model of spontaneous autoimmune 
diabetes whilst another model in common usage is the BioBreeding (BB) rat 
(Nakhooda et al., 1978). Since its introduction the NOD mouse has become the pre-
eminent model due to its better defined genome, increased availability of monoclonal 




reagents and lower maintenance costs (Atkinson and Leiter, 1999). Streptozotocin 
has been used for over 30 years to induce diabetes in rodents (Katsilambros et al., 
1970). Although Streptozotocin provides useful insights into the effects of diabetes 
and is not limited to specific genetic backgrounds, Streptozotocin induced diabetes 
has limited value to those studying the aetiology of T1DM. Lastly Zucker rats (Stern 
et al., 1972) and db db mice (Hummel et al., 1966) have been used extensively as 
spontaneous models for T2DM.  
 
1.2.1 Background to the NOD mouse strain 
Makino and colleagues were developing a strain of cataract-prone mice from the 
outbred Jcl:ICR line when they recognised an individual female mouse developed 
classic signs of diabetes mellitus (Makino et al., 1980). Breeding pairs were formed 
from her offspring and selection performed on the basis of spontaneous diabetes and 
reproductive ability. The NOD and non-obese non-diabetic (NON) strains were 
formed 6 generations later. 
From the outset a strong sex bias in the incidence of diabetes was reported: 80 per 
cent in females and less than 20% in males (Makino et al., 1980). The reported 
incidence subsequently has varied greatly between institutions, from 60 to 80% in 
females and 20 to 30 % in males (Kikutani and Makino, 1992). Castration of mice up 
to the age of 7 weeks increases the incidence of diabetes among male mice and 
decreases the incidence seen among female mice (Lampeter et al., 1989). Perhaps 
unsurprisingly, the incidence is highest when mice are kept in the strictest germ-free 
conditions (Bach, 2005). 
Because of extensive in-breeding there is an assumption that all NOD mice, in 
various colonies around the world, are genetically identical. In must be remembered 
however that NOD mice were taken out of Japan at different time points in the 1980s 
(relatively early in the evolution of the strain) and used to establish individual 
colonies with little (or no) subsequent inter-breeding between them. The NOD mice 
colonies held by Merck (USA) and Charles River (France) separated with 
approximately 30 back-cross generations between them in the 1980s and it is likely 
that subtle differences exist between various NOD colonies (personal 
communication, Linda Wicker). 




From as young as 3 weeks old, both male and female NOD mice start to develop 
mononuclear immune cell infiltrates around the islets of Langerhans in the pancreas 
(peri-insulitis). In both sexes, these infiltrates expand and start to invade the islets 
(insulitis) such that by 10 weeks of age severe insulitis is almost a universal finding 
of NOD mice with diabetes typically developing after 12 weeks of age if it is to 
occur (Anderson and Bluestone, 2005). It has therefore been argued (Andre et al., 
1996) that autoimmune diabetes in the NOD mouse requires the breakdown of at 
least 2 checkpoints against autoimmunity. The first checkpoint is the initiation of 
insulitis which is seen in virtually all NOD mice (completely penetrant) and the 
second is the progression to overt diabetes which does not occur in the majority of 
male mice (incompletely penetrant).  
The nature of the inflammatory cell infiltrate comprising the insulitis has been 
extensively investigated for over 25 years. Early reports and descriptions 
concentrated on the lymphocytic component (Miyazaki et al., 1985) and although 
CD4
+
 T cells comprise the majority of the leukocytes, CD8
+
 T cells, NK cells, B 
cells, dendritic cells (DC) and macrophages (M!) are also clearly apparent 
(Anderson and Bluestone, 2005).  
In addition to the organ-specific autoimmune disease of diabetes mellitus, NOD mice 
are also prone to a range of other autoimmune diseases (table 1.1), suggesting a 
genetic background that is generally ‘autoimmune-permissive’. 





Autoimmune Disease Comment Reference 
Coombes-positive 
Haemolytic Anaemia 
Spontaneous                                
Mice > 200 days                         
Diabetic > non-diabetic 
(Baxter et al., 1991) 
Thyroiditis similar to 
Hashimoto’s thyroiditis 
Experimentally induced                    
Mice > 4 months 
(Many et al., 1996) 
Sialitis similar to 
Sjogren’s  Syndrome 
Spontaneous                                      
Mice > 4 months old 




Spontaneous                                     
Mice > 20 weeks old 
(Salomon et al., 
2001) 
Autoimmune Prostatitis 
Experimentally induced:   
particularly aggressive                     
Young male mice 




Experimentally induced  by iv 
BCG (Prevents autoimmune 
diabetes in young mice) 
(Silveira and Baxter, 
2001) 
Table 1- 1 Autoimmune conditions to which NOD mice are prone 
* Chronic Inflammatory Demyelinating Polyneuropathy 




1.2.2 Diabetes susceptibility loci in NOD mice 
Although insulitis is almost universal amongst NOD mice, as mentioned above, 
autoimmune diabetes is not. The relevant parts of the NOD genome that contribute to 
diabetes susceptibility or protection have been the focus of research groups for 
almost 30 years. Genetic linkage studies have identified 21 different chromosomal 
loci contributing to disease susceptibility (insulin dependent diabetes [idd] loci 1 
through to 21) to date.  
Congenic NOD strains have been formed whereby genetic material from non-
autoimmune-prone strains has been substituted for the various idd loci. These 
substitute genes are frequently derived from either C57BL/6 or C57BL/10 mice. As 
techniques have become increasingly refined, it has become possible to generate 
congenic NOD strains with ever smaller chromosomal segments replaced, thus 
tightening the resolution of the various idd loci to fewer and fewer candidate genes. 
Consequently, what was originally considered a single idd locus has often been 
subdivided into 2 or 3 distinct regions, each containing a few putative susceptibility 
genes. For example idd 5 has been split into idd 5.1 and idd 5.2.  
Although several loci have had the putative gene(s) narrowed down to a select few, 
in only one or 2 instances have the genes responsible for particular loci been 
positively identified. The few examples include idd 1, the Major Histocompatibility 
Complex (MHC) Class II haplotype, idd 5.1 which has been confirmed as the T cell 
regulatory gene, Cytotoxic T Lymphocyte-associated Antigen 4  (ctla-4) and idd 3 
which has been identified as the interleukin (IL) 2 gene. Table 1.2 summarises the 
current understanding regarding the different idd loci, however the list is under 
constant revision.  
 







Chromosome Putative genes or phenotype References 
1 17 
MHC class II haplotype (H2
g7
) 
essential for the development of 
diabetes 
(Wicker et al., 
1995) 
2 9 
Interferon-" Inducing Factor 
(IGIF) 
(Rothe et al., 
1997) 
3 3 Interleukin 2 (IL-2) 
(Podolin et al., 
2000) 
4 11 Interleukin 12 (IL-12) subunit p40 
(Simpson et al., 
2003) 
4 11 
Psmb6 (involved in peptide 
formation for class I expression in 
response to IFN") 
Pld2 (regulates phagocytosis) 
Cxcl16, Alox15, Alox12e, 
(Ivakine et al., 
2006) 
4.3 11 csf2 (GM-CSF gene) 








Nramp1 (an endosomal ion 
transporter) 
(Kissler et al., 
2006; Wicker et 
al., 2004) 
 
Table 1- 2 idd loci (1 to 5) and candidate genes 







Chromosome Putative genes or phenotype References 
6 6 
Toll-Like Receptor (TLR) 1 
 
Thymocyte resistance to apoptosis 
(Vallois et al., 
2007) 
 
(Bergman et al., 
2003) 
7 7 None reported 
(McAleer et al., 
1995) 
8 14 None reported 
(McAleer et al., 
1995) 
9.1 4 
8 candidate genes identified, none 
immunologically active  





(Lyons et al., 
2000) 
9.3 4 CD137 
Members 




(Lyons et al., 
2000) 
10 3 CD101 
(Penha-Goncalves 
et al., 2003) 
11 4 
Uncertain. 
 (May control B cell Marginal Zone 
enlargement) 
(Brodnicki et al., 




12 Unclear None reported  
 
Table 1- 2 idd loci (6 to 12) and candidate genes 







Chromosome Putative genes or phenotype References 
13 15 %2 microglobulin 
(Hamilton-
Williams et al., 
2001) 
14 13 None reported 
(Brodnicki et al., 
2003) 
15 5 None reported 
(McAleer et al., 
1995) 
16 17 MHC class 1 
(Pomerleau et al., 
2005) 
17 3 
May be involved in programmed 
cell death 1 (Pdcd-1) 
(Wang et al., 
2005) 
18 3 Vav3 
(Lyons et al., 
2001) 
19 6 
Interacts with idd 6 and 20 to 
regulate T suppressor activity 
(Morin et al., 
2006) 
20 6 
Interacts with idd 6 and 19 to 
regulate T suppressor activity 
(Morin et al., 
2006) 
21 18 None reported (Hall et al., 2003) 
 
Table 1.2 idd loci (13 to 21) and candidate genes  




1.2.3 Is the NOD mouse a good model for human T1DM? 
T1DM in humans is an extremely complex disease and results from a combination of 
environmental and genetic triggers. Although experimental animal models offer a 
way to dissect the relative importance of different aetiological influences, the data 
generated may only be interpretable in the context of the model. The clinical pattern 
of TIDM in humans and autoimmune diabetes in NOD mice share several features in 
common but there are also a few subtle differences (see table 1.3). 
Association mapping using DNA from large numbers of individuals with T1DM and 
available family cohorts have identified a few of the genes that confer disease 
susceptibility in humans. There appears to be a remarkable level of concordance 
between the genes relevant to human T1DM and diabetes in NOD mice (reviewed by 
Wicker et al., 2005).   
Class II loci within the MHC are without doubt the most important, with certain DR 
and DQ haplotypes conferring a relative risk of developing T1DM of between 3 and 
50 times that of the general population (Maier and Wicker, 2005) and this is 
analogous to the NOD idd 1. Strikingly, the NOD MHC class II molecule I-A 
contains a non-aspartic acid substitution at position 57 of the # chain that is also seen 
in the human MHC class II molecule DQ # chain where it confers susceptibility to 
T1DM (Acha-Orbea and McDevitt, 1987).  
As identified in NOD mice, non-MHC genes are now known to play a role in human 
T1DM and the promoter region of the insulin gene is important in humans. Although 
the same gene does not appear to have a NOD idd equivalent, perhaps because mice 
have 2 genes responsible for the production of insulin, there is accumulating 
evidence that insulin is an important autoantigen for autoimmune diabetes in NOD 
mice (reviewed by Maier and Wicker, 2005). The human gene CTLA4 encoding 2 
isoforms is analogous to the NOD idd 5.1. (table 1.2). The human gene PTPN22 
encoding the lymphoid protein tyrosine phosphatase has recently been confirmed to 
confer disease susceptibility in humans and the mouse orthologue ptpn8 appears to 
affect disease frequency in NOD mice (Wicker et al., 2005). There is increasing 
evidence that the IL-2 receptor $ chain is similarly relevant to both human (Vella et 
al., 2005) and NOD disease where it is the major candidate for idd 3. 
 




 Type 1 (autoimmune) Diabetes Mellitus 
 Human NOD mouse 
Weight loss Present Present 
Polydipsia Present Present 
Polyuria Present Present 
Hyperglycaemia > 15 mmol/l 20 – 30 mmol/l 
Ketoacidosis Common Less severe 
Serum insulin Very low Very low 
Outcome without insulin Lethal Lethal 
Sex preponderance Female % male Female >> male 
 
Table 1- 3 Comparison of clinical features present at the onset of autoimmune 
diabetes in humans and NOD mice  
(adapted from Lampeter et al., 1989) 




1.2.4 The evidence for lymphocytes in the pathogenesis of autoimmune 
diabetes in NOD mice 
Diabetes in the NOD mouse was once regarded almost as a disease exclusively of T 




 T cells reactive to islet 
antigens such as Glutamic Acid Decarboxylase (GAD), insulinoma associated 
protein 2 (IA-2) and Heat Shock Protein 60 (HSP-60) infiltrated pancreatic islets 
(reviewed by Lieberman and DiLorenzo, 2003). In addition, diabetes may be 
transferred by the adoptive transfer of either splenocytes (Wicker et al., 1986) or 
diabetogenic T cell clones (Haskins and Wegmann, 1996). Whilst CD4
+
 T cells were 
originally considered essential for the disease transference, Susan Wong 
demonstrated that CD8
+
 T cells could transfer diabetes in the absence of CD4
+
 cells 
(Wong et al., 1996).  






 regulatory T cell (Treg) dysfunction  
leading to a breakdown of peripheral tolerance and thus autoimmunity in NOD mice 
has generated considerable interest but there is no hard evidence to date (as reviewed 
by Anderson and Bluestone, 2005). Cyclophosphamide has been used experimentally 
to accelerate the onset of diabetes in NOD mice (Harada and Makino, 1984) and it is 
possible that it acts by selectively targeting the Treg cells (Brode et al., 2006). 
Furthermore, it has become clear that B cells as well as T cells are crucial for the 
development of autoimmunity in NOD mice. Whilst autoantibodies are a feature of 
autoimmune diabetes in NOD mice, it is thought the actions of B cells as antigen 
presenting cells are more important than antibody production (Tian et al., 2006). In 
addition, Natural Killer (NK) cell numbers and NK cell-mediated cytotoxicity are 
reduced in NOD mice compared to other strains with both phenotypes linked to 
diabetogenesis in NOD mice (Carnaud et al., 2001; Esteban et al., 2003).  
 
1.2.5 Evidence that M! are important in the pathogenesis of 
autoimmune diabetes in NOD mice 
Whilst lymphocytes are undoubtedly crucial to the development of autoimmunity 
within NOD mice (Anderson and Bluestone, 2005), increasing recognition has also 
been given to the role(s) played by the innate immune system and by M! in 
particular. 
Monocyte chemoattractant protein-1 (MCP-1), an important chemokine for recruiting 
monocytes, is expressed within the islets of pre-diabetic NOD mice (Chen et al., 




2001) and there is extensive evidence, both by flow cytometry (Jarpe et al., 1990) 
and immunohistochemicy (O'Reilly et al., 1991; Reddy et al., 1993) that M! 
predominate amongst the first immunological cells to surround and then infiltrate the 
islets. Annemarie Jansen working with Drexhage in Paris described the progression 
from peri-insulitis through to full-blown invasive insulitis very clearly (Jansen et al., 
1994) as summarised in table 1.4. 
The importance of M! in the pathogenesis of autoimmune diabetes in the NOD 
mouse was recognised at an early stage. Ki-Up Lee, having appreciated that M! were 
the predominant leukocytes in the early insulitis observed in BB rats, demonstrated 
that M! ablation by intraperitoneal injections of silica prevented the development of 
diabetes in NOD mice (Lee et al., 1988). More recent evidence suggests that DC and 
M! are essential for the retention of lymphocytes within the insulitis (Nikolic et al., 
2005) and Harry Georgiou working in Australia demonstrated that allogenic transfer 
of M! from CBA mice to new born NOD mice prevented disease progression 
(Georgiou et al., 1995). 
M! and DC are the first and predominant source of Tumor Necrosis Factor (TNF) $ 
within the pancreatic islets (Dahlen et al., 1998). In 1999 Shiva Reddy demonstrated 
the colocalisation of inducible nitric oxide synthase (iNOS) with M! within the 
pancreata of NOD mice (Reddy et al., 1999). Tiina Kipari in our group convincingly 
demonstrated the role of M!-derived iNOS to induce apoptosis of renal tubular 
epithelial cells in a murine model of renal inflammation (Kipari et al., 2006). Finally, 
Boris Calderon published evidence that M! were the key effectors of % cell death in 
the islets of Langerhan (Calderon et al., 2006). 
 











No Lymphocytic infiltration; all islets contained a few M! 




adjacent to islets) 
Numbers of M! in perivascular connective tissue doubled; no 
infiltration of islets. 




Accumulation of M! and DC; no infiltration of islets. 








 cells, some 
B cells in clusters. Few islets infiltrated by M!. 





Islets were completely surrounded by this stage 





Para-insular accumulation of leukocytes apparent but massive 
infiltration of islets with M!, DC, and many T and B cells 
Only apparent in > 17-week-old female NOD mice 
6 
End-stage 
No insulin producing cells remain 
Decreasing numbers of leukocytes 
Only apparent in > 17-week-old female NOD mice 
 
Table 1- 4 Stages of insulitis observed in NOD or BALB/c pancreata as described 
by Annemarie Jansen (Jansen et al., 1994). 




1.3 THE MACROPHAGE 
Before describing abnormalities in M! populations from NOD mice, it is worth 
exploring the often conflicting roles M! play within the initiation, maintenance and 
resolution of inflammation. 
The first description of ‘macrophagocytes’ came from the seminal work of 
Metchnikoff (1845 to 1916) who inserted rose thorns into starfish larvae and 
witnessed mesenchymal cells migrate into the wounds. He named the large cells 
macrophagocytes, later termed M! while the smaller ‘microphagocytes’ later became 
known as neutrophils or PMN (Segal, 2005).  
There is recent evidence that monocytes and PMNs originate from common 
precursor cells in the bone marrow with circulating monocytes later differentiating 
into either DC, resident tissue M! or inflammatory M! (Fogg et al., 2006). There has 
been increasing evidence for different subsets of monocytes in humans, differentiated 












 monocytes are more proinflammatory with respect to their cytokine and 
chemokine profiles; in vitro studies on whole blood stimulated with LPS have shown 
they are responsible for the majority of TNF$ (but almost no IL-10) production, 
despite relatively low numbers (Belge et al., 2002). CD16
+
 monocytes also exhibit 
higher potency in antigen presentation and adhere more strongly to activated 
endothelium. Their precise role in infection and inflammation remains unclear 
(reviewed by Ziegler-Heitbrock, 2007). 
A seminal paper by Frederic Geismann demonstrated 2 corresponding subsets of 
circulating murine monocytes, differentiated by their expression of 3 surface 







 murine monocytes (analgous to the CD14
++
 human 







 murine monocytes (analgous to the CD16
+
 human monocytes) 
remained within the circulation for longer periods and were recruited to non-
inflamed tissues to replace resident tissue M!. Interestingly, both subtypes had the 
ability to differentiate into DC in vivo (Geissmann et al., 2003).  




Resident tissue M! are ubiquitous and present in all organs where they act as 
sentinels for tissue injury or infection (Sean Eardley and Cockwell, 2005). Serosal 
M! form resident populations in peritoneal and pleural cavities whilst resident 
alveolar M! are present in non-inflamed lungs. Resident M! in liver, brain and bone 
are referred to as Kupffer cells, microglial cells and osteoclasts respectively. Local 
microenvironments, connective tissue matrices and apocrine secretion products from 
neighboring resident cells result in the phenotypes of these resident M! populations 
varying markedly (Gordon, 2003). Jean-Francois Cailhier has demonstrated that 
resident M! are critical to the initiation of both thioglycollate (TG) peritonitis 
(Cailhier et al., 2005) and Carrageenan (CG) pleurisy (Cailhier et al., 2006), with an 
almost complete failure to recruit PMN to these inflammatory models in vivo 
following M! depletion (see later). 
There is extensive evidence that M! play key roles in the orchestration of 
inflammation, coordinating the early injurious, pro-inflammatory phase with the 
subsequent anti-inflammatory, resolution phase. During the injurious phase, 




 monocytes (see above) infiltrate sites 
of inflammation where they are responsible for cell death and phagocytosis of 
invading microbial pathogens (where relevant) and also apoptotic resident cells. The 
actions of M! at this stage of the inflammatory process are thought to be responsible 
for the breakdown of tissue matrix.  During the resolution phase M! activity results 
in the phagocytic clearance of apoptotic cells (AC) whether derived from senescent 
inflammatory cells such as PMN (Savill et al., 1989) or resident tissue cells 
(reviewed by Duffield, 2003). 
In the carbon tetrachloride model of hepatic fibrosis, M! depletion at the height of 
the early injurious phase ameliorated hepatic scarring, but depletion during the later 
resolution phase resulted in failure of matrix degradation and persistent scarring 
(Duffield et al., 2005). M! may also be used as anti-inflammatory ‘cell therapy’ and 
David Kluth has demonstrated reduced inflammation by the adoptive transfer of IL-
10 secreting M! to a rat model of nephrotoxic nephritis (Kluth et al., 2004; Wilson et 
al., 2002). 




1.3.1 Opposing M! actions explained by different M! Phenotypes 
 
How is it that a single cell type can have such apparent contradictory roles and be 
injurious at one time point and reparative at another? In somewhat of an 
oversimplification, 4 M! ‘phenotypes’ with different profiles of cytokine section and 
phagocytic capabilities have been described in vitro: classically activated, 
alternatively activated, type-2 activated, and the M! phenotype following 
phagocytosis of AC. 
1.3.1.1 Classically activated M! 
Classical activation occurs when a naïve resident tissue M! or monocyte derived M! 
is exposed to either IFN" and pro-inflammatory cytokines, or microbial products that 
trigger a range of ‘pattern recognition receptors’ known as Toll-like receptors (TLR) 
e.g. the bacterial endotoxin lipopolysaccharide (LPS) triggers TLR 4. 
IFN", produced in vivo by CD4
+
 or NK cells, acts synergistically to potentiate 
classical activation (Erwig et al., 1998). Classically activated M! are typically 
injurious and produce large quantities of TNF$ and nitric oxide (NO). They express 
high levels of MHC class II and CD86 (Mosser, 2003). M! production of 
chemokines recruits leukocytes whilst IL-12 production promotes a Th1 response 
from nearby CD4
+
 T cells, (figure 1.1). 
1.3.1.2 Alternatively activated M! 
If, on the other hand, naïve M! are initially confronted by Th2 cytokines (e.g. IL-4 
and IL-13) then they adopt a very different phenotype termed ‘alternative’ activation. 
These M! express high levels of mannose receptors and scavenger receptors and 
produce less NO and TNF$. They also exhibit an increased propensity for 
phagocytosis and antigen presentation (figure 1.1). 
1.3.1.3 Type 2 activated M! 
Type 2 activation is a relatively recent term for M! activation following exposure to 
CD40L in the presence of immunoglobulin G (IgG). These M! secrete high levels of 
IL-10 and reduced levels of IL-12 (Anderson and Mosser, 2002) and tend to promote 
Th2 responses from nearby lymphocytes with increased T cell IL-4 production and 
IgG class switching among B cells (Mosser, 2003). 




1.3.1.4 M! phenotype following the  phagocytosis of AC 
It is generally accepted that M! phenotype is determined by continuing initial 
cytokine exposure, making it resistant to re-programming (Erwig et al., 1998), an 
exception appears to be following the following AC phagocytosis. AC ingestion 
switches injurious, classically activated M! to a reparative anti-inflammatory 
phenotype exhibiting increased production of the anti-inflammatory cytokines 
transforming growth factor (TGF) #, IL-10 and prostaglandin E2 together with 
decreased production of TNF$ and IL-6 (Fadok et al., 1998; Voll et al., 1997). It is 
thus pertinent that TGF#1 is critical to the down-regulation of acute inflammation 
(Letterio and Roberts, 1998)  and involved in wound repair (Border and Noble, 
1994). 
This switch in phenotype is specific to the phagocytosis of AC and is not seen 
following phagocytosis of either necrotic cells or opsonised particles both of which 
promote the classical activation. Elegant work by Huynh and colleagues 
demonstrated phosphatidylserine (PS) expressed on the surface of AC was critical to 
this switching of the M! phenotype and the production of TGF#1 (Huynh et al., 
2002). AC were instilled intra-tracheally during an in vivo model of acute lung injury 
and were phagocytosed by M!. Administration of PS expressing AC resulted in 
increased TGF#1 production and enhanced resolution of the lung injury compared to 
those that received either control cells or AC from the non-PS-expressing PLB-985 
cell line. The induction of TGF#1 (and accelerated resolution of inflammation) could 
be rescued by instilling PS alongside AC from the PLB-985 cell line or by the 
instillation of liposomes expressing PS. 
Current dogma suggests this mechanism of switching M! phenotype, from injurious 
to reparative after the ingestion of AC is fundamental to limiting the excessive 
‘collateral damage’ that would otherwise be inflicted on host tissues by classically 
activated M! in vivo. 
 





Figure 1- 1 Schematic diagram contrasting and comparing the functions of 
classically and alternatively activated M!.  
(Adapted from Duffield, 2003) 
• Generation of pro-
inflammatory cytokines & 
chemokines 
• Killing cells by apoptosis 
• Phagocytosis of pathogens, 
immune complexes & debris 
• Matrix degradation 
• Phagocytosis apoptotic cells 
• Generation of anti -
inflammatory cytokines & 
chemokines 
• Matrix synthesis & repair 
• Angiogenesis 
• Antigen presentation 
Classically activated M! 
Alternatively activated M! 
Monocyte 




1.3.2 Abnormalities in M! function apparent in NOD mice 
 
Although numerous abnormalities in NOD M! phenotype and function have been 
described in vitro, it is unclear whether they are important in vivo and how they 
contribute to autoimmunity. The phenotypes of various NOD derived M! 
populations have been compared to various control M! populations by several 
research groups and a number of different defects have been identified. The data 
from different groups may appear conflicting and this may be explained in part by 
the use of differing control strains and subtly different M! populations. 
It was initially demonstrated that TG elicited PM! from NOD mice produced 
excessive amounts of IL-12, with a reduced IL-10 to TNF$ ratio in response to LPS 
compared to a number of control strains including C57BL/6 and BALB/c mice 
(Alleva et al., 2000).  In an extension of their work with NOD derived DC. Pradip 
Sen reported increased NF&B activity in response to LPS among splenic and 
BMDM! from NOD mice using BALB/c mice among the control strains (Sen et al., 
2003). A different series of experiments (Stoffels et al., 2004) reported that resident 
peritoneal M! (PM!) from NOD mice produce increased levels of IL-1% and TNF$ 
in response to AC , necrotic cells and LPS with C57BL/6 mice being used as 
controls. This consistent body of work supported the hypothesis that an increased 
pro-inflammatory response by NOD M!, together with a failure to switch phenotype 
following ingestion of AC resulted in a greater Th1 response by CD4
+
 cells and could 
thus underpin the autoimmune diseases seen in NOD mice. 
In stark contrast however, Hanli Fan reported that TG elicited PM! from NOD (and 
SLE-prone) mice were hypo-responsive to LPS in the presence of AC or Foetal 
Bovine Serum (FBS) and produce less IL-1% and other pro-inflammatory cytokines 
than control M! from various strains including C57BL/6 (Fan et al., 2004). This 
work was consistent with their previously published work using other autoimmune 
prone strains of mice (Koh et al., 2000). In a further series of experiments they 
demonstrated selective reduced activity of Rho, a cytoplasmic G protein and 
cytoskeletal regulator in M! derived from NOD and SLE-prone strains of mice (Fan 
et al., 2006) following exposure to AC or FBS.  




In addition to the work examining the inflammatory phenotype(s) of NOD derived 
M!, it has been shown that PM! and bone marrow derived M! (BMDM!) from 
NOD mice do not up-regulate CD49d adequately in response to LPS stimulation and 
exhibit defective CD49d-mediated adhesion to fibronectin compared to C57BL/6 and 
BALB/c controls (Geutskens et al., 2004). It has also been reported that bone marrow 
precursor cells from NOD mice have a skewed maturation in vitro towards M! and 
away from DC, in response to GM-CSF compared to both BALB/c and C57BL/6 
mice (Nikolic et al., 2005). 
Defective AC phagocytosis, by resident PM! from NOD mice, in vitro, was reported 
(O'Brien et al., 2002) in comparison to a range of control strains including C57BL/6 
and BALB/c mice. The NOD PM! phagocytic defect was specific for AC as it was 
not observed for polystyrene beads. It was more pronounced in female mice and 
appeared to diminish as mice aged. Although further work confirmed the phagocytic 
defect within the peritoneal cavity of NOD mice in vivo (O'Brien et al., 2006) no 
mechanism was identified.  
Fc receptors (FcR) play an important role in phagocytosis (as described above), with 
Fc"R2b inhibiting phagocytosis. Menna Clatworthy demonstrated that autoimmune 
prone strains of mice, including NOD mice, have an Fc"R2b genetic haplotype that 
results in only 50%  activity of this inhibitory receptor and as a consequence exhibit 
increased rates of phagocytosis of opsonised pneumococci in vitro (Clatworthy and 
Smith, 2004). 
 





The, phagocytosis of pathogens, cellular debris or AC, represents a key function of 
M! and is the singular action that gave them their name. Although it may seem a 
very straight forward function, phagocytosis is an extremely complex process. M! 
have to identify and differentiate particles to be phagocytosed from those that should 
remain intact. Particles identified for ingestion then have to be tethered or bound to 
the M! and then exquisitely intricate and coordinated movements of the actin 
cytoskeleton have to draw the particle into a phagosome within the M!. Finally 
lysosomes fuse with the phagosome to form a phagolysosome.  
 
1.4.1  Receptors and ligands involved in phagocytosis 
M! have an impressive array of surface receptors that identify and bind particles for 
phagocytosis. Several receptors relevant to phagocytosis by mammalian M! have 
been identified through elegant work with Drosophila melanogaster (as reviewed by 
Stuart and Ezekowitz, 2008). Several groups of receptors, particularly complement 
receptors (CR), FcR, scavenger receptors such as CD36 and pattern recognition 
molecules such as CD14 (the LPS receptor) are capable of identifying a range of 
proteins present on both AC and microbial pathogens whilst other receptors are more 
specific for invading microbes. Multiple epidermal growth factor-like domains 
(MEGF), CD91 (lipoprotein receptor related protein), scavenger receptor expressed 
by endothelial cells (SREC), and Stabilins 1 and 2 recognise are range of gram 
positive and negative bacteria including Staphylococcus aureus, Listeria 
monocytogenes and Escherichia coli. As the list of receptors involved in 
phagocytosis continually expands there is a growing understanding of how receptor 
involvement not only initiates phagocytosis but also influences the maturation of the 
resultant phagolysosome (Erwig et al., 2006).  
Broadly speaking, receptors involved in the phagocytosis of AC can be divided into 
3 groups (Savill et al., 2002): receptors that recognise non-self antigens, those that 
recognize altered (or damaged) self and finally receptors that recognise non-
detaching self. Whilst the first group of receptors are involved in phagocytosis 
generally (as mentioned above), the latter 2 groups are particularly relevant to the 
phagocytosis of AC. Table 1.5 gives a summary of molecules shown to be important 
in the recognition of AC for phagocytosis.  




1.4.1.1 Recognition of non-self antigens 
Since AC become opsonised by complement and immunoglobulins (especially 
natural IgM antibodies), these receptors are also relevant to the clearance of AC.  
The complement system is a cascade of enzymic proteins that will be discussed in 
greater detail later (chapter 1.6.3) Whilst later components of the complement system 
(C5 to C9) combine together to form the membrane attack complex that results in the 
lysis of target cells, earlier complement components, particular C3b decorate the 
surface of pathogens or AC. Professional phagocytes (M! and PMN) express 
complement receptors that recognise cell surface complement and trigger 
phagocytosis.  
Pathogens, AC, or particles bearing epitopes recognised by the adaptive immune 
system will become coated with Ig. The membranes of M! are rich in receptors for 
the Fc component of Ig molecules. Most classes of FcR such as Fc"RI and Fc"RIII 
promote phagocytosis (Clynes et al., 1999). In contrast Fc"RIIb is inhibitory and co-
ligation of Fc"RIIb with an activating FcR will inhibit phagocytosis (Clatworthy and 
Smith, 2004). Menna Clatworthy and colleagues have clearly identified how 
activatory and inhibitory Fc" receptors combine to form a balancing act between the 
requirement of the immune system to promote inflammation and clear pathogens 
whilst avoiding autoimmunity (Floto et al., 2005). 





Receptor Ligand References 
CD14 LPS 
(Devitt et al., 
1998) 
FcR Fc component of opsonising Ig 
(Clynes et al., 
1999) 
Complement Receptor 3 
(CR3 / $m#2) 
Opsonic complement component 
inactivated C3b 
(Savill et al., 
2002) 
Scavenger Receptor A 
(SRA) 
Oxidised sites on AC (Platt et al., 1996) 
CD36 Oxidised sites on AC 
(Savill et al., 
1992) 




(Hamon et al., 
2000) 
PS Receptor* PS 
(Bose et al., 2004; 





et al., 1997) 
$v#3 (Vitronectin 
Receptor) 
Milk-fat globule epidermal 
growth factor 8 
(Akakura et al., 
2004) 
Calreticulin C1q & Mannose Binding Lectin 





(Savill et al., 
1992) 
CD31 CD31 
(Brown et al., 
2002) 
 
Table 1- 5 Receptors and molecules implicated in phagocytosis of AC 
* role of the PS receptor is disputed (see text). Non-self receptors are high-lighted in yellow, 
altered self receptors in blue and non-detaching self in purple. 




1.4.1.2 Recognition of altered-self 
As cells undergo apoptosis a number of changes take place to the outer membrane as 
discussed in greater detail later in the chapter 1.5. Oxidised lipids are exposed 
(Kagan et al., 2002); PS on the internal surface of healthy cells, translocates to the 
outer surface (Fadok et al., 1992). Receptors that identify these changes are critical to 
the recognition and removal of AC. At one point it appeared that exposed PS was 
directly recognised by a PS-receptor on the surface of M!, triggering phagocytosis 
(Fadok et al., 2000; Fadok et al., 2001). Unfortunately the story is clearly much more 
complicated and PS-receptor deficient mice do not exhibit defective phagocytosis of 
AC either in vitro or in vivo (Bose et al., 2004) . 
1.4.1.3 Recognition of non-detaching self 
Elegant work by Simon Brown and colleagues demonstrated that cells actively 
communicate viability in order to escape phagocytosis since both AC and viable cells 
adhere (bind) to M! at 20°C but viable cells actively detach at 37°C. Although the 
exact mechanism has not been delineated, CD31 blocking antibodies prevented the 
detachment of viable cells thus implicating the involvement of CD31 (Brown et al., 
2002).  
 
1.4.2 Downstream signalling events 
 
Once recognized particles have been bound to the M!, intricate, downstream 
signaling leads to carefully controlled changes of the actin cytoskeleton in order to 
implement phagocytosis. Different patterns of engulfment have been described 
(Kaplan, 1977): FcR mediated phagocytosis is thought to involve the extrusion of 
pseudopodia from the phagocyte that ‘grab’ the particle whereas the particle is seen 
to ‘sink’ into a phagosome during CR mediated phagocytosis.  
The down-stream signaling events that result in these cytoskeletal movements have 
been the subject of much research with those following activation of Fc"R and CR3 
attracting the greatest interest. There is broad agreement regarding the classes of 
proteins involved, but slight variance in the exact role of certain signaling proteins 
(Castellano et al., 2001; Cougoule et al., 2006; Hall et al., 2006). Activation of either 
class of receptor appears to result in recruitment of small GTPases of the Rho family 
(Rho, Rac, and Cdc42) to the local area. These proteins cycle between inactive GDP 




forms and an active GTP forms. Guanine-nucleotide exchange factors (GEF) cycle 
GTPases to the active state whilst GTPase activating proteins cycle the active form to 
the inactive state (see figure 1.2). The Vav family of proteins is an example of GEF 
that are crucial in the downstream signaling from these receptors. The activated 
GTPases, amongst other functions, recruit the Arp 2/3 complex to affect actin 
polymerisation and thus phagocytosis. 
Castellano and colleagues (Castellano et al., 2001) argue that both Cdc42 and Rac 
are required for Fc"R mediated phagocytosis with Cdc42 required for pseudopodia 
emission by the M! and Rac required for phagosome closure. In contrast to FcR 
signalling, they propose that Rho is the critical GTPase required for CR dependent 
phagocytosis.  
The work of Cougoule and colleagues (Cougoule et al., 2006) on FcR signalling, 
whilst in agreement with the earlier published work of Castellano, went further to 
propose that the binding of IgG-opsonized particles to Fc"R induced the activation of 
Src kinases, which phosphorylated 2 tyrosines in the receptor Immunoreceptor 
Tyrosine-based Activation Motif (ITAM) domain. These in turn recruited Syk whose 
kinase activity controlled Vav which controlled Rac activation. Rac and Cdc42 
cooperated in inducing actin polymerisation at site of receptor activation and thus 
phagocytosis. 
Hall and colleagues performed an elegant series of experiments using primary 
BMDM! from knock-out (KO) mice. They found M! from Vav KO mice had a clear 
phagocytic defect for complement-opsonised sheep red blood cells (rbc) opsonised 
with complement but exhibited normal phagocytosis of IgG-opsonised rbc. They 
demonstrated that this was associated with a failure to recruit the Arp 2/3 complex to 
the nascent phagosome and hence construct the actin polymerisation during CR 
mediated signaling. Using Rac KO BMDM! they demonstrated that Rac was 
required for actin polymerisation following both complement and Fc" receptor 
activation. Furthermore, the transfection of Vav KO BMDM! with constituitively 
active Rac rescued the phagocytic defect whilst constituitively active Cdc42 had no 
effect. Specific inhibition of Rho inhibited phagocytosis (but not actin 
polymerisation) following both CR and Fc"R activation. Unlike the earlier 
descriptions that phagocytosis mediated via different receptors was visibly different, 




they offered electron micrographs demonstrating pseudopodia and similar 
cytoskeletal movements following activation of both receptor pathways.  
The data from Hall and colleagues (summarized in figure 1.3) is therefore subtly 
different from earlier published work as there was clear evidence Vav was not 
required, or at least was redundant, in FcR signaling, contrary to Cougoule and 
colleagues. Rho was required for both receptor pathways, although its function 
appears distinct to that of Rac and the necessity of Cdc42 was questionable, contrary 
to the earlier review by Castellano and colleagues. The reasons behind these subtle 
differences may be partly explained by the extensive use of immortalized cell lines 
and reconstructed phagocytic receptors in earlier work. 
 






Figure 1- 2 Schematic diagram showing the activation / deactivation of the Rho 
family of small GTPases 






Figure 1- 3 Schematic diagram of the down-stream phagocytic signaling events  
Following ligation of Complement Receptors and Fc Receptors in primary M", Guanidine 
Exchange Factors (GEF) are recruited to the nascent phagosome. Vav is required to activate 
Rac following ligation of Complement, but not Fc Receptors. Rac recruits the Arp 2/3 
complex to achieve actin polymerization. Activation of Rho is achieved via alternative GEF. 
Although Rho is not required for actin polymerization, activation of both GDPases is required 
for successful phagocytosis (Hall et al., 2006). 




1.5 APOPTOSIS  
Apoptosis was first described in a seminal paper by Kerr and colleagues and indeed 
their beautiful description of the defining morphological changes visible by light 
microscopy during apoptosis remain amongst the clearest available: 
 “The earliest indication of pending [apoptosis] 
was found to be aggregation of condensed chromatin beneath the nuclear 
envelope. This is followed by breaking up of the nucleus, and cytoplasmic 
condensation and budding with the production of a number of compact, 
membrane-bounded cell fragments with relatively well preserved organelles.” 
(Kerr et al., 1974). 
 
Apoptosis has been shown to play a central role in embryogenesis where it helps to 
‘sculpt’ the embryonic form into the adult shape (for example tadpoles’ tails are 
‘trimmed’ by apoptosis and in humans, inter-digital cells are removed to form 
discrete fingers by apoptosis). Within the early thymus autoreactive thymocytes are 
selected and die by apoptosis in order to prevent autoimmunity. Apoptosis is also 
fundamental to the maintenance of tissue homeostasis in adult life and facilitates the 
removal of senescent cells. During inflammation senescent PMN die by apoptosis, an 
act that limits tissue damage from the leaking of disrupted granules. Apoptosis is 
especially important for the removal of potentially cancerous cells that have 
sustained DNA damage. 
The term apoptosis means ‘leaves falling from a tree’ and indicates that it was 
originally thought to be an immunologically silent in contrast to cell death by 
necrosis. Whilst apoptosis is ordered and programmed, necrosis is much more 
random. Necrosis is often the result of noxious stimuli such as ischemia or toxic 
substances and frequently affects whole fields of adjacent cells simultaneously.  
Necrotic cells lose membrane integrity as they ‘fall apart’ in a disorganised fashion, 
releasing cytoplasmic contents into the intercellular fluid where they may well prove 
to be inflammatory (Kanduc et al., 2002; Wyllie et al., 1980). As discussed earlier, 
phagocytosis of necrotic cells is frequently pro-inflammatory, inducing classical 
activation of M! whereas phagocytosis of AC induces an anti-inflammatory M! 
phenotype. AC are usually cleared rapidly by adjacent cells (Hughes et al., 1997) or 
professional phagocytes (Ren and Savill, 1998; Savill, 1997; Savill et al., 2002; 




Savill et al., 1989) whilst those that are not cleared rapidly may undergo secondary 
necrosis with additional immunological consequences. 
 
1.5.1 Apoptotic Pathways 
 As mentioned above, apoptosis is an orderly process. Kerr and colleagues described 
a regulated series of morphological changes that typically affected all cells 
undergoing apoptosis regardless of whether the cells were from a tadpole or human. 
Two distinct pathways have been described that initiate apoptosis: the intrinsic and 
extrinsic pathways. The extrinsic pathway of apoptosis is triggered by specific ‘death 
receptors’ displayed on the surface membrane of the cells whereas the intrinsic 
pathway is triggered as a result of noxious stimuli or by the loss of survival signals 
such as growth factors.  
Fas (CD95) is a member of the Tumour Necrosis Factor Receptor (TNFR) 
superfamily and is among the best characterised of the death receptors. The ligand 
for Fas (FasL) may be expressed on the surface of leukocytes such as M! or T cells 
(Brown and Savill, 1999). Ligation of Fas ultimately results in activation of caspase-
8 and then caspase-3. The intrinsic pathway will occur if a stimulus such as DNA 
damage recruits pro-apoptotic members of the Bcl family of proteins such as Bax to 
the outer mitochondrial membrane where they trigger the opening of mitochondrial 
pores. This results in the release of pro-apoptotic molecules such as Apoptosis 
Inducing factor (AIF) and cytochrome C into the cytoplasm. These molecules trigger 
a cascade of events involving the formation of the Apoptosome - a multimolecular 
complex comprising Apoptotic Protease Activating Factor 1 (APAF-1), cytochrome 
C and pro-caspase 9. This proteolytic complex converts pro-caspase-3 to active 
caspase-3 that is capable of cleaving many intracellular proteins. There are additional 
checks and balances on the intrinsic pathway to prevent inadvertent activation. For 
example, Inhibitor of Apoptosis Proteins (IAPs) act as an internal ‘buffer’ and can 
inhibit the activation of caspase-3. However in addition to pro-apoptotic molecules 
released from the mitochondria, Smac/DIABLO (second mitochondria-derived 
activator of caspase / direct inhibitor of apoptosis binding protein)  is also released 
from the mitochondria following activation of the intrinsic pathway and 
Smac/DIABLO inhibits IAPs thereby ensuring that apoptosis ensues. A simplified, 
schematic diagram is offered in figure 1.4 whilst Hengartner describes the pathways 
in much greater detail in a comprehensive review (Hengartner, 2000). The activation 




of caspase-3 is a key initial step of the final execution pathway that leads to cleavage 
of chromosomal DNA, nuclear condensation and apoptosis.   
Caspases have a rather unique ability to activate each other merely by proximity 
(Hengartner, 2000) and most of the components required for activation and execution 
of the intrinsic pathway are pre-formed and ‘ready to go’ (Rich et al., 2000). 
Apoptosis is held in check by ensuring that the protagonists are separated and tightly 
controlled. The benefit of this arrangement is, of course, that when necessary 
apoptosis can be rapidly activated in an injured or dysfunctional cell. 






Figure 1- 4 Schematic diagram of apoptotic pathways  
Apoptosis can be initiated via the extrinsic pathway via the4 cell surface Fas death receptor 
or via intrinsic mitochondrial pathway. Fas ligation by Fas ligand results in trimerisation of 
Fas and clustering of Fas-associated death domain and pro-caspase-8. Proximity activation 
results in the conversion of pro-caspase-8 to active caspase-8. Caspase-8 activates 
caspase-3 to initiate apoptosis. Injurious stimuli, including DNA damage will result in the 
release of p53 from the nucleus and translocation of pro-apoptotic members of the Bcl family 
of proteins such as Bax to the mitochondria. Pro-apoptotic and anti-apoptotic members of 
the Bcl family of proteins compete on the mitochondrial surface membrane. If the pro-
apoptotic signal is dominant then pro-apoptotic such as cytochrome c will be released. 
Cytochrome c interacts in the cytosol with Apaf-1 and pro-caspase-9 to form the 
Apoptosome which can also activate caspase-3 to initiate the final execution phase of 
apoptosis. (Modified from Hengartner, 2000) 
 




1.5.2 Failure to clear AC contributes to autoimmunity 
 
In the previous paragraphs, phagocytosis and apoptosis have been discussed. It is 
evident that there are numerous receptors involved in the phagocytic clearance of 
AC. Whilst several of these receptors appear to be important in vitro, their absence in 
vivo using specific knockout mice, often produces a far less dramatic phenotype than 
predicted. For example, targeted disruption of SRA in murine thymic M! resulted in 
a 50% reduction in the phagocytosis of apoptotic thymocytes in vitro (Platt et al., 
1996).  However, analysis of thymuses from SRA knock out (KO) mice 
demonstrated no increased number of AC even following exposure of mice to 
gamma radiation that increases the rate thymocyte apoptosis (Platt et al., 2000). One 
explanation is that there is considerable redundancy built into the clearance of AC 
such that failure of a single receptor will not compromise the AC clearance system. 
Redundancy of this type underscores the evolutionary importance of phagocytic 
clearance of AC. 
An exception to the above phenomenon is the C1qa KO mouse. C1q is the first 
component of the pathway of classical complement activation. The globular heads of 
C1q (often described as a bunch of tulips) bind to motifs on the surface of pathogens 
and AC, whilst the stalk binds to calreticulin on the surface of M! to facilitate 
phagocytosis (Ogden et al., 2001). Both in vitro and in vivo studies using peritoneal 
M! from C1q KO mice have demonstrated reduced clearance of AC with the 
intraperitoneal administration of C1qa replete serum to C1q KO mice restored the 
effective clearance of AC (Taylor et al., 2000). Interestingly, C1qa KO mice develop 
an autoimmune disease resembling Systemic Lupus Erythematosis (SLE) in humans, 
with autoantibodies targeting antinuclear antigens and a proliferative 
glomerulonephritis (Botto et al., 1998). The evidence that links the defective 
clearance of AC in these mice to the subsequent development of autoimmunity is 
largely circumstantial, but compelling nonetheless. 
Increased numbers of free AC were apparent in the glomeruli of C1qa KO mice. In 
additional studies, C1qa KO mice developed more severe injury than wild-type mice 
following the induction of experimental nephrotoxic nephritis with increased 
numbers of free AC visible within the glomeruli. Importantly, mice lacking 
components of the alternative complement cascade or components of the classical 




activation pathway downstream from C1q did not develop an aggravated form of 
inflammation thereby localising the phenotype to C1qa deficient mice with defective 
AC clearance (Robson et al., 2001). Furthermore, normal mice injected with 
irradiated, syngeneic AC have been shown to transiently develop low levels of anti-
nuclear autoantibodies, anti-cardiolipin antibodies and anti-single-strand DNA 
autoantibodies, together with mild glomerular immunoglobulin deposition 
(Mevorach et al., 1998): potential hallmarks of SLE. 
In humans, homozygous C1q deficiency is the strongest independent predictor for 
SLE development (Botto and Walport, 2002) and monocyte-derived M! isolated 
from patients with SLE have been shown to exhibit defect phagocytosis of AC in 
vitro (Herrmann et al., 1998). Autoantigens targeted in SLE such as Ro, La and 
nucleosomal DNA, have been identified on the surface of apoptotic blebs derived 
from keratinocytes undergoing apoptosis (Casciola-Rosen et al., 1994).  
Taken together, the accumulated body of circumstantial evidence becomes quite 
compelling. The mechanisms by which AC persisting in an inflammatory milieu 
could contribute to autoimmunity remain largely speculative (as reviewed by Rosen 
and Casciola-Rosen, 1999). Phagocytosis and subsequent degradation of AC by M! 
is highly efficient, minimises the presentation of apoptotic material and induces an 
anti-inflammatory phenotype as previously discussed. They propose that ineffective 
M! clearance of AC may result in AC phagocytosis by DC.  The caspase mediated 
cleavage of proteins during apoptosis produces novel autoantigens with a ‘non-
tolerized structure’. Impaired clearance of AC would permit these novel antigens to 
accumulate to ‘suprathreshold levels’ in the presence of co-stimulatory molecules 
and thus enter class II MHC presentation. Thus, following AC phagocytosis, DCs 
may subsequently present autoantigen resulting in T cell activation. As mentioned 
above, this remains speculative. Other data suggests that phagocytosis of AC by DC 
contributes to both induction and maintenance of immunological tolerance (Huang et 
al., 2000). In addition Lynda Stuart demonstrated that DC that phagocytosed AC 
were subsequently defective in their production of IL-12 and exhibited an inability to 
stimulate naïve T cells (Stuart et al., 2002). Furthermore, not all experimental mice 
with defects in the clearance of AC develop autoimmunity, for example CD14 KO 
mice. Lars-Peter Erwig has therefore argued that it is the context in which AC 
material is presented to lymphocytes that is critical with autoimmunity developing if 




the AC material is presented in conjunction with “danger-signals” (Erwig and 
Henson, 2007). 
Jacqueline Trudeau published how the neonatal pancreas undergoes a wave of 
apoptosis as it undergoes the tissue remodelling required for adult life with this wave 
of cell death occurring shortly before NOD mice develop signs of autoimmunity 
(Trudeau et al., 2000).  Importantly, as mentioned above (O'Brien et al., 2002), PM! 
from NOD mice appear to exhibit defective clearance of AC in vitro, consistent with 
the observations of Jaqueline Trudeau that increased numbers of free AC were 
visible in the neonatal pancreata of these mice (Trudeau et al., 2000). 
There is convincing circumstantial evidence defective that defective AC clearance 
may lead to autoimmunity, but clearly more work is required to prove a causal link 
and identify the mechanism(s).  
 
1.6 IN VIVO MODELS OF INFLAMMATION 
It is clear, as illustrated by work with receptors involved in phagocytic clearance of 
AC, that whilst in vitro studies can offer valuable insights, it is still necessary to test 
hypotheses in vivo. M! function and phenotype can be examined in vitro, but this 
does not necessarily predict their behaviour during inflammation in vivo. Before 
describing the peritoneal and pleural models of inflammation used in this thesis and 
the rationale for their choice, it is useful to review some of the key cells, chemokines, 
cytokines and protein cascades involved. 
Descriptions of inflammation date back over 2000 years, referring to rubor (redness), 
tumor (swelling), calor (heat) and dolor (pain) as the visible, cardinal signs (Celsius 
30BC to 38AD). Following on from Virchow (1799 to 1878), more recent 
descriptions tend to concentrate on the tissue infiltration by various leukocytes, the 
leakiness of blood vessels and the release of various proteins and regard these as the 
processes that generate the cardinal signs recognised for so long. It is descriptions of 
these latter processes that this review will focus on. 
 




1.6.1 Key cells involved in peritoneal and pleural inflammation 
Following an inflammatory stimulus, resident leukocytes together with local 
mesothelial cells, produce chemokines and cytokines that act to recruit additional 
leukocytes in an attempt to clear the noxious stimulus and ensure tissue repair.   
In the early stages of inflammation cytokines induce blood vessels to constrict then 
dilate, increasing the blood supply and hence ensuring the rapid arrival of additional 
leukocytes. Cytokines also stimulate the vascular endothelium to display various 
adhesion molecules such as selectins, integrins and immunoglobulin-like adhesion 
molecules (ICAMs). These enable circulating leukocytes to roll along the 
endothelium cell surface (selectin-mediated) prior to firm binding to the endothelial 
cells (integrin-mediated). The leukocytes then transmigrate between cells, cross the 
basement membrane and enter the extravascular connective tissue. Chemokines 
released locally form chemical gradients that attract specific classes of leukocyte 
towards the site of inflammation. 
Initially there is a rapid influx of large numbers of inflammatory cells, primarily 
polymorphonuclear cells (PMN). Monocytes leave blood vessels and become 
inflammatory M! (or DC) as they cross the basement membrane. NK cells arrive a 
little later. These cells together constitute the ‘innate’ immune response that is not 
targeted to specific antigens but capable of rapid mobilisation and effective action 
against a broad spectrum of threats. If inflammation persists, T and B lymphocyte 
populations are activated and are recruited to promote the highly focused ‘adaptive’ 
immune response. What follows below is a brief overview of various key cell 
populations and their roles in the inflammatory process. Although not an exhaustive 
account, it is clear that the different cell types influence maturation and function of 
each other in complex and often poorly understood interactions. 
1.6.1.1 Mesothelial Cells 
Peritoneal and pleural cavities are lined by a monolayer of mesothelial cells which 
constitute a slippery, non-adhesive and protective barrier against physical and 
infectious injury (Mutsaers, 2004). However these cells are not mere inactive 
bystanders in inflammation but play an active role as they can produce significant 
amounts of pro-inflammatory cytokines such as IL-1# (Lanfrancone et al., 1992) and 
IL-6 (Topley et al., 1993) as well as anti-inflammatory cytokines such as IL-10 (Yao 




et al., 2004). Human mesothelial cells have also been demonstrated to release 
chemokines such as IL-8, MCP-1 and Regulated upon Activation, Normal T 
Expressed and Secreted (RANTES) following stimulation (Li et al., 1998). 
Fibroblasts are present beneath the mesothelial monolayer and have also been 
implicated in the inflammatory response with the production of chemokines 
(Loghmani et al., 2002; Witowski et al., 2001). 
1.6.1.2 M! 
The roles played by both resident and inflammatory M!, initiating and orchestrating 
different aspects of inflammation, have been described in detail elsewhere (chapter 
1.3). It should be noted, however, that resident M! populations are crucial for the 
initiation of the inflammatory response in both TG peritonitis and CG pleurisy. If the 
resident M! populations are depleted, the subsequent inflammatory response is 
almost completely muted. The response can be rescued by adoptively transferring 
appropriate numbers of the relevant resident M! (Cailhier et al., 2005; Cailhier et al., 
2006).  
1.6.1.3 DC 
Immature DC reside in almost all peripheral tissues and serosal cavities. They 
express low levels of both MHC class I/II molecules and lack co-stimulatory 
molecules such that they have a limited capacity to activate lymphocytes (Janeway et 
al., 2004). They have numerous surface receptors in common with M!, including 
pattern recognition receptors such as Toll-like receptors and are constantly sampling 
the microenvironment. Similar to M!, immature DC are proficient at recognising and 
phagocytosing pathogens, a process which leads to their activation and maturation. 
Mature DC may produce large quantities of pro-inflammatory cytokines such as TNF 
$, and migrate through the lymphatic vessels to regional lymph nodes. Expression of 
MHC and co-stimulatory molecules is up-regulated and mature DC are thus highly 
effective stimulators of naïve T cells. 
1.6.1.4 Mast cells 
Like M!, mast cells originate in the bone marrow and enter tissues. Immature mast 
cells are agranular or poorly granular whilst mature mast cells are highly granular 
and have a characteristic appearance. They are highly specialised cells and express 




Fc& receptors on their surface. Mast cell degranulation occurs within seconds of these 
Fc& receptors becoming cross-linked by antigen. Mast cells produce a wide array of 
biologically active substances (Janeway et al., 2004) including preformed enzymes 
(such as tryptases) and vasoactive mediators such as histamine. Pro-inflammatory 
cytokines such as TNF$ or anti-inflammatory cytokines such as IL-4 or IL-13 are 
synthesised after activation. Peritoneal mast cells are also a source of chemokines 
and play an important role in the recruitment of PMN to sites of inflammation 
(Qureshi and Jakschik, 1988). 
1.6.1.5 Natural killer cells 
NK cells are large granular lymphoid-like cells and account for approximately 3% of 
resident peritoneal cells (Kawamura et al., 1999). As reviewed by Wilson and 
Delovitch (Wilson and Delovitch, 2003), NK cells can rapidly produce a broad 
spectrum of both Th1 cytokines such as TNF$ and IFN", as well as Th2 cytokines 
such as IL-4 and IL-13. Production of IFN" appears to be dependent on IL-12 
production by M! (Kawamura et al., 1999) NK cells also mediate cytotoxicity 
directly either through Fas-Fas Ligand interactions or perforin/granzyme pathways. 
As such, they are thought to play important regulatory roles during both innate and 
adaptive immune responses. NK cells (via activation of B1 cells) are essential in the 
recruitment of T cells to delayed hypersensitivity reactions in the skin (Szczepanik et 
al., 2003). 
1.6.1.6 Lymphocytes 
T lymphocytes (T cells) are derived from the bone marrow but mature in the thymus. 
They are classified according to the markers expressed on the cell surface. The 
majority express the $# T cell receptor (TCR), and these are then subdivided 
according to the expression of CD4 and CD8. CD8
+
 cytotoxic (Tc) cells recognise 
antigens presented by MHC class I molecules present on all nucleated cells and then 
use perforin and granzyme to induce lysis of the targeted cell.  CD4
+
 T helper (Th) 
cells recognise antigens presented by MHC class II molecules present only on 
specific antigen presenting cells such as DC, M! and B cells in conjunction with co-
stimulatory molecules such as CD80 and CD86. They then provide a range of 
cytokines and chemokines important to the innate immune response and critical to 
development of the adaptive immune response. CD4
+
 cells are further subdivided 
according to the pattern of cytokines they produce: Th1 cytokines promote a typically 




pro-inflammatory response whereas Th2 cytokines are typically anti-inflammatory 
but tend to be important in the immune response generated against parasites such as 
filarial worms. Lower numbers of T cells express a "' TCR and these cells do not 
express either CD4 or CD8. 
T lymphocytes are present in the naive peritoneum and the majority express the 
typical $# TCR. The majority of these peritoneal T cells in humans are CD8
+
 T cells. 
Most of the T cells within the peritoneum appear to secrete Th1 cytokines. Although 
only a minority of cells secrete Th2 cytokines, they appear to play a vital role in 
supporting B cell differentiation and synthesis of IgA and IgG (Birkhofer et al., 
1996). 17% of T cells in the peritoneum express the "' TCR and interestingly this 
group of cells appears important in promoting differentiation of inflammatory 
monocytes to tissue M! as infection resolves (Skeen et al., 2004). They also appear 
to limit leukocyte recruitment early in the inflammatory response to Bordetella 
pertussis within the lung (Zachariadis et al., 2006). 
B lymphocytes (or B cells) account for a substantial proportion of the cell population 
resident in either peritoneal or pleural cavities. Within the peritoneal cavity they 
account for up to 40% of total cells and can be divided into roughly equal numbers of 
either B1 or B2 cells (Hayakawa et al., 1985).  
B2 cells are the circulating B cells derived from the bone marrow and matured in 
peripheral lymphoid tissue. They express a specific, membrane-bound 
immunoglobulin on their cell surface (the B cell receptor). Mature B cells circulate 
through the tissues until they encounter the specific antigen capable of stimulating 
their specific BCR, but they cannot become fully activated until they receive an 
additional signal from a Th cell in a peripheral lymph node. Upon full activation 
these cells undergo clonal expansion and maturation to antibody producing plasma 
cells. B2 cells are also proficient antigen presenting cells, capable of recognising, 
processing and presenting antigen to Th cells in conjunction with MHC class II. 
Although not as proficient as DC at T cell activation, they are frequently present in 
much greater numbers. 
B1 cells are much rarer outside serosal cavities. An important function of B1 cells is 
the production of polyspecificity natural antibodies (IgM) that are synthesised and 
excreted prior to pathogen exposure. These antibodies bind other immunoglobulins, 




self antigens and common bacterial polysaccharides. They are therefore effective at 
opsonising bacterial pathogens and AC thus facilitating phagocytosis. Unlike B2 
cells, the B1 cell response is independent of T cells.  
Mice deficient in B1 cells exhibit defective viral clearance, even if production of 
IgM by B2 cells is normal (Baumgarth et al., 2000). The presence of B1 cells is 
essential for subsequent T cell recruitment, both to delayed hypersensitivity reactions 
in the skin (Szczepanik et al., 2003) and also to filarial infections (Ramalingam et al., 
2003) in the peritoneum. Interestingly secreted IgM from B cells appears effective in 
augmenting IgG responses to pathogens whilst reducing IgG autoantibodies (Boes et 
al., 2000). 
1.6.1.7 PMN 
PMN originate in the bone marrow from a common precursor cell shared with M! 
and DC (Fogg et al., 2006). Once released, PMN circulate between the vascular tree 
and the bone marrow until they either migrate into an inflammatory site or become 
senescent and are removed (Martin et al., 2003). There is therefore a pool of PMN, 
ready and waiting to react to inflammatory stimuli, enabling the rapid influx 
mentioned above. PMN do not appear to constitute a significant number of 
residential peritoneal cells but are rapidly recruited if required. 
Once they arrive at the site of inflammation, PMN play an important part in the 
phagocytosis of pathogens opsonised with immunoglobulins or complement factors. 
Intracellular granules within the PMN, containing bactericidal substances such as 
proteases, myeloperoxidase, hydrolase enzymes and defensins, fuse with the 
phagosome surrounding the ingested bacteria. The PMN generates NO, the 
superoxide anion (O2
-
) and hydrogen peroxide (H2O2), in a ‘respiratory burst’ and 
these are also directly toxic to bacteria. 
PMN are terminally differentiated cells and once they have crossed the vascular 
endothelium, entered a site of inflammation and become activated, they cannot return 
to the circulation. Either shortly after phagocytosis or once they become senescent, 
they die by apoptosis and in turn, are removed by phagocytosis. The ordered, 
controlled, death of infiltrating PMN by apoptosis is thought to be important to 
prevent the release of the highly toxic granules into surrounding tissues. 




Having briefly reviewed the key cells involved in peritoneal and pleural 
inflammation, it is sensible to review some the cytokines and chemokines produced 
by these cells.  
 
1.6.2 Cytokines 
These can be defined as proteins released by cells that have an affect on other cells 
via specific receptors. They are released by tissues (mesenchymal cells) as well as 
leukocytes and together they affect a myriad of diverse outcomes. The functions of 
different cytokines can directly oppose each other, offering inflammatory processes a 
system of ‘checks and balances’ or they can have synergistic effects to amplify an 
inflammatory response. In the paragraphs that follow, the functions of important 
cytokines have been briefly reviewed. These are not intended to be exhaustive 
reviews and further reading may be desired. 
1.6.2.1 TNF" 
This is a potent pro-inflammatory cytokine that act through the NF(B intracellular 
pathway. It iss produced by a wide range of cells such as classically activated M!, 
NK cells, T cells and also epithelial cells. It acts locally to activate vascular 
endothelial cells, upregulate adhesion molecules and increase vascular permeability, 
thus increasing access of effector cells into inflamed tissue. Conversely it also works 
to increase drainage of fluid and the exit of cells such as maturing DC to lymph 
nodes. It contributes to local tissue damage and can provoke apoptosis. Systemically 
TNF$ contributes to fevers and the systemic inflammatory response syndrome. 
TNF$ also acts to increase production of other pro-inflammatory cytokines such as 
IL-1# and IL-6 (O'Shea et al., 2002). 
1.6.2.2 IFN# 
This is predominantly produced by cells of lymphoid origin (NK and T cells), with 
production by cells of myeloid lineage being uncertain. As a member of the 
interferon family it has important functions in host defense against viral infection, 
but its actions are far broader. Like IL-1# and TNF$, it is a potent pro-inflammatory 
cytokine, but acts via the STAT-1 pathway. CD4
+
 cells that mature in the presence of 
IFN" will be committed to a Th1 differentiation. It has also been shown to have a 
major impact on chemokine production (see below) and thus leukocyte recruitment 
as MCP-1 and RANTES are increased whilst IL-8 is decreased (Robson et al., 2001). 





IL-6 is a complex cytokine that exhibits a pro-inflammatory phenotype and recruits 
leukocytes to sites of inflammation (Cuzzocrea et al., 1999; Romano et al., 1997). 
Also circulating IL-6 acts upon hepatocytes and stimulates an acute phase response 
with the production of a range of proteins including the opsonins C-reactive protein 
and mannose-binding lectin (Janeway et al., 2004). IL-6 also displays anti-
inflammatory properties and up-regulating the M! production of IL-1 receptor 
antagonist and soluble TNF$ receptors, thus limiting the biological effect of these 
cytokines (Tilg et al., 1997). IL-6 KO mice exhibit much greater TNF$ responses 
and PMN recruitment to endotoxin-exposed lungs than wild-type mice (Xing et al., 
1998). The exact mechanisms or situations that determine whether IL-6 will act as a 
pro or anti-inflammatory cytokine remain unclear. 
1.6.2.4 IL-10 
IL-10, produced by M!, lymphocytes and keratinocytes is classified as an anti-
inflammatory cytokine. By inhibiting IL-12 release from M! it tends to inhibit Th1 
and promote Th2 responses. IL-10 inhibits PMN recruitment by downregulation of 
CXC chemokine production and appears to have a profound affect on PMN function, 
impairing phagocytic and bactericidal ability (Laichalk et al., 1996). In a murine 
model of Klebsiella pneumonia, neutralisation of IL-10 in vivo resulted in enhanced 
pro-inflammatory cytokine production, bacterial clearance and increased short and 
long-term survival (Standiford et al., 1996).  In addition to being anti-inflammatory 
IL-10 seems to play a central role in the maintenance of peripheral tolerance as the 
activation of CD4
+







 Treg cells. Conversely DCs exposed to IL-10 develop 
an alternatively activated state, resistant to maturation that induces expansion of the 
IL-10 secreting Treg population (Lan et al., 2006). Thus there appears to be a “two-
way relationship” between tolerogenic DC and Treg (Mahnke et al., 2007). 
1.6.2.5 IL-12 
IL-12 links the innate and adaptive arms of the immune system. IL-12 is primarily 
produced by M!, DC and B cells and induces Th1 differentiation of CD4
+
 cells. As a 
result of skewing CD4
+
 cells towards a Th1 phenotype IL-12 has marked pro-
inflammatory consequences. 
 





Chemokines are small proteins released by a wide range of cells to attract leukocytes 
bearing the relevant chemokine receptor as leukocytes migrate down a chemokine 
gradient towards the source of secretion. Differential receptor expression across 
leukocyte groups allows chemokines to achieve selective recruitment of different cell 
types at appropriate stages of the inflammatory process. Chemokines may have 
additional properties as outlined in tables 1.6 and 1.7.  
Chemokines are classified into 4 groups according to the number of amino acids 
between the two cysteine residues nearest the N terminal position: CC, CXC, CX3C 
and C.  The former 2 groups make up the vast majority of known chemokines, with 
only one example of each of the latter 2 groups known. Broadly speaking CXC 
chemokines recruit PMN or lymphocytes whereas CC chemokines attract M! and 
DC (see tables 1.6 and 1.7). 
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Table 1- 6  Properties of selected CXC chemokines  
(modified from Janeway et al., 2004).
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Table 1- 7  Properties of selected CC chemokines  
(modified from Janeway (Janeway et al., 2004)). 




1.6.4 Additional inflammatory mediators 
In addition to the cytokines and chemokines outlined previously, there are numerous 
additional immunologically active molecules produced during inflammation, 
including prostaglandins, prostacylins, thromboxanes and leukotrienes that are 
derived from arachidonic acid metabolism. Prostaglandins in particular effect several 
of cardinal signs of inflammation such as swelling and pain, whilst thromboxanes 
play important roles in platelet activation and clot formation. 
The complement system was discussed earlier in relation to phagocytosis, but as a 
cascade of proteolytic enzymes it is intimately involved in several functions of the 
immune system. Figure 1.5 summarises the complement cascade, and the different 
pathways capable of initiating the system. The effects of some of the smaller 
cleavage products especially C3a, C4a and C5a are of particular relevance to this 
thesis since NOD mice have been shown to be completely deficient in C5 (Lynch 
and Kay, 1995), the most potent of them all. All 3 complement cleavage products 
induce smooth muscle contraction and increase vascular permeability. C5a and C3a 
can also induce expression of adhesion molecules enhancing the influx of 
inflammatory leukocytes (and the efflux of maturing DC). They activate mast cells to 
release histamine and pro-inflammatory cytokines such as TNF$. C5a also effects 
PMN and monocytes directly with a potent chemokine effect, and in addition 
enhances phagocytic abilities. 





Figure 1- 5 Complement Pathways 
The complement cascade can be activated by 3 distinct pathways. The classical pathway is 
initiated when the C1q complex binds the surface of a pathogen directly, or binds to either 
CRP or immunoglobulin adherent on the surface. C1q binding activates C1r to activate C1s. 
C1s then cleaves C4 and C2 to release C4b and C2b respectively and these components 
combine to form C3 convertase. The mannose binding lectin (MBL) pathway is initiated by 
MBL binding to mannose, activating MASP-2 to cleave C4 and C2 which then go on to form 
C3 convertase. The alternative pathway results from spontaneous hydrolysis of C3 enabling 
it to bind factor B which is then cleaved by factor D producing a soluble C3 convertase. C3 
convertase, capable of cleaving C3 into C3a and C3b, unites the different arms of the 
complement cascade.  C3b on the surface of pathogens can utilize components C5 through 
to C9 to form the membrane attack complex, which effectively punches holes in the cell 
membrane. Complement inhibitors on the surface of host cells act to limit complement-
mediated injury to host cells. C3b itself is a potent opsonin and can interact with complement 
receptors on phagocytes. C3a and C5a are potent inflammatory mediators with chemotactic 
effects (modified from Janeway et al., 2004). 




1.6.5 TG peritonitis 
Brewer’s thioglycollate (TG), originally devised as a culture medium, has long been 
used to generate a form of peritonitis in mice (TG peritonitis). It is a spontaneously 
resolving model of inflammation, characterised by a brisk influx of PMN that peaks 
at 6 to 12 hours after the intraperitoneal injection of TG and resolves by 36 hours 
(Baron & Procter, 1982). The monocytes influx is slower and more prolonged, 
peaking at 48 to 72 hours. The inflammatory response subsides by day 7 to 10 
(Melnicoff et al., 1989). 
The exact nature of the inflammatory stimulus is unknown and probably non-specific 
in view of the cocktail of ingredients! The solution of TG in sterile water is 
autoclaved during preparation, prior to injection raising the possibility that advanced 
glycation end-products (AGEs) and their receptor (RAGE) may be important 
(Chavakis et al., 2003; Li et al., 1997). Importantly, in light of the fact NOD mice 
lack C5, TG peritonitis appears to involve complement independent pathways (White 
et al., 2002). The main attraction of TG peritonitis over the years has been as a 
source of M! or PMN for use in ex-vivo experiments (Baron and Proctor, 1982; 
Gallily et al., 1964). 
Within our laboratory, Jean-Francois Cailhier and colleagues, used a conditional M!-
depletion system to demonstrate the critical importance of resident peritoneal M! in 
sensing the TG stimulus and initiating the subsequent inflammatory process, 
recruiting the initial PMN influx via the CXC chemokine MIP-2 (Cailhier et al., 
2005). The model therefore has certain advantages over other, more ‘disease 
relevant’ models of inflammation when probing M! function in vivo in the NOD 
mouse model of autoimmune diabetes as it is reasonably well characterised and 
clearly profoundly dependent on resident M! function. 
 
1.6.6 CG pleurisy 
CG, an Irish sea moss, has become well established as an induction agent for pleural 
inflammation (Murai et al., 2003). When injected into the pleural cavity, it produces 
a self-limiting inflammatory process, generally considered an acute, complement-
dependent, model of sterile inflammation. Akin to TG peritonitis, CG pleurisy is 
characterised by a brisk PMN influx followed by slower monocyte infiltration 
(Ackerman et al., 1980). 




Frequent use has been made of the model by the pharmaceutical industry, using the 
PMN influx as an experimental read-out, to assess anti-inflammatory properties of 
their agents (Cuzzocrea et al., 2000; Cuzzocrea et al., 2004; Cuzzocrea et al., 1999). 
It has also been widely used to assess the importance of various established 
inflammatory mediators in vivo. (Cuzzocrea et al., 2000; Gilroy et al., 1999; Gilroy 
et al., 2004). Similar to TG peritonitis, the resident pleural M! has been shown to be 
critical for sensing the inflammatory stimulus and orchestrating the subsequent 
inflammatory process via the chemokine MIP-2 and a range of pro-inflammatory 
cytokines (Cailhier et al., 2006) 
 
1.6.7 Delayed Type Hypersensitivity Pleurisy 
Delayed Type Hypersensitivity (DTH), or Allergic Pleurisy, is used to examine 
aspects the adaptive immune system. Animals are actively sensitised to an antigen by 
subcutaneous or intra-dermal injection in conjunction with haptens. Langerhans cells 
within the dermis process the antigen and present it to CD4
+
 cells with IL-12 thereby 
skewing a Th1 response. A brisk adaptive immune response is initiated some days 
later when the animal is re-exposed to the antigen by an intra-pleural injection (see 
figure 1.6). Antigen presenting cells within the pleural cavity process the antigen and 
present it to the primed CD4+ cells which in turn produce large quantities of pro-
inflammatory cytokines and CCL3 (MIP-1$) to recruit inflammatory M!. The M!, 
CD4
+
 cells and local mesothelial cells all act to recruit additional inflammatory cells 
to the pleural cavity including PMN, mast cells and eosinophils resulting in an acute 
inflammatory response and local tissue damage. 
Within the recent published literature, the DTH model of allergic pleurisy has been 
used to dissect mechanisms underpinning delayed hypersensitivity. The fact the 
inflammatory response takes place within a serosal cavity whereby the infiltrating 
cells are easily recoverable by lavage makes it extremely attractive for these uses. 
Cytokines and chemokines produced can be measured in the lavage fluid; blocking 
antibodies can introduced and their effects quantitatively measured (Aliberti et al., 
2003; Klein et al., 2002; Klein et al., 2000; Pinho et al., 2003; Sampaio et al., 2000). 
Although monocyte and M! recruitment is a major part of DTH, the process is not 
dependent on these cells for the initiation of the inflammatory response as the CD4
+
 




T cell is key. It is therefore a useful model to contrast with the M!-dependent models 
of TG peritonitis and CG pleurisy. 
 





Figure 1- 6 Delayed-Type Hypersensitivity Pleurisy 
The initial phase of the inflammatory response, sensitization, follows the intra-dermal or 
subcutaneous injection of antigen together with a hapten. The antigen is taken up by 
dendritic cells, processed and presented to CD4
+ 
cells to elicit a Th1 response, memory T 
cells are formed. The second phase occurs when antigen alone is injected intra-pleurally 
several days later. It is quickly picked up by antigen presenting cells (APC) and presented to 
memory T cells, again eliciting a Th1 response characterized by IFN", TNF#, macrophage 
inhibitory factor (MIF) and the important CC chemokine, MIP-1#. These chemokines and 
cytokines recruit inflammatory monocytes, mast cells and eosinophils. These leukocytes and 
the local mesothelial cells in turn produce a range of CC and CXC chemokines plus 
additional pro-inflammatory cytokines, recruiting PMN and provoking local tissue damage 
and oedema. 
 




1.7 AIMS OF THE STUDY 
 
The aims of this study were to examine the role(s), if any, that M! function played in 
the development of autoimmunity in general and autoimmune diabetes in particular 
within the NOD mouse.  
The first aim was to confirm or refute the phagocytic defect observed in NOD M! 
during the clearance of AC in vitro and in vivo. If this defect was confirmed then 
what was the nature of the underlying mechanism and could this be linked to the 
development of diabetes? 
The second aim of the project was to probe the apparent contradictory nature of the 
inflammatory phenotype of NOD-derived M!, both in vitro and in vivo.



























































2.1 EXPERIMENTAL ANIMALS 
 
Mice were housed in cages with free access to food and drinking water in a constant 
temperature room with a 12-hour light/dark cycle. All experiments were performed 
in accordance with the UK Government Home Office regulations. 
 
2.1.1 Non Obese Diabetic Mice 
 
NOD mice used in this thesis come from 3 distinct sources that may exhibit slight 
genetic differences. The NOD mice used for the in vitro phagocytosis experiments 
(chapter 3.2.1) were a gift from Dr FS Wong, Bristol University. Subsequently a 
breeding pair was purchased from Charles River (Italy), and a breeding colony 
established in the BRR animal facility, Little France, Edinburgh. NOD mice from 
this colony were used for all remaining experiments conducted at the Centre for 
Inflammation Research, Edinburgh University. In vivo phagocytosis assays and 
studies of sterile peritonitis were also conducted at the Cambridge Institute of 
Medical Research, Cambridge University (see chapter 5.2.3) and used NOD mice 
from their breeding colony which were originally obtained from Taconic Farms, 
USA.  
All NOD mice were regularly tested for diabetes mellitus, either by blood or urine 
testing, as part of routine animal husbandry. Any NOD mice that tested positive for 
diabetes mellitus were immediately sacrificed and not used in any experimental 
procedure.  
 
2.1.2  C57BL/6 Mice 
 
C57BL/6 mice were bred at the BRR animal facility. 
 




congenic mice were a gift from Dr FS Wong, Bristol University. 
 
2.1.4 NOD.R320, NOD.R20, NOD.1591 and NOD.R905 Congenic Strains 
 




Various congenic NOD strains including NOD.R320, NOD.R20, NOD.1591 and 




2.2.1 Resident Peritoneal Macrophages 
2.2.1.1 Recovering and Purifying Resident Peritoneal Macrophages 
The abdomen of a mice killed by schedule 1 was liberally sprayed with 70% ethanol 
and the abdominal skin reflected away from the intact peritoneal membrane by a 
midline incision and blunt dissection. Peritoneal cells were recovered by peritoneal 
lavage using 5ml of ice-cold phosphate buffered saline without cations (PBS). 
Depending on the experiment, samples of recovered lavage fluid (usually > 
4ml/mouse) were either kept separate in 15ml tubes (BD Falcon, UK) or pooled 
according to strain in 50ml tubes (BD Falcon, UK). All tubes of lavage fluid were 
kept on ice pending further analysis.  
Total leukocyte count of lavage fluid was obtained by haemocytometer. The samples 
were then centrifuged at 300g for 5 minutes at 4
o
C and re-suspended at 1 x 10
6
 
cells/ml in Dulbecco’s Modified Eagle medium with F12 (DMEM/12). Resident 
PMø were isolated from other peritoneal cells by adhesion to tissue culture plastic. 
Peritoneal cells were seeded into Costar plastic wells (Corning Life Sciences, 
Netherlands) and incubated for 1 hour at 37
o
C with 5% CO2. The numbers of cells 
and well size varied between experiments (see results chapters). Cells were then 
washed gently 3 times with warm DMEM/12 using a 1ml Pasteur pipette to remove 
non-adherent cells. After the 3
rd
 wash the remaining adherent cells were incubated in 
DMEM/12 containing 100U/ml penicillin, 100U/ml streptomycin, supplemented 
with or without 10% Foetal Bovine Serum (FBS from Life Technologies, UK) as 
required. 
2.2.1.2 Assessing Purity of Resident Peritoneal Macrophages 
 
The purity of isolated PM! was assessed by flow cytometry using F4/80, a murine 
marker with a high specificity for macrophages (McKnight et al., 1996). 1 x 10
6
 
peritoneal cells were seeded into 12-well plates and PM! purified as described 
above. After the 3
rd
 wash the media was replaced with 1ml ice-cold PBS and the 
adherent cells were scraped off using a cell scraper and transferred to chilled 




polystyrene fluorescence-activated cell sorter (FACS) tubes (BD Falcon, UK). As a 
control, 200µl aliquots of peritoneal cells were placed directly in chilled FACS tubes 
and kept on ice. Cells were then centrifuged at 300g for 5 minutes at 4°C, re-
suspended in 200µl blocking solution (PBS containing 10% mouse serum) and 
incubated for 30 minutes on ice. 50µl Allophycocyanin (APC) conjugated 
monoclonal rat-anti-mouse F4/80 (IgG2a(, Caltag Laboratories, UK) diluted 1/100 in 
blocking solution, or the isotype control, was then added. Cells were mixed gently 
and incubated on ice for a further 30 minutes in the dark. Cells were then washed 
with cold PBS to remove excess antibody and re-suspended in 200µl of PBS. 
Analyses were performed using a FACScan instrument (Becton Dickinson, UK) and 
the results analysed by FlowJo software (Treestar, USA).  
Over 86% of cells purified by adhesion were PM!, characterized as F4/80
HI
, whilst 
PM! comprised ~50% of total resident peritoneal cells (figure 2.1).  
 
2.2.2 RESIDENT PLEURAL MACROPHAGES 
To avoid potential haemorrhage into the thoracic cavity from cervical dislocation, 
alternative methods of schedule 1 killing were employed such as rising 
concentrations of CO2. The abdomen of the mouse was sprayed with 70% ethanol 
and the abdominal cavity opened by a wide transverse incision just below the rib 
cage. The abdominal organs were reflected away to expose the diaphragm. The 
diaphragm was punctured by a small, anterior, mid-line incision and the pleural 
cavities were lavaged with 1ml sterile 3.88% sodium citrate (Sigma, UK) in saline 
using a sterile Pasteur pipette. The recovered lavage fluid was either placed 
individually in 1.5ml Eppendorf tubes or placed in 15ml tubes (BD Falcon) and 
pooled according to strain, depending upon experimental requirements. Cells were 
kept on ice pending further analysis and/or purification of resident pleural 






















Figure 2- 1 Analysis of resident peritoneal macrophages purified by adhesion 
Resident peritoneal cells recovered by lavage with ice-cold PBS were plated into plastic 
wells and left to adhere for 1 hour at 37
o
C. Non-adherent cells were removed by washing 
and adherent cells were mechanically removed by cell scraper and stained for the murine 
M" marker F4/80 before analysis by flow cytometry. (A) Forward and side scatter plots of 
peritoneal lavage fluid. (B) Forward and side scatter plots of peritoneal cells following 
purification by adhesion. (C) Over 86% of adherent cells (brown line) were strongly F4/80 
positive indicating a high purity of M" achieved by this method of purification. 
A B 
C 




2.2.3 Bone Marrow Derived Macrophages 
2.2.3.1 Macrophage Colony Stimulating Factor from L929 cells 
 
Maturation of bone marrow derived macrophages (BMDM!) requires the presence 
of macrophage colony stimulating factor (M-CSF) in the culture medium and this 
was derived in-house using medium conditioned by L929 cells. L929 cells are a 
malignant murine fibrosarcoma cell line and spontaneously secrete M-CSF into the 
supernatant. L929 cells were maintained in DMEM/12 medium supplemented with 
penicillin (100U/ml), streptomycin (100)g/ml) and 10% FBS (referred to as ‘M! 
medium’). The cells were grown in Costar T162cm
2
 flasks (Corning Life Sciences, 
Netherlands) with 25ml medium and split 1:30 when they reached confluency, 
usually after 7 days. Supernatants were harvested, filtered through a 0.45µm filter, 
aliquoted and then stored at -80ºC until required. 
2.2.3.2 Dissection of intact femurs and maturation of BMDM! 
 
Mice were sacrificed and liberally spayed with 70% ethanol. Fur over the hind legs 
was removed by pulling from a transverse skin incision across the anterior abdomen 
to “de-trouser” the mouse. As much muscle as possible above and below the femur 
was carefully removed using sterile scissors. In order to free the femur, the tibia and 
fibula were cut distally whilst the pelvic bones were cut through proximally. Care 
had to be taken not to cut through the femur itself. Residual muscle was removed 
with disinfectant wipes and the femur dipped briefly in 70% ethanol before being 
placed in a sterile container with chilled Hank’s Buffered Salt Solution (HBSS) 
containing 100U/ml penicillin and 100µg/ml streptomycin. The bones were placed 
on ice and transported to a sterile pre-cleaned tissue culture hood where the femurs 
were removed from the transport media and wiped thoroughly with a disinfectant 
wipe before being placed in a sterile Petri dish. Both ends of the femurs were 
removed with a sterile scalpel blade. A 25-gauge needle connected to a 10ml syringe 
filled with M! media supplemented with 20% L929 supernatant was inserted into the 
cavity of the femur and the bone marrow flushed into a 60ml Teflon pot (Roland 
Vetter Laboratory). This was repeated from both ends of the femur until the bone 
went translucent. Each femur was flushed into a separate Teflon pot. Further M! 
media supplemented with 20% L929 supernatant was added to each pot to bring the 
total volume to 40ml and the cells gently re-suspended. The pots were incubated at 






C in 5% CO2 for 7 days. 10ml of the fluid from the top of each pot was carefully 
aspirated (trying not to disturb the cells at the bottom) on days 2, 4 and 6 being was 
replaced each time with fresh medium. 
2.2.3.3 Characterisation of BMDM! 
 
This method of maturing BMDM! produces typically between 10 and 15 x 10
6
 cells 
per femur. Aliquots of the cells thus matured were assessed for the purity of 
BMDM! by 2 distinct methods: microscopy and flow cytometry.  
Microscopic examination of BMDM! using a cytospin 
 
Cells were re-suspended in PBS containing 10% FBS at 1 x 10
6
/ml. 200µl of the 
suspension was placed in the well of a cytospin holder and spun at 300g for 3 
minutes using a Shandon Cytospin II (Shandon, UK). Cells were fixed with 100% 
methanol for 2 minutes, followed by staining in the Diff-quik Red solution for 1 
minute and Diff-quik Blue solution for 1 minute (both from Gamidor Ltd, UK). 
Slides were air-dried overnight before being cover-slipped and mounted. As can be 
seen from figure 2.2, almost all the cells exhibit typical BMDM! morphology. 
Flow cytometric analysis of BMDM! in suspension 
 
Similar to PM!, mature BMDM! are also F4/80
HI
 whilst immature BMDM! or 
monocytes are F4/80
LO
or negative. Day 7 cells were harvested from the Teflon pots, 
washed in ice-cold PBS, resuspended at 1 x 10
6
 cells/ml in blocking solution and 
stained with either anti-F4/80 monoclonal antibody (mAb) or isotype control as 
described previously. Greater than 93% of cells were F4/80
HI
 and therefore mature 
BMDM! (figure 2.3). 










Figure 2- 2 Photomicrographs of typical cytospins of day 7 BMDM! 
Femurs were harvested and BMDM" matured in teflon pots for 7 days in media containing 
20% L929. Aliquot of BMDM" were cytospun onto glass slides, fixed with methanol and 
stained with Diff-quik Red and Blue. (A) Low power view (x100) with numerous M" but no 
contaminating neutrophils. (B) High power view (x1000) from the same cytospin 














Figure 2- 3 Flow cytometric analysis of BMDM!  
Femurs were harvested and BMDM" matured in teflon pots for 7 days in media containing 
20% L929. Aliquots of cells were stained for the murine M" marker F4/80 and analysed by 
flow cytometry. (A) Mature BMDM" lie in a characteristic position on the forward and side 









2.2.4 Apoptotic Cells  
 
All AC used in the work described in this thesis were derived from 4 to 8 week old 
C57BL/6 mice. 
2.2.4.1 Preparation and labelling of apoptotic cells from thymocytes 
After sacrifice by cervical dislocation mice were liberally sprayed with 70% ethanol 
and the 4 limbs pinned to a polystyrene board. A longitudinal skin incision was made 
from the abdomen to the throat and the skin reflected to expose the underlying 
structures of the thorax and abdomen. A transverse incision was made through the 
peritoneum along the costal margin to expose the diaphragm. A further transverse 
incision through the entire width of the diaphragm was extended up each side of the 
thorax by longitudinal cuts through the ribs to form a flap that could be reflected 
superiorly thereby exposing the mediastinum. In young mice the thymus is easily 
visible as a pale grey, friable organ in the superior, anterior mediastinum. It is largest 
in young animals and becomes progressively smaller and less cellular as mice age. A 
sterile pair of fine, curved forceps was used to hold the thymus at its base and 
carefully ‘pluck’ it free, trying to avoid any haemorrhage that may result from a tear 
in the great vessels around the heart. The removed thymus was placed in a container 
with ice-cold Roswell Park Memorial Institute 1640 (RPMI) media and kept on ice 
for transport to a sterile tissue culture hood. 
30ml of RPMI was added to a sterile Petri dish and within the tissue culture hood the 
thymus was gently ground between 2 sterile glass slides to release thymocytes into 
the media. When all thymocytes have been released, only a remnant of fibro-
membranous tissue remains. The liberated thymocytes in RPMI were then passed 
through a 40µm filter into a Costar T75cm
2
 flask. 1µl of Cell Tracker Green CMFDA 
dye (Invitrogen, UK) was added for every 1 x 10
6
 cells within the suspension and the 
suspension incubated in the dark for 30 minutes at 37
o
C. 1ml of FBS was added to 
remove excess dye and the volume of RPMI was topped up to 100ml. 
Dexamethasone (Mayne Pharma, UK) was added to a final concentration of 1µM and 
the thymocytes incubated for a further 15 hours at 37
o
C in 5% CO2. Following 
incubation the cell suspension was washed twice by centrifuging at 300g for 5 
minutes at 4
o
C, decanting the supernatant and replacing it with fresh PBS in order to 




remove any trace of lingering steroid.  Finally, the cells were re-suspended at 10 x 
10
6
/ml in either media or PBS and kept on ice until used.  
2.2.4.2 Characterisation of apoptotic cells 
Typically each thymus yielded approximately 400 x 10
6 
viable thymocytes at the 
outset, reducing to 50 x 10
6 
AC following serum starvation and exposure to 
dexamethasone for 15 hours as above. The proportions of viable, apoptotic and 
necrotic cells remaining in suspension following aging of thymocytes was assessed 
by (i) microscopy following staining with Hoescht 33342 and trypan blue (both from 
Invitrogen, UK) and (ii) flow cytometry with annexin V conjugated to phycoerythrin 
(PE) and the vital dye 7-Amino-actinomycin (7-AAD) using the apoptosis detection 
kit I (BD Pharmingen, UK). 
Microscopic examination of AC 
The level of apoptosis was assessed by staining 0.5ml aliquots of the cell suspension 
with Hoescht 33342 (1µg/ml) for 15 minutes at room temperature. Hoescht 33342 is 
a blue fluorescent, cell permeable, nucleic acid stain that binds to double stranded 
DNA (Mocharla et al., 1987) The condensed pyknotic nuclei of AC can be 
distinguished from viable cells by their markedly bright fluorescence. Following 
staining the cells were photographed by inverted ultra-violet fluorescent microscopy 
on a Zeiss Axiovert microscope (Carl Zeiss Ltd, UK; original magnification x 400) 
using a blue filter. In general, greater than 95% of cells exhibited pyknotic nuclei 
(see figure 2.4) with very little variation between different preparations of AC. The 
level of necrosis was assessed by staining 0.5ml aliquots with 0.5ml 0.4% trypan 
blue and incubating for approximately 3 minutes at room temperature. Only cells that 
have lost membrane integrity (late apoptotic or secondarily necrotic cells) will stain 
blue. 10µl aliquots of the stained cells were added to a haemocytometer slide and the 
numbers of blue (necrotic) and clear (viable) cells were counted.  Using this method 
of assessment approximately 45% of cells stained blue, again with little variation 
between different preparations of AC. Therefore only 5% of thymocytes remained 
viable with 50% exhibiting features of early apoptosis. The remaining 45% exhibited 
features of  late apoptosis or secondary necrosis. 




2.2.4.3 Flow cytometric analysis of AC 
The membrane phospholipid, phosphatidylserine (PS) is translocated from the inner 
to the outer leaflet of the plasma membrane in AC, thereby exposing PS to the 
external cellular environment. Annexin V is a calcium dependent protein that has a 
high affinity for PS and binds to cells with exposed PS. Calcium rich binding buffer 
solution is supplied with the kit to facilitate the binding of annexin V to PS. Annexin 
V conjugated to PE fluoresces in the FL-2 channel of the flow cytometer. 7-AAD is a 
vital dye that only stains cells that have lost membrane integrity and fluoresces in the 
FL-3 channel. It is therefore possible to identify 3 distinct populations of cells:  
• viable cells: annexin V negative and 7-AAD negative 
• early apoptotic cells: annexin V positive but 7-AAD negative 
• late apoptotic (secondarily necrotic) cells: annexin V positive and 7-
AAD positive. 
Apoptotic thymocytes were washed twice in PBS and resuspended in 1 x binding 
buffer solution at a concentration of 1 x 10
6
 cells/ml as per the manufacturer’s 
instructions. 100µl of the solution (1 x 10
5
 cells) was transferred to a polystyrene 
FACS tube and 5µl of Annexin V-PE and 5µl of 7-AAD were added. Cells were 
gently vortexed and incubated for 15 minutes at room temperature in the dark. A 
further 400µl of 1x binding buffer solution was added to each tube prior to analysis. 
Typical findings are illustrated in figure 2.5. 
The flow cytometric and microscopic analysis gave similar results. The cell 
suspension contains very few viable cells with the majority of cell population being 
split equally between early AC and late apoptotic or secondarily necrotic cells.  








Figure 2- 4 Assessing the proportion of pyknotic nuclei by Hoescht 33342  
Thymuses were harvested and thymocytes were aged for 15 hours in the absence of serum 
and in the presence of 1µM Dexamethasone. They were subsequently stained with 1µg/ml 
Hoescht 33342 and photographed (x 400) using an inverted fluorescence microscope. (A) 
The phase image taken with white light. (B) Image taken using a blue filter with ultraviolet 
(UV) light. (C) composite image of (A) and (B); whilst  few viable cells are visible (white 
arrows), over 95% of cells have the typical pyknotic nuclei of apoptotic cells, fluorescing 














Figure 2- 5 Flow cytometric analysis of apoptotic thymocytes 
Thymi were harvested and thymocytes aged for 15 hours in the absence of serum and in the 
presence of 1µM Dexamethasone. Aliquots of cells were dual stained with annexin V-PE and 
7-AAD and assessed by flow cytometry. (A) Characteristic position on forward and side 
scatter plots occupied by thymocytes. (B) Unstained thymocytes used as a control sample. 
(C) the overwhelming majority of thymocytes were either early apoptotic (annexin V positive, 
7-AAD negative) or late apoptotic/necrotic (dual positive). 
A B 
C 






Fluorescein isothiocyanate (FITC) labeled, heat killed pneumococci, stored in PBS 
and kept at -80
o
C were a gift from Menna Clatworthy, Cambridge University. 
Aliquots of pneumococci were thawed immediately prior to use and washed twice in 
fresh PBS, centrifuged for 2 minutes at 10,000 rpm between washes, and finally 
resuspended in serum-free M! media at 1 x 10
6
/µl. When required, aliquots of 
pneumococci were opsonised in serum taken from mice 2 weeks after vaccination 
with the pneumovax vaccine (also a gift from Menna Clatworthy and stored at -
80
o
C). The pneumococci were thawed, centrifuged at 10,000 rpm and resuspended in 
PBS supplemented with 1% serum for 30 minutes at 37
o
C in a water bath. They were 
then washed twice and resuspended in serum free M! media as described above 
 
2.3 IN VITRO PHAGOCTOSIS ASSAYS 
 
When assessing phagocytosis of particles by M! there is always a question as to 
whether the particle has been ingested, is bound to the M! or is merely ‘overlying’ 
the M! in a slightly different plane of view. Different strategies can be employed to 
answer this question. High magnification with confocal microscopy to assess a very 
narrow plane of view is extremely accurate but too prohibitively expensive and time 
consuming to be a practical solution. A particle could be regarded as phagocytosed if 
of the entire particle appears within the M! or alternatively, other investigators have 
argued they can identify the phagolysosome around a phagocytosed particle (O'Brien 
et al., 2002). A new strategy was developed for this project that effectively 
demonstrated whether or not a particle was phagocytosed. 
 
2.3.1 In vitro phagocytosis assay using microscopic analysis 
 
LysoTracker Red (Invitrogen, UK) is a vital dye that accumulates in intracellular 
compartments with a low internal pH such as lysosomes and fluoresces red under UV 
light. When added to the adherent M! that have been ‘fed’ either AC or beads, the 
dye is rapidly taken up by the M! and concentrates in lysosomes including 
phagolysosomes. If the ‘phagocytic feed’ has been pre-labeled with a green 
fluorescent dye, when located within a red phagolysosome the combined appearance 
would be predicted to be orange by fluorescence microscopy. 




2.3.1.1 Development and characterisation of a phagocytosis assay 
 
PM! were harvested from an 8 week old male C57BL/6 mouse and purified as 
previously described (chapter 2.2) onto 1cm glass cover slips at the bottom of 24-
well plates. After to the removal of non-adherent cells by washing, 0.5ml of M! 
media was left in each well and 2.5 x 10
6
 AC re-suspended in 250µl M! media were 
added to each well giving a ratio of ~10 AC to each PM!. Following incubation for 1 
hour at 37
o
C, 5% CO2, wells were placed on ice and excess feed removed by gentle 
washing 3 times with ice-cold PBS. After the 3
rd
 wash the cells were left in 200µl 
PBS and LysoTracker Red was added to a final concentration of 200nM. Cells were 
incubated for a further 15 minutes on ice. Immediately prior to microscopy, the 
cover-slips were removed from the PBS, inverted and placed onto a glass microscopy 
slide. Images were taken in turn with an Axioskop 2 microscope (Carl Zeiss Ltd, 
UK) using UV light with red and green filters (original x1000 magnification). A 
phase image was taken using white light and the 3 images were then merged using 
Photoshop software (Photoshop elements 2.0, Adobe USA) to produce a composite 
image. Figure 2.6 illustrates the accuracy of this technique, as one AC is clearly 
adjacent to a PM! whilst another AC is located within a phagolysosome.  
To test the hypothesis that the orange appearance indicated that an AC was within a 
phagolysosome, a series of 3 photographs (x 1000 magnification) were taken every 
200µm through the presumed phagolysosome in order to form a ‘Z’ stack. The 
images were then deconvoluted and reconstructed into a 3-dimensional image using 
Velocity 2.5.1 software (Improvision, UK). Whilst one green apoptotic cell is clearly 
visible, the other AC is clearly located within a red phagolysosome (figure 2.7 and 
movie 2.1 on the supplementary CD ROM). 
To obtain real-time video-microscopy of phagocytosis, PM! were purified as above 
using 3 x 10
6
 peritoneal cells per WillCo-dish®, glass bottom dishes (WillCo Wells, 
The Netherlands). Following purification of PM! by adhesion, the cells were 
incubated in 1ml M! media containing 200nM LysoTracker Red. AC were prepared 
as before and re-suspended in M! media at 1 x 10
6
 AC/ml. A Leica SP5C confocal 
laser scanning microscope was used (Leica Microsystems, UK) and the WillCo dish 
was placed on the stage heated to 37
o
C within a climate control box maintaining 5% 
CO2. Immediately prior to running the video microscopy AC were added to the PM! 




at a ratio of 10:1. Red and green fluorescent images together with a phase images 
were taken every minute for 30 minutes (original magnification x1000). The images 
were merged and run together to produce a short video using LAS AF software 
(Leica Microsystems, UK). It is possible to clearly see green AC being drawn into 
PM! as red phagolysosomes form (movie 2.2 on supplementary CD ROM). 
An assumption is made in the use of LysoTracker red dye that all phagolysosomes 
promptly acidify at a uniform rate. Recent data suggests that this may not be the case, 
with M! phagolysosomes containing material ingested via FcR maturing slower than 
those triggered by alternative receptors (Erwig et al., 2006). These factors are 
considered likely to be of relatively limited importance in assessing rates of 
phagocytosis and the addition of LysoTracker red dye to a conventional phagocytosis 
assay results in an extremely rigorous assay that is capable of assessing differences in 
the rates of phagocytosis of different M! populations.  





      
 
      
 
Figure 2- 6 Photomicrographs of PM! and AC in the process of phagocytosis 
Resident peritoneal M" were harvested, plated onto glass cover slips and purified. 
Fluorescent green apoptotic cells were added for 1 hour at 37oC before excess feed was 
washed away, leaving the cells bathed in PBS supplemented with 200nM LysoTracker Red 
dye. The cover-slips were inverted and placed onto glass microscope slides and viewed 
under fluorescent microscopy. (A) Image taken under phased white light. (B) Image taken 
under UV light with green filter. (C) Image taken under UV light with red filter. (D) Composite 
images were merged using Photoshop software; one adherent but non-ingested AC (d1) and 










      
 
      
 
Figure 2- 7 Three dimensional analysis of PM! following interaction with AC 
Using ultraviolet light with the green and red filters as above, a series of images were taken 
every 200µm through the PM" and AC seen in figure 2.6. The images were deconvoluted to 
remove extraneous light and then reconstructed into a 3-dimensional image using velocity 
software that could be viewed from different perspectives (images A to D). It is clearly 
apparent that one apoptotic cell (green) remains un-eaten, whilst the other is wrapped within 








2.3.1.2 Performing phagocytosis assays using LysoTracker Red 
Resident peritoneal cells were harvested and PM! purified by adhesion after seeding 
peritoneal cells into wells of costar plates. PM! from individual mice were kept 
separate. After the 3
rd
 wash, the PM# were incubated in 200µl per well of warm M! 
media. The phagocytic ‘feed’ consisting of either fluorescent AC or 3µm fluorescent 
green latex beads (Polysciences Inc, Germany) were added to PM# at a ratio of 10:1 
in order to ensure that particle availability was not a rate limiting factor for 
phagocytosis. All strains of mice and different feed types were represented equally 
on any individual plate. The plates were gently agitated for a few seconds before they 
were incubated at 37
o
C, 5% CO2 in the dark for 60 minutes. Following incubation 
the plates were placed on ice to terminate any ongoing phagocytosis and the excess 
feed removed by gently washing 3 times with ice-cold PBS, using a 1ml Pasteur 
pipette.  
After the final wash the cells were left bathed in 200µl PBS containing 200nM 
LysoTracker Red and incubated for a further 15 minutes on ice in the dark. The 
plates were finally photographed by inverted fluorescent microscopy on a Zeiss 
Axiovert microscope using original magnification x 400. Phase and fluorescent 
images were taken as above and merged together to form composite images for 
assessment of phagocytosis. 3 or 4 random fields of view were taken per well, 
incorporating at least 300 PM!. 
The percent of PM! exhibiting evidence of phagocytosis was calculated for each 
well expressed as the percentage of PM! that had ingested at least one AC. The 
phagocytic index was calculated for each well by calculating the number of AC 
phagocytosed by 100 PM! that had eaten at least one AC. In other words the 
phagocytic index is a measure of how well the phagocytically active PM! have 
eaten. Both a low percent phagocytosis and phagocytic index would indicate a 
reduced phagocytic capacity for the PM!. In contrast, a low percent phagocytosis 
with a normal phagocytic index would identify a sub-group of PM! that exhibit a 
reduced phagocytic capacity whilst the remaining PM! phagocytose normally. 
 




2.3.2 In vitro phagocytosis assay using flow cytometric analysis 
The phagocytosis assay described above is particularly robust and gives useful 
information regarding both the percentage of phagocytic cells and the phagocytic 
index. It is, however, not suitable for all particles such as bacteria which are difficult 
to visualise and count individually using light or fluorescent microscopy. Flow 
cytometry is capable of counting several thousand fluorescent events, such as 
fluorescently labeled bacteria, very rapidly and is an attractive method to assess 
phagocytosis. Dr Menna Clatworthy developed and validated a protocol for assessing 
the percentage phagocytosis of fluorescent pneumococci by PM! using flow 
cytometry (Clatworthy and Smith, 2004) and this method was adapted to assess 
phagocytosis of pneumococci, beads and AC. 
2.3.2.1 Conduction of the phagocytosis assay 
 
PM! were purified by adhesion following seeding 1 x 10
6
 peritoneal cells into the 
wells of Costar 12-well plates. A typical peritoneal lavage yields approximately 3 x 
10
6
 cells and peritoneal lavages were pooled together in 50ml Falcon tubes according 
to strain to provide sufficient cells. Alternatively BMDM! were seeded at 5 x 10
5
 
cells/well into Costar 12-well plates and incubated in 0.5ml of M! media either with 
or without 10% FBS according to the experimental requirements. 
Phagocytic ‘feed’ particles were added to each well and the plate gently agitated. 
Pre-labeled AC or 3µm fluorescent green latex beads (Polysciences Inc, Germany) 
were added to M! at a ratio of 10:1 whilst 6 x 10
6
 pneumococci were added to each 
well. Plates were then placed in a dark incubator for the specified time at 37
o
C, 5% 
CO2. One experimental plate was kept on ice in order to prevent phagocytosis and 
was used to assess non-specific binding. Wells containing M! alone were used to 
assess the auto-fluorescence of M! alone.  
On completion of the incubation period, all plates were placed on ice and the wells 
washed vigorously 3 times with ice-cold PBS to remove excess feed. M! were then 
scraped off using a cell scraper and the cells were transferred into chilled polystyrene 
FACS tubes and stained for F4/80. Cells were analysed by FACScan with FlowJo 
software. 




2.3.2.2 Analysis of phagocytosis assay 
M! alone were used to draw a rough gate around the cells on the forward and side 
scatter plot (figure 2.8) and only F4/80
HI
 events within this gate were analysed. The 
initial gating by forward and side scatter prevented F4/80
HI
 fragments of M! created 
by the mechanical scraping of cells from potentially contaminating the analysis. The 
use of the F4/80 stain reliably excluded any cell types other than M! being assessed 
or any isolated feed such as clusters of AC that might have fallen into the original 
gate from the analysis. At least 2000 PM! events were collected for each well.  
AC, beads or pneumococci were all fluorescent in the FL-1 channel. The percentage 
of M! that shifted further than auto-fluorescence in FL-1 was recorded for each well 
(figure 2.9). These M! included those that had phagocytosed fluorescent feed or had 
feed bound to their surface. A measure of non-specific binding was obtained for each 
strain by analysing the plates kept on ice for the duration of the experiment to 
prevent phagocytosis. Binding of AC to M! at 37
o
C may well be higher than that 
achieved at 4
o
C, however the difficulties in separating out binding from phagocytosis 
at the higher temperature meant assessment of binding at 4
o
C was the pragmatic 
approach.  The percent phagocytosis in each well was then calculated by subtracting 
the degree of binding obtained for the strain from the total percentage of M! shifting 
in FL-1.  The number of wells per condition gave the experimental ‘n’ number. 





    
Figure 2- 8 Setting up gates to assess phagocytosis 
M" were seeded into Costar 12-well plates and incubated for 1 hour at 37oC. The plates 
were then placed on ice and washed vigorously with ice-cold PBS. The cells were scraped 
off the plastic wells, transferred to chilled FACS tubes and stained with an anti-murine F4/80 
antibody conjugated to APC prior to analysis by flow cytometry. (A) A gate was drawn 
around the cells by forward and side scatter to exclude debris. (B) Cells within this gate were 
analysed further. FL-4 (F4/80) was used to gate on M" alone. Autofluorescence in FL-1 was 
assessed and gates drawn to distinguish M" alone (non-eaters) from those associated with 
fluorescent feed (eaters). 
A B 






      
      
Figure 2- 9 Calculation of the percentage of M! exhibiting phagocytosis by flow 
cytometry 
M" were seeded into Costar 12-well plates and feed was added. The plates were incubated 
for 1 hour at 37oC and then placed on ice and washed vigorously with ice-cold PBS. The 
cells were then scraped off the plastic wells, transferred to chilled FACS tubes and stained 
with an anti-murine F4/80 antibody conjugated to APC prior to analysis by flow cytometry. 
(A) An initial forward and side scatter gate excluded cell fragments and the majority of 
remaining feed (AC in this instance). Gated events were analysed by fluorescence in FL- 4 
(F4/80) and FL- 1 (feed) using gates established for that experiment as previously shown. 
(B) M" incubated with pneumococci. (C) M" incubated with AC. (D) M" incubated with 
beads. Phagocytosis was assessed as the percentage of M" classified as ‘eaters’ at 37oC 
over and above the percentage of eaters seen with that strain of mice from experimental 
wells kept on ice to assess non-specific binding. N.B. examples are drawn from different 
experiments with different M" populations and FACScan settings and this is the reason for 
the different auto-fluorescence of M" evident.  
A B 
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2.4 IN VIVO PHAGOCYTOSIS ASSAY 
 
The method used to assess phagocytosis in vivo in these studies is a modification of 
that developed by Philip Taylor (Taylor et al., 2000). AC were injected 
intraperitoneally (ip) and the loss of free AC from peritoneal lavage fluid was 
measured at various time points on the assumption that this represents AC clearance 
by phagocytosis. The same technique was also used to assess the phagocytosis of 
fluorescent green, 3µm latex beads in vivo. 
 
2.4.1 Performing the in vivo phagocytosis assay  
 
AC were resuspended in sterile PBS and kept on ice until used. The concentration of 
AC in PBS following resuspension was either 10 or 20 x 10
6
 per ml, so that the 
numbers of AC required were contained in a final volume less than 0.5ml. Sterile 
3µm latex beads were washed twice in sterile PBS, centrifuged at 10,000 rpm, and 
resuspended in sterile PBS at 10 x 10
6
 per ml. Before injection the abdomen of the 
mouse was sprayed briefly with cleansing solution and wiped with a disinfectant 
wipe. The required numbers of AC or beads were drawn up into 1 ml syringe and 
injected ip via a 26-gauge needle.  
Mice were sacrificed by cervical dislocation at various time points following 
injection. Immediately following death a peritoneal lavage was performed with 5ml 
ice-cold PBS. Due to the time taken for post mortem reflexes to subside, the lavage 
typically took place 1 minute after cervical dislocation. The time point used to 
measure the baseline numbers of AC or beads, when mice were sacrificed 
immediately following the ip injection, was therefore recorded as 1 minute and not 
zero. The strains of mice and the time points examined were scheduled such that any 
changes in the AC suspension would affect all strains and all time points equally. 
Lavage fluid recovered, usually in excess of 4ml, was immediately placed in a 15ml 
Falcon tube and kept on ice pending analysis. 
 




2.4.2 Analysis of the in vivo phagocytosis assay following injection of 
apoptotic cells 
2.4.2.1 Microscopic analysis of peritoneal lavage fluid by cytospin 
Experimental data from our group has convincingly demonstrated that PM! localise 
to the milky spots of the omentum and elsewhere following phagocytosis of AC and 
are not recoverable by peritoneal lavage (Simon Watson, PhD thesis, 2007). Initial 
samples of lavage fluid recovered were examined by cytospin. Analysis of these 
cytospins demonstrated readily identifiable individual PM! without AC or with AC 
possibly bound to their surface in all samples. PM! with a definite apoptotic body 
within a phagolysosome were extremely rare (figure 2.10) and accounted for less 
than 1% of PM! identified, regardless of strain of mouse or time point examined. No 
further attempt was made to assess phagocytosis by microscopic analysis of 
cytospins and it was decided to use the loss of free recoverable AC from the 
peritoneal lavage fluid as a surrogate marker for the phagocytic clearance of AC or 
particles. 





Figure 2- 10 Cytospin analysis of peritoneal M! following an ip injection of 
apoptotic cells  
5 x 106 AC were injected ip and mice sacrificed 30 minutes later. Peritoneal lavages were 
performed immediately following death with 5ml ice-cold PBS. Samples of lavage fluid were 
cytospun onto glass slides, fixed with methanol and stained with Diff-quik Red and Blue. 
High power images (x1000 original magnification) were taken.  (A) PM" with a phagocytosed 
AC (black arrow). (B) PM" with possible phagocytosed AC (black arrows). (C & D) Multiple 









2.4.2.2 Assessment of phagocytosis of AC by flow cytometry 
Use of Flowcheck™ beads to count absolute numbers by flow cytometry 
In order to assess the apparent loss of free AC and count the numbers of PM! present 
within a sample of peritoneal lavage fluid it is necessary to be able to convert the 
numbers of events counted by flow cytometry to an absolute number of cells per ml 
of lavage fluid. A technique developed by Simon Watson was employed involving 
the spiking of samples with Flowcheck™ synthetic polystyrene beads (Flowcheck™ 
Beckman Coulter, UK) immediately prior to flow cytometric analysis analysis. 
Samples were spiked immediately prior to analysis to reduce potential binding of 
beads to M!. Samples were then thoroughly mixed by multiple pipetting by a 200µl 
Gilson pipette rather than vortex to avoid margination of the beads. 
Each sample was spiked with a known number of beads and by counting the number 
of beads analysed it is possible to calculate the proportion of the aliquot analysed by 
the FACScan. By noting how many cellular events were counted from the sample it 
is then a simple calculation to determine how many cells were in the aliquot. If the 
size of the aliquot is known, it is possible to deduce the concentration of cells per ml 





For all experiments, 400µl aliquots of lavage fluid were spiked with 50,000 
Flowcheck beads immediately prior to flow cytometric analysis. The formula 




Flowcheck™ beads fluoresce brightly in all FACScan channels, including FL-3 and 





Number of beads spiked 
Number of bead events recorded 
Number of cell events recorded 
Volume of lavage aliquot 
= 







Number of cell events recorded 
Number of bead events recorded 
X 




the beads had FL-3 fluorescence around 10
3
 on the log scale.  With these settings, 
other cells had FL-3 fluorescence of 10
1
 or less and beads were easily counted and 
excluded from further analyses (figure 2.11).    
Counting PM! and numbers of free apoptotic cells by flow cytometry 
 
Following sacrifice of the mouse and peritoneal lavage, 400µl aliquots of fluid were 
transferred to chilled polystyrene FACS tubes, stained with F4/80 conjugated to APC 
as described previously. Samples were washed and spiked with 50,000 Flowcheck™ 
beads immediately prior to analysis by flow cytometry. Flowcheck™ beads were 
counted and gated out as described above. All of the remaining events were analysed 
according to fluorescence in FL-4 (F4/80 labeling PM!) and FL-1 (Cell Tracker 
Green labeling AC). Quadrants were drawn separating 4 distinct populations (figure 
2.12) and the numbers events counted in each:  
• the quadrant with F4/80HI FL-1LO events represented PM! with no AC 
involvement,  
• the quadrant with F4/80HI FL-1HI events were considered to be PM! 
associated with AC in some way (see below),  
• the quadrant with F4/80LO FL-1HI events were free AC,  
• the quadrant with F4/80LO FL-1LOevents contained all other peritoneal cells 
such a B lymphocytes, mast cells and any contaminating red blood cells.  
Using the formula described above, the numbers of free AC and total PM! per ml of 
lavage fluid were calculated. Each peritoneal lavage used 5ml of PBS and an 
assumption made that the fluid flowed freely throughout the peritoneum mixing all 
cells equally. The numbers of cells per mouse were therefore estimated by 
multiplying the number of cells per ml by 5, regardless of actual volume of lavage 
fluid recovered. Phagocytosis of AC in vivo was estimated by the loss of free AC 
from lavage fluid. Different strains of mice, even if the same age, will vary in size 
and typically NOD mice are larger than their age and sex matched C57BL/6 controls. 
It is likely that the numbers of AC recovered at any given time point will be affected 
by the size and complexity of the peritoneal cavity as well as phagocytosis. To 
control for this variable, the loss of free AC was calculated by comparison to the 




mean baseline numbers recovered for each strain and not from the numbers of AC 
injected. 
A significant proportion of the F4/80
HI
 events (PM!) were also FL-1
HI
. Whilst some 
of these events represented AC within PM!, some represented AC bound to PM! (as 
in figure 2.10). Due to the dynamics of the interactions between AC and PM! 
described by Simon Watson (PhD thesis 2007), with PM! becoming non-recoverable 




 events were not a 
reliable measure of phagocytosis and they were not used in any calculations. 





Figure 2- 11 Counting and gating out Flowcheck™ beads by flow cytometry 
400µl aliquots of peritoneal lavage fluid were spiked with 50,000 Flowcheck™ beads 
immediately prior to flow cytometric analysis. Flow cytometry plot demonstrating how the 
Flowcheck™ beads are approximately 10
2
 times brighter in FL-3 than other cells and are 
thus easily gated upon, counted and excluded from further analyses. 






Figure 2- 12 Flow cytometric analysis of lavage fluid following an ip injection of AC 
Mice were injected ip with 5 x 106 AC pre-labelled with Cell Tracker Green. They were 
sacrificed and peritoneal lavages performed at various time points. PM" were stained with 
an anti-murine F4/80 antibody conjugated to APC. Immediately prior to analysis by flow 
cytometry, aliquots of lavage fluid were spiked with 50,000 Flowcheck™ beads. (A) Typical 
forward and side scatter profile of peritoneal lavage fluid: populations of red blood cells (grey 
arrow) and apoptotic cells (black arrow) are seen to partially overlie each other, Flowcheck™ 
beads are ringed. (B) Same lavage fluid once Flowcheck™ beads had been counted and 
excluded from further analyses. (C) All remaining events were analysed by their 
fluorescence in FL-4 (F4/80) and FL-1 (Cell tracker Green): Quadrant A = pure PM"; 









2.4.3 Analysis of the in vivo phagocytosis assay with beads 
Analysis of the phagocytic clearance of 3µm fluorescent green latex beads was 
almost identical to assessing the clearance of labelled AC. The FACScan settings had 
to be altered to capture the extremely small size of the latex beads (smaller than the 
Flowcheck™ beads). Crucially, the latex beads were not as bright in FL-3 as the 
Flowcheck™ spheres and differentiation between beads and spheres was therefore 
straightforward. A gate was drawn around the Flowcheck™ beads in order to count 
them and exclude them from further analysis and quadrants were used to count the 
numbers of free latex beads and total PM! (figure 2.13). Further analyses were as for 
AC. 





Figure 2- 13 Flow cytometric analysis of lavage fluid following an injection of latex 
beads 
3µm, fluorescent green, latex beads were injected ip and the mice sacrificed 20 minutes 
later. Peritoneal lavages were performed immediately following death with 5ml ice-cold PBS 
and PM" stained with an anti-murine F4/80 antibody conjugated to APC. Immediately prior 
to analysis by flow cytometry, aliquots of lavage fluid were spiked with 50,000 Flowcheck™ 
beads. Peritoneal cells, the latex beads used as feed' and the Flowcheck™ beads used for 
counting all particles exhibit different fluorescent properties in FL-3. (A) Gates were drawn 
using side scatter and FL-3 to count the FlowcheckTM beads and exclude them from further 
analyses. (B) Typical forward and side scatter profile of recovered lavage fluid: red blood 
cells are indicated by the arrow whilst cells and latex beads are labeled. (C) Events plotted 
according to fluorescence in FL-4 (F4/80) and FL-1. Quadrant A = pure PM"; quadrant B = 









2.4.4 Rationale for excluding samples from analysis 
 
There were a number of reasons for excluding a small proportion of samples from 
analysis: 
Occasionally no AC were identified within the lavage fluid, which to all intents and 
purposes resembled lavage fluid recovered from a naïve abdomen. It was assumed 
the ip injection had failed and been subcutaneous or missed the peritoneal cavity 
altogether (figure 2.13). 
Occasionally the sample was very heavily blood stained presumably the result of 
bleeding occurring at the time of the ip injection. There are no data as to how 
additional serum proteins associated with excessive haemorrhage might affect the 
physiology of resident peritoneal cells or PM! phagocytosis. The addition of a red 
cell lysis step to the protocol would require at least 2 additional washes and this 
would result in increased cell loss as some cells are lost from the pellet each time a 
wash step is introduced. This technique of assessing phagocytosis in vivo relies on 
counting the absolute numbers of AC and PM! recovered and therefore would be 
very sensitive to the additional washes. It was decided to exclude heavily blood 
stained samples rather than subject all samples to a red cell lysis step and potentially 
reduce accuracy (see figure 2.14). 
Very rarely a sample would appear to have lost virtually all injected AC and PM!. 
Although this pattern is consistent with effective phagocytosis by PM! leading to a 
brisk localisation to milky spots, it would also be consistent with a large proportion 
of the pellet being lost from the FACS tube during washing. These 2 options were 
distinguished by counting the lymphocytes within the samples. Numbers of 
lymphocytes are not affected by the MDR and remain reasonably constant. If the 
sample in question was also noted to have vastly reduced numbers of lymphocytes 
then it was excluded from analysis (figure 2.15). 
For inexplicable reasons occasionally the data obtained by the flow cytometer for a 
particular sample was meaningless, showing a diffuse ‘smear’ on all channels. These 
samples were uninterpretable and were also excluded from analysis (figure 2.16). 





Figure 2- 14 No evidence of apoptotic cells in lavage fluid 
Mice were injected ip with 5 x 10
6
 AC pre-labelled with Cell Tracker Green, sacrificed at 
various time points thereafter and peritoneal lavages performed.  Recovered PM" were 
stained with an anti-murine F4/80 antibody conjugated to APC and fluid analysed by flow 
cytometry. Occasionally there would be no evidence of any AC within the lavage. An 
assumption was made that the ip injection had been sub-cutaneous and that particular 





      
 
 
Figure 2- 15 Heavily blood stained lavage fluid 
Mice were injected ip with 5 x 10
6
 AC pre-labelled with Cell Tracker Green, sacrificed at 
various time points thereafter and peritoneal lavages performed.  Recovered PM" were 
stained with an anti-murine F4/80 antibody conjugated to APC and fluid analysed by flow 
cytometry. (A) Forward and side scatter profile of heavily bloodstained sample. (B) The same 
heavily bloodstained sample analysed by fluorescence in FL-4 and FL-1. Even with 
erythrocytes gated out as unstained in the bottom left quadrant PM" numbers in particular 
appeared reduced.  
A B 










Figure 2- 16 Using analysis of lymphocyte numbers to assess partial loss of pellet 
Mice were injected ip with 5 x 10
6
 AC pre-labelled with Cell Tracker Green, sacrificed at 
various time points thereafter and peritoneal lavages performed.  Recovered PM" were 
stained with an anti-murine F4/80 antibody conjugated to APC and fluid analysed by flow 
cytometry. (A) Typical forward and side scatter plot of peritoneal lavage fluid. (B) Forward 
and side scatter plot of the same sample with PM", AC and Flowcheck™ beads gated out: 
lymphocytes are clearly visible and easily gated. (C) Lymphocyte numbers remained 
reasonably constant despite the M" disappearance reaction. (D) Occasionally a sample 
would be analysed with apparently very few PM" or AC recovered. If lymphocyte numbers 
were also greatly reduced it was presumed that a significant part of the cellular pellet had 












Figure 2- 17 Inexplicable smears 
Mice were injected ip with 5 x 10
6
 AC pre-labelled with Cell Tracker Green. Mice were 
sacrificed at various time points thereafter, peritoneal lavages performed and PM" stained 
with an anti-murine F4/80 antibody conjugated to APC to fluoresce in FL-4. (A) Samples 
analysed by flow cytometry occasionally exhibited an inexplicable ‘smear’ on both forward 
and side scatter profiles. (B) The same sample analysed by fluorescence in FL-4 and FL-1. 
These samples were uninterpretable and not included in further analysis. 
A B 




2.5 MEASURING MESSENGER RNA LEVELS WITHIN MACROPHAGES 
Messenger RNA (mRNA) for a specific cellular protein can be measured within cell 
populations. The first step is to isolate the cells of interest and then extract total RNA 
from the cells ensuring separation from DNA present. The RNA is reverse 
transcribed to generate complimentary DNA (cDNA) and specific primers, targeting 
the signal for the requisite protein are used together with the Real Time Polymerase 
Chain Reaction (RT-PCR) to amplify and measure the signal.  
 
2.5.1 Exracting mRNA using Trizol 
RNA is very sensitive to RNAses which are ubiquitous. All plastic ware should be 
clean, (preferably from unopened bags or new racked Gilson pipette tips) or wiped 
with RNase inhibitor solution (Sigma, UK). Gloves must be worn at all times. 
Resident PM! or BMDM! prepared as previously described were plated in wells of 
6-well plates. For best results considerable numbers of cells are required and 
peritoneal cells pooled from 3 mice, or 3 x 10
6
 BMDM!, were used per well. One ml 
of Trizol solution (Gibco, UK) was added to the cells of each well. The Trizol/cell 
suspension mixture was passed through the Gilson pipette tip several times before 
transfer to a 1.5ml Eppendorf container and frozen at -80
o
C pending RNA isolation.  
To isolate the RNA, 0.2ml chloroform was added to each Eppendorf and vigorously 
mixed for several minutes at room temperature. Tubes were then centrifuged at 
12,000 rpm for 15 minutes at 4
o
C following which 2 liquid phases were evident - a 
clear aqueous phase containing the RNA, and a pink organic phase containing DNA 
and protein. The clear phase was extracted using a Gilson pipette and transferred to a 
fresh 1.5ml Eppendorf taking extreme care not to transfer any of the underlying 
phase. 0.5ml isopropranolol was added and samples incubated for 10minutes at room 
temperature to precipitate RNA from the aqueous phase. Samples were centrifuged at 
12,000 rpm for 10 minutes at 4
o
C and the supernatants discarded. The pellets were 
washed with 200µl 75% ethanol, vortexed gently and centrifuged at 7,500 rpm for 5 
minutes at 4
o
C. Excess ethanol was carefully aspirated and the remainder allowed to 
air dry at room temperature for 30 minutes. Once dry the RNA was dissolved in 20µl 
RNase free water (Sigma, UK) and frozen at -80
o
C pending analysis. RNA 
concentration and purity were assessed by spectrophotometry by measuring OD at 
260 and 280nm. 





2.5.2 Reverse Transcription and Real Time PCR 
 
The cDNA library was constructed using the TaqMan® Reverse Transcription kit 
(Applied Biosystems, USA) according to the manufacturer’s instructions. Table 2.1 
provides a summary of reagents and volumes used whilst Table 2.2 gives the 
program timings and temperatures required for reverse transcription. The resultant 
100µl of cDNA solution was diluted 1:5 in RNase free water and stored at -80
o
C 
pending further RT-PCR analysis. TaqMan® Universal PCR Master Mix (Applied 
Biosystems, USA) was used to quantify the mRNA signal by RT-PCR according to 
manufacturer’s instructions. Table 2.3 gives a summary of reagents used whilst Table 
2.4 details the timings and temperature settings for the PCR cycles using an Applied 
Biosystems 7700 single reporter Real Time PCR machine. All sequence detection 
primers used (CD14, CD36, CD51, CD61, SRA, TSP and C1q) were a kind gift from 
Aili Zhang (Centre for Inflammation Research, Edinburgh).  
 
2.5.3 Data Analysis 
 
Two chemical reporters are incorporated within the TaqMan® RT-PCR mix. Each 
cycle of RT-PCR incorporates a reporter into the new DNA, cleaving it from its 
quencher and thus permitting it to fluoresce.  RT PCR uses the accumulation of 
fluorescence as a measure of the quantity of the gene of interest present. In the 
system used, FAM was the reporter for the gene of interest and VIC for the house 
keeping gene 18s. The above system then counted the number of PCR cycles 
required to achieve a certain level of fluorescence for each reporter. $$CT represents 
the difference between the number of VIC cycles and number of FAM cycles 
required to achieve the set level of fluorescence and $$CT was calculated for each 
cDNA sample. The levels of each gene were therefore measured in comparison to 
18s levels within each sample and not in absolute amounts thereby correcting for any 
minor differences that could occur between samples in the quantity of cDNA loaded 
into the RT-PCR mix. 
Since the question of interest lay in the comparison between NOD M! and C57BL/6 
M!, the data were normalised to the mean $$CT for the comparable C57BL/6 M! 




and plotted on a logarithmic scale with  the 95% confidence intervals. Statistical 
significance was determined by a student’s t test between $$CT values. 





Component Volume (µl) Final value 
10 x TaqMan® Reverse 
Transcriptase buffer 
10 1 x 
25mM MgCl2 22 5.5mM 
deoxyNTPs mixture 20 500µM of each 
Random Hexamer 5 2.5µM 
RNase Inhibitor 2 0.4U/µl 
MultiScribe Reverse 
Transcriptase (50U/µl) 
2.5 1.25 U/µl 
RNA Sample + RNase 
free water 
38.5 200ng 
Total 100  
 
Table 2- 1 Reagents and quantities used for Reverse Transcription PCR 











 HOLD HOLD HOLD 
Time 10 minutes 1 hour 5 minutes 
Temperature 25oC 48oC 95oC 
 
Table 2- 2 Temperatures and times used for Reverse Transcription 





 Volume (µl) 
TaqMan® Master Mixture 
(2x) 
12.5 
FAM mix 7 
VIC mix (20x) Reagent 1.25 
cDNA (1:5 dilution) 2.5 
RNase free water 1.75 
Total 25µl 
 
Table 2- 3 Reagents and volumes used for Real Time PCR 






2 minutes 50oC 
10 minutes 95oC 
15 seconds 95oC 
1 minute 60oC 
HOLD 4oC 
 
Table 2- 4 Times and temperatures used for Real Time PCR 
CYCLE 




2.6 MEASURING CELL SURFACE EXPRESSION OF PROTEINS 
 
Monoclonal antibodies are available that will bind to several of the various proteins 
on the surface of cells involved in the phagocytic process. An assumption was made 
that higher levels of protein expression would result in quantitatively more binding 
of the monoclonal antibody to the cell. If the primary monoclonal antibody is then 
linked to a fluorochrome this would result in a increased signal detectable by flow 
cytometry. An arbitrary measure of the expression of a particular protein on a 
particular cell type can thus be derived from the mean fluorescence of that cell type 
following immunolabeling with a particular monoclonal antibody. 
Peritoneal cells were harvested from individual mice as previously described and 
kept separately on ice. 400µl aliquots of each lavage were placed in chilled FACS 
tubes and 50µl of mouse serum added to each sample as an Fc receptor blocker prior 
to incubation on ice for 30 minutes. Each sample was then dual stained with both a 
rat anti-mouse F4/80 monoclonal antibody conjugated to APC and either the 
monoclonal antibody targeting the cell surface receptor of interest or the appropriate 
isotype control. Monoclonal antibodies were diluted 1:100 with PBS containing 10% 
mouse serum. Table 2.5 provides a comprehensive list of the monoclonal antibodies 
and isotype controls used. 50µl of the antibody dilution was added to each sample 
prior to incubation on ice for a further 30 minutes in the dark. Cells were then 
washed in PBS to remove excess antibody. Alexa Fluor® 488 streptavidin 
(Invitrogen, UK) was added at a dilution 1:200 for a further 30 minutes on ice to 
samples using a biotinylated primary antibody or biotinylated isotype control and 
these samples were washed in PBS for a second time. Similarly samples 
immunolabeled with the primary antibody for CD36 were restained with a secondary 
antibody conjugated to FITC for a further 30 minutes on ice. All cells were 
resuspended in PBS containing 10% mouse serum immediately prior to analysis by 
flow cytometry using a FACScan instrument (Becton Dickinson, UK). Results were 
analysed by FlowJo software (Treestar, USA).  
FITC and Alexa Fluor® 488 fluoresce in FL-1 and fluorescence in the FL-1 channel 
was therefore used as the measure of the expression of the protein of interest. 
Fluorescence in FL-1 was only assessed on F4/80
HI
 cells (PM!). Because 




fluorescence assessed by flow cytometry was measured using a logarithmic scale, a 
geometric mean rather than arithmetic mean was used. 








































































2.7 MEASURING IN VITRO PRODUCTION OF CHEMOKINES AND 
CYTOKINES 
 
Different populations of M! including resident PM! and PLM! and BMDM! were 
obtained as described in chapter 2.2. 1 x 10
6
 peritoneal or pleural cells, or 0.5 x 10
6
 
BMDM! were seeded into wells of 12-well plates. Plates were incubated for 1 hour 
at 37
o
C, 5% CO2 prior to removal of non-adherent cells by gentle washing with 
warm M! media using a sterile 1ml Pasteur pipette. 
After the 3
rd
 wash to remove non-adherent cells, the M! media was replaced by 
either: 
1. Standard M! media without additional stimulation (quiescent) 
2. M! media supplemented with 1µg/ml LPS (Sigma, UK) 
3. M! media supplements with 0.5% thioglycollate (TG) 
4. M! media supplemented with 0.25% carrageenan (CG) 
Within the confines of a single experiment, all conditions arose from the same batch 
of quiescent M! media.  
Plates were then incubated at 37
o
C, 5% CO2 and at the requisite time point (1, 4 or 
24 hours later) plates were viewed by light microscopy (original magnification x 
400) to assess cell morphology. Supernatants were carefully aspirated using a Gilson 
pipette into 1.5ml Eppendorf containers, trying not to disturb the cell layers adherent 
to the plastic. Supernatants were centrifuged at 12,000 rpm for 15 minutes at 4
o
C to 
remove any cell debris. The resultant solutions, containing chemokines and cytokines 
produced by the cells, were decanted to fresh 1.5ml Eppendorf containers and frozen 
at -80
o
C pending analysis.  
Levels of chemokines (MIP-2, KC, and MCP-1) and cytokines (TNF$, IL-10 and IL-
6) were measured either by ELISA (R&D, UK) or by cytometric bead array (CBA) 
(BD Biosciences, UK) according to manufacturer’s instructions. The same methods 
were employed regardless of whether the chemokines and cytokines were produced 
in vitro (in supernatants as above) or in vivo and measured in lavage fluid or serum 
(see chapter 2.9 below). 




Once supernatants had been aspirated from the wells, the plates were washed 3 times 
with ice-cold PBS and placed on ice. 0.5ml ice-cold cell lysis buffer (BD 
Pharmingen) containing proteinase inhibitors (Sigma, UK) was added to each well 
and vigorously agitated several times using a 1ml Gilson pipette. The solution, 
containing the contents of the lysed cells, was transferred to 1.5ml Eppendorf 
containers and centrifuged at 12,000 rpm for 15 minutes to remove cellular debris. 
The resultant solutions containing total cellular proteins were decanted to fresh 1.5ml 
Eppendorf containers and subsequently frozen at -80
o
C pending analysis. 
Protein levels in the protein lysis buffer were measured by the detergent compatible 
(DC) protein assay (Bio Rad, USA) according to manufacturer’s instructions for low 
protein concentration assays. 
 
2.8 IN VIVO MODELS OF INFLAMMATION 
 
2.8.1 Thioglycollate peritonitis 
 
Brewer’s Thioglycollate (TG) (Sigma, UK) was reconstituted in sterile, distilled 
water at either 3 or 10% weight/volume (w/v). The resultant solution was then 
aliquoted to 5ml sterile aliquots and stored at 4
o
C until used.  
Mice selected for zero time points were not injected with TG. The abdomens of all 
other mice were cleaned with a disinfectant wipe and TG Peritonitis initiated with an 
ip injection using either 1ml of 3% w/v or 0.5ml 10% w/v TG depending on the 
experiment. Mice were sacrificed at the appropriate time point by cervical 
dislocation. Peritoneal lavage was performed immediately following death with 5ml 
ice-cold PBS as previously described. Lavage fluid recovered, usually in excess of 
4ml, was placed in 15ml falcon tubes and kept on ice pending analysis (Figure 2.17).  
The samples were gently vortexed and 400µl aliquots removed to chilled FACS 
tubes. Remaining lavage fluid was centrifuged at 300g for 10 minutes at 4
o
C. The 
supernatant was then decanted off and stored at -80
o
C pending analysis of 
chemokines and cytokines as described above. Mouse serum was added to each 
FACS tube as an Fc receptor blocking agent and the cells incubated on ice for 30 
minutes. The aliquots were then immunolabeled with rat-anti-mouse monoclonal 
antibodies (see table 2.6 for full details of antibodies and isotypes used) and 
incubated in the dark and on ice for a further 30 minutes. The cells were then washed 




with PBS and analysed by flow cytometry. Different immunolabeling combinations 
and flow cytometry gates were used for different experiments as detailed below. 
 
2.8.1.1 Analysis of leukocyte cell kinetics:  zero to 96 hours 
 
Three aliquots were removed from each sample of lavage fluid. The first aliquot was 
immunolabeled for F4/80 conjugated to APC and GR-1 conjugated to PE. The 
second sample was immunolabeled for B220 conjugated to PE and the third sample 
was stained for CD3 conjugated to PE.   
Figure 2.18 illustrates the representative forward and side scatter plots of peritoneal 
lavage fluid recovered at zero, 24, 48 and 96 hour time points following the ip 
injection of TG. The gate used to define leukocytes, excluding debris and 
erythrocytes, is shown.  Figure 2.19 demonstrates how the fluorescent profiles in FL-
4 (F4/80) and FL-2 (GR-1) change with time over the 96 hours and the gates used to 







. Figure 2.20 demonstrates how B and T lymphocytes 








 respectively. Figure 
2.21 demonstrates the characteristic profiles of M!, PMN and lymphocytes on the 
forward and side scatter plots;  
The first set of aliquots from each mouse was spiked with 50,000 Flowcheck™ 
spheres immediately prior to analysis to facilitate counting absolute numbers of cells, 
as previously discussed. The absolute numbers of B cells and T cells in the second 
and third series of aliquots respectively were calculated as a percentage of total 
leukocytes number determined from the first aliquot. 
2.8.1.2 Analysis of leukocyte cell kinetics: zero to 24 hours 
 
TG peritonitis was initiated as described above using 0.5ml 10% TG in sterile 
distilled water and peritoneal cells harvested by peritoneal lavage at zero, 1, 4, 8 and 
24 hour time points as previously described. Aliquots of lavage fluid were removed 
from each sample and triple stained for F4/80 conjugated to APC, GR-1 conjugated 
to PE, and CD11b conjugated to FITC.  




The gates and flow cytometer settings used for the first series of time points (2.8.1.1 
above) did not fit as well to the cells infiltrating the peritoneum in the early hours 
following initiation of inflammation as they did to the later time points. Separation of 
infiltrating monocytes, M! and PMN by flow cytometry at these time points required 
additional gating as some PMN express significant amounts of CD11b and some 
F4/80
LO
 monocytes express significant amounts of GR-1 (Geissmann et al., 2003) . 















 (see figure 2.22). 
 





Figure 2- 18 Schematic diagram of Thioglycollate peritonitis studies 
Intra-peritoneal 





Flow cytometric analysis 




























































































Table 2- 6 Monoclonal antibodies and isotypes used for flow cytometric analysis 
of leukocytes








Figure 2- 19 Forward and side scatter plots of peritoneal cells during TG peritonitis 
TG peritonitis was initiated by the injection of 1ml 3% TG. Peritoneal cells recovered at 
various time points by peritoneal lavage. Cells were immunolabeled and analysed by flow 
cytometry. Representative forward and side scatter profiles of peritoneal cells recovered are 
shown together with the gate used to count total leukocytes but exclude red blood cells (red 
arrow, image C) and debris. (A) Zero time point or resident cells. (B) 24 hours post TG 
injection. (C) 48 hours post TG injection. (D) 96 hours post TG injection. As the inflammatory 
process progresses, with different inflammatory cells entering and leaving the peritoneum, 










Figure 2- 20 Analysis of M! and neutrophil kinetics during TG peritonitis  
TG peritonitis was initiated by the injection of 1ml 3% TG. Peritoneal cells were recovered at 
various time points by peritoneal lavage. Samples were immunolabelled for F4/80 
conjugated to APC (FL-4) and GR-1 conjugated to PE (FL-2). Cells were then washed and 
analysed by flow cytometry. Leukocytes, gated as above, were analysed according to their 
F4/80 and GR-1 expression. Representative fluorescent profiles of leukocytes in FL-4 and 
FL-2 are shown together with the gates used to count M" (F4/80HI) and PMN (GR-1HI-
F4/80NEG). (A) Zero time point or resident cells. (B) 24 hours post TG injection. (C) 48 













Figure 2- 21 Analysis of B and T lymphocyte numbers during TG peritonitis 
TG peritonitis was initiated by the injection of 1ml 3% TG. Peritoneal cells were recovered at 
various time points by peritoneal lavage. Samples were immunolabeled either for B220 
conjugated to PE (FL-2) or CD3 conjugated to PE or the appropriate isotype control. Cells 
were then washed and analysed by flow cytometry. Leukocytes, gated as above, were 
analysed according to their side scatter profile and FL-2 fluorescence. Representative side 
scatter / FL-2 plots of leukocytes are shown together with the gates used to count 
lymphocytes. (A) Peritoneal cells immunolabelled with B220 isotype control. (B) Peritoneal 
cells immunolabelled for B220. (C) Peritoneal cells immunolabelled with CD3 isotype control. 











Figure 2- 22 Forward and side scatter profiles of leukocytes during TG peritonitis 
TG peritonitis was initiated by the injection of 1ml 3% TG. Peritoneal cells recovered at 
various time points by peritoneal lavage. Samples were immunolabeled, washed and 
analysed by flow cytometry as above. Representative forward and side scatter plots of 
leukocytes are shown: M" in blue, lymphocytes in red and PMN in green. (A) Naïve 

















    
 
Figure 2- 23 Analysis of M! and neutrophil kinetics during TG peritonitis  
TG peritonitis was initiated by the injection of 0.5ml 10% TG. Peritoneal cells were recovered 
at various time points by peritoneal lavage. Samples were immunolabeled for F4/80 
conjugated to APC (FL-4), GR-1 conjugated to PE (FL-2) and CD11b conjugated to FITC 
(FL-1). Cells were then washed and analysed by flow cytometry. Leukocytes, gated as 














) were then gated and counted from 
amongst the remaining cells. (B) Resident peritoneal cells. (C) 1 hour post TG injection. (D) 








2.8.2 Carageenan pleurisy 
 
Carrageenan (CG), a kind gift from Marine Colloids Inc, Philadelphia, USA, was 
reconstituted in sterile distilled water at 1% w/v immediately prior to use. 
All mice, except those selected for the zero time point, were anaesthetised with 
isofluorothane gas. Whilst anaesthetised, the thoraces of the mice were sprayed with 





intercostal muscles. 0.1ml CG was injected intrapleurally (i.pl) into all mice with a 
blunted 21G needle and the wound closed with a Michel clip. 
Mice were sacrificed under general anaesthesia, at appropriate time points, by 
transection of the great vessels in the posterior abdominal cavity causing 
exsanguination. As much blood as possible was harvested into 1.5ml Eppendorf 
tubes and centrifuged at 14,000 rpm for 15 minutes at 4
o
C. The serum was then 
aspirated and frozen at - 80
o
C pending analysis of chemokines and cytokines as 
described previously. 
Once death was confirmed a wide transverse incision just below the rib cage was 
made. The abdominal organs were reflected away to expose the diaphragm which 
was then punctured by a small, anterior, mid-line incision. The pleural cavities were 
lavaged with 1ml 3.88% sodium citrate (Sigma, UK) in saline using a sterile Pasteur 
pipette. Lavage fluid recovered was placed in 1.5ml Eppendorf tubes, weighed 
accurately to measure the volume recovered and kept on ice pending further analysis. 
The samples were gently vortexed prior to removal of 50µl aliquots to chilled FACS 
tubes. The remaining fluid was centrifuged at 2000 rpm for 5 minutes at 4
o
C. 
Supernatants were again decanted off and stored at -80
o
C pending analysis of 
chemokines and cytokines as described above. 
Mouse serum was added to each FACS tube as an FcR blocking agent and the cells 
incubated on ice for 30 minutes. The aliquots were then immunolabeled with 
monoclonal antibodies (see table 2.6 for full details of antibodies used) and incubated 
in the dark, on ice, for a further 30 minutes following which the cells were washed 
with PBS and analysed by flow cytometry. 




2.8.2.1 Analysis of cell kinetics: zero to 72 hours 
A schematic diagram of an experiment studying carrageenan pleurisy is given in 
figure 2.23. Two aliquots were removed from each pleural lavage sample. The first 
aliquot was immunolabeled for F4/80 conjugated to APC, GR-1 conjugated to PE 
and CD11b conjugated to FITC. The second sample was immunolabelled for CD11c 
conjugated to APC.   
Figure 2.24 illustrates representative flow cytometry plots of pleural lavage fluid 
recovered at both the zero and 24 hour time points following the intrapleural 









 cells. DC were defined as 
CD11c
HI
 and were counted as demonstrated in figure 2.25. 






Figure 2- 24 Schematic diagram of Carrageenan pleurisy 
 
 





0, 24, 48 or 72 
hours later 
Flow cytometric analysis 
















Figure 2- 25 Analysis of leukocytes recruited to CG pleurisy 
CG pleurisy was initiated by the injection of 0.1ml 1% CG i.pl. Pleural cells were recovered 
by pleural lavage at various time points and immunolabeled for F4/80 conjugated to APC 
(FL-4), GR-1 conjugated to PE (FL-2) and CD11b conjugated to FITC (FL-1). Samples were 
analysed by flow cytometry. (A) Representative forward and side scatter plot of naïve pleural 
cells and Flowcheck™ beads. (B) Representative forward and side scatter plot of pleural 
cells 24 hours after initiation of pleurisy with gate used to count leukocytes, excluding red 
blood cells and debris. (C) Representative plot of pleural cells 24 hours after initiation of 





). (D) Representative plot of pleural cells 24 hours after initiation of pleurisy 











Figure 2- 26 Analysis of dendritic cells in CG pleurisy 
CG pleurisy was initiated by the injection of 0.1ml 1% CG i.pl. Pleural cells were recovered 
by pleural lavage at various time points and immunolabelled either for CD11c conjugated to 
APC (FL-4), or the isotype conjugated to APC. Samples were analysed by flow cytometry. 
(A) Side scatter, FL-4 plot of pleural cells 24 hours after initiation of pleurisy following 
immunolabeling with the isotype antibody: the gate used to count CD11c
HI
 dendritic cells is 
illustrated. (B) Representative side scatter, FL-4 plot of pleural cells 24 hours after initiation 
of pleurisy following immunolabeling for CD11c conjugated to APC. 




2.8.3 Delayed-Type Hypersensitivity Pleurisy 
 
Initiation of delayed-type hypersensitivity pleurisy (DTH pleurisy) required 2 phases 
undertaken 12 days apart. Phase 1 was the sensitisation of the mice to Methylated 
Bovine Serum Albumin (Meth’BSA). Phase 2, was initiation of pleurisy by the i.pl. 
injection of meth’BSA. 
1% meth’BSA was homogenised in complete Freud’s adjuvant (CFA) immediately 
prior to use. Mice to be sensitised were anaesthetised with isofluorothane gas and the 
base of their tails carefully shaved using an electric razor. Whilst still under general 
anaesthesia the skin was wiped with a medicated swab and 0.1ml of meth’BSA in 
CFA was injected intradermally using a sterile 26g needle. Care was taken to avoid a 
subcutaneous injection. Mice were then allowed to recover from the anaesthesia.  
DTH pleurisy was initiated 12 days later in exactly the same way as for CG pleurisy 
except that 0.1ml of 1% meth’BSA in sterile distilled water was injected.  
Whilst all mice were sensitised, those for the zero time point (i.e. naïve mice) were 
not injected i.pl. with meth’BSA. Mice were again sacrificed by exsanguination 
under general anaesthesia to permit collection of blood for serum analysis. Pleural 
lavages were collected, leukocyte numbers together with cytokine and chemokine 
levels were analysed as for CG pleurisy. A schematic diagram of an experiment 
studying DTH pleurisy is given in figure 2.26. 





Figure 2- 27 Schematic diagram of Delayed Hypersensitivity pleurisy  
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2.9 ANALYSIS OF CIRCULATING LEUKOCYTES 
 
Attempts were made to use blood retrieved from the abdominal cavity during 
exsanguination under general anaesthesia following transection of the great vessels 
(see models of CG pleurisy and DTH pleurisy above). Blood recovered using that 
technique however clotted extremely rapidly such that data collected could be 
inaccurate. The whole blood used in this thesis to analyse circulating leukocytes 
came from a tail bleed. Mice were warmed gently under a lamp and restrained 
gently. A small nick was made near the base of the tail using a sterile scalpel. Once a 
large droplet of blood had formed, 50µl was collected using a sterile 200µl Gilson 
pipette and immediately mixed vigorously with 100µl of 3.88% citrate in a 500µl 
Eppendorf. The resultant mixture was then split equally between 2 chilled FACS 
tubes labeled A and B and kept on ice. Each tube was then immunolabeled with 50µl 
of a solution containing 3 monoclonal antibodies, each diluted 1:100 in PBS with 
10% mouse serum. Tube A was immunolabeled for F4/80 conjugated to APC, GR-1 
conjugated to PE and CD11b conjugated to FITC. Tube B was immunolabeled for 
CD8a conjugated to APC, B220 conjugated to PE and CD4 conjugated to FITC. 
Cells were incubated on ice, in the dark, for 30 minutes and then washed in PBS. 
Pharm Lyse™ lysing solution (BD Biosciences) was used according to 
manufacturer’s instructions to remove red blood cells from the analysis. 
Following red cell lysis, leukocytes were resuspended in PBS with 10% mouse 
serum. Samples were spiked with 50,000 Flowcheck™ beads immediately prior to 
analysis by flow cytometry. Representative dot plots of total leukocytes and gates 
used to define monocytes and PMN are illustrated in figures 2.27. Gates used to 
count lymphocytes are shown in figure 2.28. The numbers of events were translated 
into absolute numbers of leukocytes by comparison to beads counts as previously 
described. 





Figure 2- 28 Analysis of circulating monocytes and PMN 
Blood was collected from a tail bleed into 3.88% citrate. Leukocytes were immunolabeled 
and red cells lysed using a lysis buffer. Cells were analysed by flow cytometry using 
Flowcheck
TM
 beads to count absolute circulating numbers. (A) Representative forward and 
side scatter plot demonstrating the positions occupied by the major leukocyte groups 
(labeled). (B) Representative plot of all leukocytes assessed by fluorescence in FL-4 (F4/80) 
and CD11b (FITC). The gate used to count monocytes is shown. (C) Representative plot of 
monocytes alone when assessed by fluorescence in FL-4 (F4/80) and FL-2 (GR-1): 2 distinct 




) were easily distinguished and counted as shown. 
(D) Representative plot of all leukocytes examined by fluorescence in FL-4 (F4/80) and FL-2 











Figure 2- 29 Analysis of circulating lymphocytes 
Blood was collected from a tail bleed into 3.88% citrate. Leukocytes were immunolabeled 
and red cells lysed using a lysis buffer. Cells were analysed by flow cytometry using 
Flowcheck
TM
 beads to count absolute circulating numbers. (A) Representative plot of all 
leukocytes assessed by side scatter profile and fluorescence in FL-1 (CD4). The gate used 
to count CD4 T lymphocytes is shown. (B) Representative plot of all leukocytes assessed by 
side scatter profile and fluorescence in FL-4 (CD8a). The gate used to count CD8 T 
lymphocytes is shown. (C) Representative plot of all leukocytes assessed by side scatter 
profile and fluorescence in FL-2 (B220). The gate used to count B lymphocytes is shown. 
 




2.10 STATISTICAL ANALYSIS 
 
All statistical analyses were done using PRISM 4 (GraphPad, San Diego, USA). 
Student’s t tests were used to compare an individual pair of mean values whilst 
Analysis of variance (ANOVA) was used to compare differences across several 
mean values. 2 way ANOVA was used to compare the effects of 2 variables such as 
strain of mouse and duration of inflammation. Bonferonni post tests were used to 
compare individual means within the context of an ANOVA. 























Chapter 3. NOD Macrophages 
Exhibit Reduced Phagocytic 
Clearance In Vitro 





Apoptotic cells are usually rapidly cleared by M!, regarded as a ‘professional’ 
phagocyte, as well as other non-professional phagocytic cells within tissues. The 
defective clearance of AC has been linked with a predisposition to autoimmunity 
(Casciola-Rosen et al., 1994). It is hypothesised that the persistence of AC may result 
in the presentation of autoantigen to T cells by DC and that this might contribute to a 
breakdown in peripheral tolerance and the generation of autoimmune responses. For 
example, C1q knockout mice exhibit a well documented defect in AC clearance and 
have a tendency to develop glomerulonephritis that is characterised by the presence 
of AC (Robson et al., 2001).  Similarly other strains of mice prone to develop 
autoimmune diseases such as SLE exhibit defective clearance of AC by M!. In 2002 
O’Brien et al demonstrated that M! from NOD mice phagocytosed AC less 
effectively in vitro compared to M! from a number of other control strains that do 
not develop autoimmune diabetes (O'Brien et al., 2002). The impaired ability to 
ingest AC was age-dependent and was most pronounced in mice as young as one 
week old and was almost undetectable in mice at 12 weeks of age. They also noted 
that M! from female NOD mice cleared AC less effectively than those from male 
NOD mice and that the defective clearance was more apparent among resident PM! 
than BMDM!. In their experiments, they found that the phagocytic ingestion of 
polystyrene beads was comparable across all strains studied, thereby suggesting the 
defect was specific to AC and did not result from a generalised phagocytic defect. 
They argued that these data fitted the observations that diabetes develops with a 
much higher incidence in female rather than male NOD mice and occurs shortly after 
a wave of apoptosis in the neonatal pancreas as it is remodelled in preparation for 
adult life. 
In the studies described in this thesis, C57BL/6 mice were chosen as the main control 
strain for 2 reasons. Firstly, O’Brien et al (O'Brien et al., 2002) demonstrated that 
M! from C57BL/6 mice exhibited the level of phagocytosis that was closest to NOD 
M!. As a result, it was felt this would make them the most rigorous control strain to 
use. Secondly, congenic NOD strains usually have C57BL/6 chromosomal segments 
replacing parts of their NOD genome. The H-2
i7
 is a congenic NOD strain that differs 
from the NOD genome only in its MHC genes which are derived from C57BL/6 
mice. It does not, however, develop insulitis or autoimmune diabetes.   







3.2.1 NOD and H-2i7 PM! demonstrate reduced phagocytic clearance of 
AC and latex beads in vitro. 
Peritoneal cells were harvested from 6 female NOD mice aged 5 weeks together with 
age and sex matched C57BL/6 and H-2
i7
 control mice (see above). Phagocytosis 
assays were performed as previously described in chapter 2.3. In brief, PM! were 
exposed to either fluorescently labelled AC or 3µm latex beads (at a ratio of one 
PM! to ten particles) for one hour in the presence of 10% FBS. The percentage 
phagocytosis and phagocytic index were assessed by fluorescence photography 
followed by manual counting. Over 300 PM! were counted to give values per well 
and 3 to 4 wells were examined to give values per mouse. Since 6 mice were 
assessed from each strain, each value therefore represents at least 5400 PM!. 
Statistical analysis was by 2-way analysis of variance (ANOVA) with Bonferroni 
post tests. 
In accordance with the previously published work of O’Brien et al (O'Brien et al., 
2002), NOD PM! exhibited both a lower percentage phagocytosis and phagocytic 
index compared to C57BL/6 PM! following exposure to AC in vitro. These data 
indicate that fewer NOD PM! phagocytosed AC and, of those that did ingest AC, 
they ingested fewer in the allotted time than the C57BL/6 control PM! (figure 3.1). 
In marked contrast to the published data, however, defective clearance of latex beads 
by NOD PM! was also evident. As expected, since the MHC is not implicated in 
phagocytosis, H-2
i7
 PM! behaved in an identical fashion to NOD PM! following 
exposure to either AC or 3µm latex beads in vitro and exhibited a significantly lower 
percentage phagocytosis and phagocytic index than C57BL/6 derived PM! (figure 
3.1). These mice develop neither insulitis nor diabetes and thus these data do not 
support the hypothesis that it is the impaired phagocytic clearance of AC, specifically 
of apoptotic beta cells in the pancreas, by NOD M! in the second and third weeks of 
life that predisposes to organ specific autoimmune diabetes in NOD mice. The data, 
however, are consistent with a hypothesis that impaired phagocytosis contributes to 
the predisposition to generalised autoimmunity seen in NOD mice. 
 

























































Figure 3- 1 Analysis of phagocytosis of AC and 3µm latex beads in vitro  
Resident peritoneal cells were harvested from C57BL/6 mice, NOD mice and the congenic 
NOD mouse strain H2
i7
. PM" were purified by adhesion and fed AC at a ratio of 10:1 for 60 
minutes at 37
o
C. Phagocytosis was analysed by microscopy following the addition of 
LysoTracker Red. Percentage phagocytosis was defined as the percent of PM" that had 
ingested at least 1 AC whilst phagocytic index was defined as the number of AC eaten by 
100 PM" that had eaten at least 1 AC. (A) PM" from NOD and the congenic NOD strain H2
i7
 
exhibit reduced percentage phagocytosis in vitro compared to C57BL/6 PM" (B) PM" from 
NOD and the congenic NOD strain H2
i7
, exhibit reduced phagocytic index in vitro compared 
to C57BL/6 PM"; * p < 0.05, ** p < 0.01; C57BL/6 vs. NOD and H2
i7
; 2-way ANOVA with 










3.2.2 NOD M! in vitro do not exhibit reduced clearance of opsonised 
pneumococci 
Having demonstrated that NOD PM! demonstrate impaired phagocytic clearance of 
both AC and latex beads in vitro, it was felt important to assess whether this was 
generalised to all particles, or whether under certain conditions NOD PM! would 
clear particles at comparable rates to a control strain. It has been convincingly 
demonstrated that C57BL/6 mice lacking the inhibitory Fc"R2b exhibit enhanced 
clearance of opsonised pneumococci (Clatworthy and Smith, 2004). Many lupus-
prone strains of mice as well as NOD mice have a genetic haplotype that results in an 
approximately 50% reduced expression of Fc"R2b on the cell surface of M! 
compared to control strains including C57BL/6 M! (Clatworthy and Smith, 2004). It 
would therefore be reasonable to hypothesise that NOD PM! would exhibit 
increased phagocytosis of opsonised pneumococci compared to C57BL/6 PM!. 
The small size of pneumococci makes the assessment of percentage phagocytosis and 
phagocytic index by direct microscopy as described above extremely difficult.  An 
alternative method of assessing phagocytosis by flow cytometry described and 
validated by Menna Clatworthy (Clatworthy and Smith, 2004) and described 
previously in chapter 2.3 was therefore employed. In brief, fixed, fluorescent 
pneumococci were either opsonised in serum from mice vaccinated with pneumovax 
2 weeks previously or left non-opsonised. Pooled PM! from 6 week old female NOD 
mice or C57BL/6 control mice were ‘fed’ opsonised or non-opsonised pneumococci 
or fluorescently labeled AC for one hour at 37
0
C. The phagocytosis assay was 
performed in serum-free media in order to avoid unintentional opsonisation of 
pneumococci. Control wells were kept on ice for the duration of the phagocytosis 
assay in order to assess non-specific binding. PM! were removed from the plastic by 
scraping, placed in FACS tubes, stained with anti-murine F4/80 antibodies 
conjugated to APC to fluoresce in FL-4 and assessed by flow cytometry. Since all 
phagocytosed particles were fluorescent in FL-1, the percentage phagocytosis was 
assessed as the percentage of PM! that shifted in FL-1 over and above the rate of 
non-specific binding. Twelve mice from each strain were used to supply sufficient 
PM! for 4 wells per strain for AC (n = 4) and 6 wells per strain for opsonised and 
non-opsonised pneumococci (n = 6). Over 5000 PM! events were recorded per well. 




The phagocytic defect for AC seen with NOD PM! compared to C57BL/6 PM! was 
consistent with phagocytosis being reduced by 32% despite the alternative method of 
assessing phagocytosis and the use of serum-free media. A small, but statistically 
significant, defect was detected for the phagocytosis of non-opsonised pneumococci 
but no difference between the 2 strains was detected for the phagocytosis of 
opsonised pneumococci (see figure 3.2) 
Thus, the in vitro phagocytic defect seen with NOD PM! is neither limited to AC, 
nor is it dependent on the presence or absence of serum. It can however be corrected 
by opsonising the feed, thereby bringing different factors into play, such as FcR. 

































Figure 3- 2 Analysis of in vitro phagocytosis of opsonised pneumococci 
Resident peritoneal cells from NOD and C57BL/6 mice were harvested by peritoneal lavage, 
pooled according to strain, plated into plastic wells and purified by adhesion. PM" were ‘fed’ 
either apoptotic cells at a ratio of 10:1 or an excess of pneumococci (opsonised or non-
opsonised) in the absence of serum. Phagocytosis was assessed after 1 hour. Cells were 
washed, scraped from the plastic and immunolabeled for F4/80 prior to analysis by flow 
cytometry. NOD mice exhibited reduced clearance of both AC and non-opsonised 








3.2.3 Both BMDM! and PM! from 15-week-old female NOD mice exhibit 
a marked in vitro phagocytic defect for AC 
Having demonstrated the in vitro phagocytic defect was clearly apparent in very 
young NOD mice, it was considered important to examine whether the defect was 
still apparent in much older but still pre-diabetic NOD mice. It was also important to 
know whether it is indeed more pronounced in resident, sentinel M! such as PM! or 
whether alternative M! populations such as BMDM! exhibit a similar phagocytic 
defect.  
PM! were harvested from 15-week-old female NOD and C57BL/6 mice. Femurs 
were harvested and BMDM! matured in Teflon pots for 7 days as described 
previously (chapter 2.2) and plated for 24 hours prior to use. Phagocytosis assays 
were performed using pooled M! and assessed by flow cytometry as described above 
(and chapter 2.3). Six NOD and 8 C57BL/6 mice were used, providing sufficient 
PM! for 8 wells per strain (n = 8) and BMDM! for 12 wells per strain (n = 12). Over 
5000 M! events were recorded per well. Statistical analysis was by 2-way ANOVA 
with Bonferroni post tests. 
Even with 15 week old mice there was a clear, albeit somewhat reduced, phagocytic 
defect still apparent in NOD PM! compared to controls. However, BMDM! from 
the same mice exhibited a marked reduction in phagocytosis of AC (see figure 3.3). 
O’Brien’s original paper had argued that defective clearance of AC by NOD M!, 
although still evident in BMDM!, was more pronounced in PM! and that the defect 
became less apparent as NOD mice aged to the point of almost resolving by 12 
weeks. These data were used to support the hypothesis that defective clearance of 
apoptotic Beta cells, at a very specific time point during the development of neonatal 
mice when the pancreas undergoes a wave of apoptosis, lead to the development of 
organ specific autoimmunity. The data from the studies outlined in this thesis 
suggests that the phagocytic defect is present in a much broader context. 
































Figure 3- 3 Analysis of in vitro phagocytosis by PM! from 15 week old NOD mice 
and BMDM! from the same mice 
Resident peritoneal cells from NOD and C57BL/6 mice were harvested by peritoneal lavage, 
pooled according to strain, plated into plastic wells and purified by adhesion. Femurs were 
harvested from the same mice and BMDM" matured in Teflon pots for 7 days in the 
presence of 20% L929. Mature BMDM" were plated into plastic wells 24 hours prior to 
analysis. M" were ‘fed’ AC at a ratio of 10:1 in the absence of serum and phagocytosis was 
assessed after 1 hour. Cells were washed, scraped from the plastic and immunolabeled for 
F4/80 prior to analysis by flow cytometry. PM" and BMDM" from NOD mice exhibited 








3.2.4 The phagocytic defect for AC is clearly apparent with both 30 and 
60 minute feed times 
Having demonstrated that the phagocytic defect was clearly apparent in 15-week-old 
as well as very young NOD mice and was just as marked in BMDM! as PM!, it was 
felt important to examine whether the duration of the in vitro phagocytosis assay was 
important. Did NOD M! initially ingest AC at a rate comparable to controls, but then 
“fatigue” or “saturate” at an early stage? 
BMDM! were harvested from 9-week-old female NOD mice and C57BL/6 controls. 
An in vitro phagocytosis assay was performed as described above (and chapter 2.3) 
using pooled M! and assessment by flow cytometry. AC were used as ‘feed’ at a 
ratio to M! of 10:1 with ‘feed’ times of either 30 or 60 minutes. Once again, NOD 
BMDM! exhibited a marked reduction in the percentage phagocytosis of AC that 
was clearly apparent at both 30 and 60 minutes (figure 3.4).  
These data therefore suggest that the defective phagocytosis of AC by NOD M! in 
vitro is not merely due to early saturation of the phagocytic capacity of M! for AC.  

































Figure 3- 4 Analysis of the effect of incubation time on in vitro phagocytosis 
Femurs were harvested and BMDM" matured in Teflon pots for 7 days in the presence of 
20% L929. Mature BMDM" were plated into plastic wells 24 hours prior to analysis. M" were 
‘fed’ AC at a ratio of 10:1 in the absence of serum and phagocytosis assessed after 30 or 60 
minutes. Cells were washed, scraped from the plastic and immunolabeled for F4/80 prior to 
analysis by flow cytometry. BMDM" from NOD mice exhibited reduced phagocytosis of AC 
by 30 minutes with the defect being maintained at 60 minutes; *** p < 0.001, ** p < 0.01; 
NOD vs. C57BL/6; 2-way ANOVA with Bonferroni post tests.  






PM! and BMDM! from NOD mice exhibit a striking phagocytic defect in vitro. 
The defect is apparent for AC, 3µm latex beads and non-opsonised pneumococci, but 
not opsonised pneumococci. 
 The defect is evidently independent of the presence or absence of FBS. 
The defect is clearly present in older pre-diabetic NOD mice as well as very young 
mice. 
The defect is clearly demonstrable by 30 minutes. 






















Chapter 4. NOD Macrophages 
Exhibit Reduced Phagocytic 
Clearance of Apoptotic Cells In 
Vivo 






The work outlined in Chapter 3 confirmed the previously published work that NOD 
mice exhibit a marked phagocytic defect for AC in vitro and extended this by 
demonstrating that the defect is neither limited to AC nor confined principally to 
young mice (chapter 3). It was now crucial to determine whether the defect was 
present in vivo.   
O’Brien, having originally published data regarding defective clearance of AC by 
NOD M! in vitro in 2002 (O'Brien et al., 2002), published further work in 2006 
trying to demonstrate an AC clearance defect in vivo (O'Brien et al., 2006).  They 
described 2 experimental techniques to address the question. In the first experiment, 
AC were injected ip and at various time points resident peritoneal PM! were 
recovered by peritoneal lavage. These cells were cytospun, stained and examined by 
light microscopy to assess the percentage phagocytosis and phagocytic index. In the 
second technique the mice were injected with dexamethasone to induce thymocyte 
apoptosis. The mice were subsequently sacrificed and the thymi removed. Tisue 
sections were then stained and examined by light microscopy.  Free AC were 
counted as a measure of the phagocytic capability of resident thymic M!. 
There are theoretical problems with both these techniques used to examine 
phagocytosis in vivo. It is well documented that injecting thioglycollate or LPS ip 
results in the rapid disappearance of PM! from the peritoneal cavity, a phenomenon 
termed the M! Disappearance Reaction (MDR) (Nelson and Boyden, 1963).Simon 
Watson clearly demonstrated that the ip administration of AC elicited a profound and 
rapid MDR such that very few PM! could be obtained by peritoneal lavage 30 mins 
following AC administration (PhD, University of Edinburgh 2007). Furthermore, he 
demonstrated that PM! that had phagocytosed an AC preferentially ‘disappeared’ by 
localising to M!-rich milky spots of the omentum. Thus, performing a cytospin of 
the cells that are retrieved from the peritoneum by peritoneal lavage after ip AC 
administration fails to appreciate the dynamic nature of the peritoneal cavity in vivo 
and examining the low number of retrievable PM! could be extremely misleading. It 
has also been documented that thymocytes from NOD mice are resistant to apoptosis 
induced by dexamethasone in vitro (Bergman et al., 2003) although the susceptibility 
in vivo is unknown. The assessment of phagocytic capacity using this model is 




difficult to interpret unless the level of apoptosis induced among the thymocytes of 
NOD and control strains in vivo are equal.  
Bearing in mind the limitations above, it was decided to use the in vivo phagocytosis 
assay employed by Taylor et al (Taylor et al., 2000) that had been adapted by Simon 
Watson (PhD, University of Edinburgh 2007). Fluorescently labeled AC were 
injected ip and phagocytosis was assessed by the relative numbers of free AC 
recovered by peritoneal lavage at various time points. Unlike Taylor et al, no attempt 




4.2.1 Similar numbers of AC are recovered from NOD and C57BL/6 
mice, despite increased numbers of resident PM! present in the 
peritonea of NOD mice  
Having demonstrated that the NOD phagocytic defect for AC in vitro was pervasive, 
male mice aged 8 to 12 weeks were selected with age and sex matched C57BL/6 
controls. In vivo phagocytosis assays were performed as previously described 
(chapter 2.5). In brief, 5 million pre-labelled AC (prepared as described in chapter 
2.2) were injected ip and mice subsequently sacrificed after 1, 15 or 30 minutes. Free 
AC and remaining peritoneal cells were recovered by peritoneal lavage. Aliquots of 
lavage fluid were kept on ice and stained with anti-murine F4/80 antibodies 
conjugated to APC. Cells recovered were assessed by flow cytometry. The absolute 
numbers of AC and PM! were calculated by spiking the sample with a known 
number of fluorescent beads immediately prior to analysis as described in chapter 
2.4. Eight mice of each strain were used for each time point (n = 8). Statistical 
analysis was by 2-way ANOVA with Bonferroni post tests.  




Occasionally a sample was excluded from the analysis either because the injection of 
AC had not been into the peritoneal cavity, intraperitoneal bleding, loss of the cell 
pellet during washing or because the FACS plot was uninterpretable (explained in 
great detail in methods chapter 2.5). Once these samples were excluded there were 
between 6 and 8 mice per group per time point. 
NOD mice had significantly more PM! recovered by peritoneal lavage than 
C57BL/6 controls after 1 minute and a trend to more PM! at both later time points 
(figure 4.1(A)). However, despite the presence of almost twice as many PM! 
initially present to phagocytose and clear AC, strikingly similar numbers of free AC 
were recovered from the 2 strains of mice at all 3 time points assessed (see figure 
4.1(B)).  
Since it is highly likely that there was no influx of M! into the peritoneal cavity 
during this period, the implication of these data is that each NOD PM! cleared AC 
less efficiently than each C57BL/6 PM!. 
 
4.2.2 Adjusting clearance of free AC for numbers of resident PM! 
unmasks a marked in vivo phagocytic defect within NOD mice  
 
The different strains of mice frequently differ in size despite matching for sex and 
age. There may well be other complexities between the peritonea of the 2 strains that 
are poorly understood and could not be anticipated that may affect recovery of AC 
by peritoneal lavage. These differences mean that although similar numbers of AC 
are injected ip, there is a difference in the numbers of AC recovered from each strain, 
even at time zero when no phagocytic clearance has taken place. Using the clearance 
of free AC by each strain at each time point makes some allowance for these 
complexities. The numbers of free AC cleared by each mouse at each time point are 
estimated by comparing the numbers of AC recovered at each time point to the mean 
baseline number of AC recovered from that particular strain. 














































































Figure 4- 1 Analysis of free AC and PM! numbers recovered  
5 x 10
6
 AC were injected ip. Mice were sacrificed either immediately post injection of ip cells 
(1 minute) or after 15 or 30 minutes. Free AC and remaining peritoneal cells were recovered 
by peritoneal lavage with ice-cold PBS. Aliquots of lavage fluid were immunolabeled for 
F4/80 and analysed by flow cytometry. Samples were spiked with 50,000 Flowcheck
TM
 
beads immediately prior to analysis to facilitate counting absolute numbers of free AC and 
PM" recovered. (A) NOD mice had significantly higher numbers of resident PM" at baseline 
to participate in phagocytic clearance of AC. (B) No differences were observed in the 
numbers of free AC recovered at any time point; *** p < 0.001; NOD vs. C57BL/6; 2-way 








There are different ways to adjust the clearance of free AC to compensate for 
differing numbers of PM! present in naïve peritonea of NOD and C57BL/6 mice. 
Assuming there is no influx of M! into the peritoneal cavity to contribute to the loss 
of AC, the simplest method is to adjust the clearance of free AC according to the 
number of PM! present in the naïve abdomen at the start of the experiment. Using 
clearance of free AC as a surrogate marker for phagocytosis, an estimate is thus 
made of the mean number of AC phagocytosed per PM!. The mean number of PM! 
recovered from that strain at 1 minute was used to estimate numbers of PM! present 
in the naïve peritoneal cavity.  
One potential source of error present is the assumption that M! do not enter the 
peritoneal cavity (a reasonable assumption since in the time frame of these 
experiments it would be a monocyte influx and these would be expected to be 
inefficient phagocytes). An additional source of error is that the arithmetic means of 
AC and PM! numbers recovered at 1 minute provide only an estimate of baseline 
numbers. Nonetheless, accepting these limitations a defect in the clearance of AC 
starts to emerge with NOD mice exhibiting markedly reduced phagocytosis of AC 
per PM! at both 15 minutes and 30 minutes (figure 4.2).  
A similar pattern emerged when larger numbers (10 x 10
6
) of AC were injected ip, 
using 8 female mice aged 6 to 8 weeks old per group (figure 4.3) suggesting that 
despite the increased numbers of resident PM! found in NOD mice, the phagocytic 
defect can not be explained merely by AC availability being a rate limiting factor for 
phagocytosis by NOD PM!.  



















































Figure 4- 2 Analysis of AC phagocytosis, adjusted for baseline numbers of PM!  
5 x 10
6
 AC were injected ip. Mice were sacrificed either immediately post injection of ip cells 
(1 minute) or 15 or 30 minutes later. Free AC and remaining peritoneal cells were recovered 
by peritoneal lavage with ice-cold PBS. Aliquots of lavage fluid were immunolabeled for 
F4/80 and analysed by flow cytometry. Samples were spiked with 50,000 Flowcheck
TM
 
beads immediately prior to analysis to facilitate counting the absolute numbers of free AC 
and PM" recovered. Clearance of AC was calculated for each strain by comparing numbers 
of free AC recovered from each mouse to mean baseline numbers of recovered AC. The 
clearance of AC was then adjusted for numbers of resident PM" present; * p < 0.05, ** p < 
0.01; NOD vs. C57BL/6; 2-way ANOVA with Bonferonni post tests 
* 
** 












Figure 4- 3  Analysis of in vivo phagocytosis following ip administration of 10 x 10
6
 AC  
10 x 10
6
 AC were injected ip. Mice were sacrificed either immediately post injection of ip cells 
(1 minute) or 20 minutes later; 8 mice per group. Free AC and remaining peritoneal cells 
were recovered by peritoneal lavage with ice-cold PBS. Aliquots of lavage fluid were 
immunolabeled for F4/80 and analysed by flow cytometry. Samples were spiked with 50,000 
Flowcheck
TM
 beads immediately prior to analysis. (A) No difference was seen in the number 
of free AC recovered (B) Higher numbers of free PM" were recovered from NOD mice. (C) 
Clearance of AC was calculated for each strain by comparing numbers of free AC recovered 
from each mouse to mean baseline numbers of recovered AC; the clearance of AC was then 
adjusted for numbers of resident PM" present; C57BL/6 mice cleared more AC per PM". * p 















































4.2.3 Relating the numbers of free AC recovered to the numbers of 
resident PM! recovered at each time point 
 
Professor Sherratt (Professor of Mathematics, Heriot-Watt University, Edinburgh) 
was consulte in the light of the potential sources of error inherent in the above 
method of analysing the available data as he specialises in mathematical modelling 
of biological systems. Professor Sherratt’s analysis indicated that the clearance of 
AC by PM! can be accurately described using a mathematical model: 
 
'A/'t  = -k1PA / (k3 + A)  A  AC number  
 
'P/'t  = -k2PA / (k3 + A)  P  PM! number 
 
     k1-3  constants 
 
This model assumes that the rates of clearance of AC and the disappearance of PM! 
are proportional to the numbers of PM! and AC present (see figure 4.4). He fitted 
the data points from the above experiment to these equations using a least squares 
method to make two separate and interesting predictions (see figure 4.5). 
The first prediction concerns rate of clearance of AC. Because in this general form of 
the model the clearance rate depends on the number of apoptotic cells, he took the 
clearance rate when A = 2 (million) as a specific statistic with which to compare the 
models. The best-fit parameters gave rates of 0.065 (units: per minute) for the 
C57BL/6 strain and 0.032 for the NOD strain. These numbers indicate that, when 
there are 2 x 10
6
 AC present, the average time taken by a PM! to locate and clear 
one of these cells is 1 / 0.065 or approximately 15 minutes for the C57BL/6 mice and 
1 / 0.032 or approximately 31 minutes for the NOD mice. 
The second prediction concerned the parameter k3. The best-fit value was quite 
different for the two cases. For the C57BL/6 strain the data implied k3 was very large 
(effectively infinite). This would mean that the time needed to find an AC was 
significantly greater than the time needed to clear it i.e. an increase in the numbers of 
AC present would result in a further increase in the clearance rate. On the other hand, 
for the NOD strain the best fit was with k3 = 0. This would indicate that the time 
needed to locate an AC was insignificant compared to the time needed to clear it i.e. 
increasing the numbers of AC present would have no impact on the clearance rate. 




Therefore, this mathematical analysis and modeling of the experimental data 
suggested a very different behaviour between the PM! of the two strains. 
 
4.2.4 NOD mice exhibit reduced in vivo phagocytosis of beads 
 
Having clearly identified the phagocytic defect of NOD mice for AC in vivo, it was 
important to examine whether the clearance 3µm latex beads in vivo was also 
impaired in the light of the defective clearance of 3µm latex beads in vitro outlined in 
Chapter 2. The method was very similar to that employed for AC above and 
described in detail in chapter 2.5. In brief, 10 x 10
6
 fluorescent green, latex beads 
were injected ip into 8 week old female NOD or age and sex matched C57BL/6 
control mice. Mice were sacrificed by cervical dislocation either immediately (n = 4 
per group) or 20 minutes later (n = 8 per group). Peritoneal cells and latex beads 
were recovered by peritoneal lavage, PM! were immunolabeled for F4/80 and 
samples analysed by flow cytometry. Aliquots were again spiked with 50,000 
Flowcheck
TM
 beads immediately prior to analysis to facilitate counting absolute 
numbers of beads and PM! recovered. 
Even though, once again NOD mice had higher numbers of resident PM! (2.9 ± 0.2 
vs. 2.0 ± 0.14; NOD vs. C57BL/6; p < 0.01), the C57BL/6 mice were strikingly more 
efficient at clearing the latex beads (figure 4.6). This confirmed the in vitro data 
suggesting the phagocytic defect of NOD mice is not confined to AC as previously 
published.  
















%A/%t  = -k1PA / (k3 + A)    
%P/%t  = -k2PA / (k3 + A) 
 
Figure 4- 4 Explanation of the meaning behind constant k3  
The model implies that the rate of phagocytic clearance of apoptotic cells is dependent on 
the availability of apoptotic cells i.e. their numbers present. When the numbers of apoptotic 
cells increases, the rate of clearance will increase. The size of the constant k3 indicates 












   
Figure 4- 5 Illustrations of the ‘best fit’ lines used to analyse experimental data 
(A) Best fit parameters for the NOD strain of mice require k3 to be effectively zero. (B) Best-fit 
parameters for the C57BL/6 strain of mice require k3 to be effectively infinite  
A 
B 






Figure 4- 6 NOD mice exhibit defective clearance of latex beads in vivo 
10 x 10
6 
fluorescent green 3µm latex beads were injected ip. Mice were sacrificed either 
immediately post injection of ip cells (n = 4) or 20 minutes later (n = 7). Free latex beads and 
remaining peritoneal cells were recovered by peritoneal lavage with ice-cold PBS. Aliquots of 
lavage fluid were immunolabeled for F4/80 and analysed by flow cytometry. Samples were 
spiked with 50,000 Flowcheck
TM
 beads immediately prior to analysis. After 20 minutes 
significantly fewer latex beads were recovered from the peritonea of C57BL/6 mice 
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Resident peritoneal macrophages from NOD mice exhibit a striking defect in the 
phagocytic clearance of AC compared to C57BL/6 mice in vivo 
Results of mathematical modelling imply that NOD resident peritoneal macrophages 
take twice as long to clear an apoptotic cell in vivo as C57BL/6 controls 
The mathematical modelling also implies that the defect lies with the phagocytosis of 
the apoptotic cell as suspected from the in vitro data and not locating the apoptotic 
cell 
Defective phagocytosis of 3µm latex beads, as well as AC is evident in vivo 






















Chapter 5. The in vivo 
phagocytic defect of NOD mice 
localises to idd18 & Vav3  
 






Data presented in chapters 3 and 4 demonstrated a clear defect in the phagocytic 
clearance of AC and latex beads by M! of NOD mice compared to C57BL/6 mice. 
This defect was clearly present in BMDM! and resident PM! in vitro and was also 
evident in PM! in vivo. These experiments, however, did not provide any insights 
into the underlying cause of the defect. Contrary to the implication of the work done 
by Simon Levine’s group in Boston, USA (Fan et al., 2006) the in vitro phagocytic 
defect was found to be present irrespective of the presence or absence of FBS. Also, 
in contrast to the work of O’Brien et al (O'Brien et al., 2002) the phagocytic defect 
was clearly present in pre-diabetic NOD mice of all ages tested. Furthermore, the 
phagocytic defect was not limited to AC alone and did diminish with age. In 
addition, mathematical modelling of the data generated from the in vivo experiments 
suggested that the rate at which NOD PM! could physically engulf and clear an AC 
was the key rate-limiting step. These data support the hypothesis that the slower 
phagocytic clearance of NOD M! is the result of a defect in one of the many crucial 
steps that are required for efficient phagocytosis.  
It was decided to explore this issue by two distinct approaches. The first approach 
was to examine the expression of surface receptors previously documented to play an 
important role in the phagocytic clearance of AC seeking a clear difference between 
the M! from NOD and C57BL/6 mice. This strategy will detect a difference in the 
level of expression of receptors and will give no indication regarding function. The 
second approach was to compare the efficiency of in vivo phagocytosis in various 
congenic strains of NOD mice in an attempt to localise the defect to a specific idd 
locus. Whilst this genetic approach may not identify a single responsible gene, it may 
narrow it down to a few candidate genes within an idd locus. Furthermore, within the 
candidate genes suggested by such an approach, a limited number that might play a 
role in the regulation of phagocytosis. The advantage of this approach is that it gives 
functional information and, if it can be demonstrated that the phagocytosis defect 
does localise to an idd locus, gives a strong indication that the defect plays an 
aetiological role in the development of type 1 diabetes mellitus in NOD mice.  






5.2.1 No consistent differences were identified between NOD and 
C57BL/6 M! in the production of mRNA for several key phagocytic 
receptors  
 
Real Time PCR makes it possible (as described in chapter 2.6), to assess 
quantitatively the amounts of mRNA coding for a specific protein present within a 
given a population of cells. It was decided to use this approach to analyse the 
production of mRNA for a range of key receptors known to play a role in the 
phagocytic process, comparing PM! and BMDM! from NOD mice to those from 
C57BL/6 mice. The receptors chosen were the scavenger receptors CD36 and SRA, 
the integrins CD51 ($V), CD61 (#3) and CD29 (#1), the LPS receptor CD14, the 
complement protein C1q and thrombospondin (TSP).  
RNA was isolated and quantified by Real Time PCR as previously described.  In 
brief, PM! were harvested by peritoneal lavage from either 6 week old female NOD 
mice or age and sex matched C57BL/6 controls. Due to the paucity of mRNA 
available from the PM! of a single mouse, peritoneal cells from 3 mice were pooled 
together, plated in 6-well plates for 1 hour and the PM! purified by adhesion. Nine 
individual mice from each strain were therefore required to give 3 RNA samples for 
analysis (n = 3). RNA was extracted from cells using Trizol and frozen at -80
o
C until 
further analysis. BMDM! from the same mice (4 of each strain, n = 4) were matured 
in Teflon pots for 7 days as previously described (chapter 2.2). 3 x 10
6
 BMDM! 
were plated into the wells of a 6-well plate for 1 hour before non-adherent cells were 
removed by gentle washing with warm media. RNA was again extracted from cells 
using Trizol and frozen at -80
o
C until further analysis. A cDNA library was then 
constructed by Reverse Transcription and the samples assessed by Real Time PCR. 
Each result was expressed as a fraction of the 18s housekeeping gene mRNA. NOD 
M! and C57BL/6 M! were then compared directly and plotted on a logarithmic 
scale with 95% confidence intervals. Statistical analysis was by student’s t test.  
Figure 5.1 illustrates the data for BMDM! whilst figure 5.2 illustrates the data for 
PM!. As can be seen, analysis of mRNA from BMDM! indicated that NOD M! 
underexpressed TSP but overexpressed CD14. In contrast, analysis of mRNA from 
PM! indicated no difference in the expression of these 2 proteins but overexpressed 
CD61. Since the phagocytic defect of NOD mice compared to C57BL/6 mice was 




clearly evident in both PM! and BMDM!, these inconsistent differences in mRNA 
are unlikely to be significant.  
Rather than continue comparing the production of mRNA for an ever greater number 
of receptors, it was decided to examine the expression of receptors on the cell surface 
using flow cytometry. It could be argued that surface expression, rather than 
expression of mRNA is physiologically more important. 
 





















Figure 5- 1 mRNA expression by NOD and C57BL/6 BMDM! 
Femurs were harvested and BMDM" matured for 7 days in Teflon pots prior to plating into 
plastic wells. mRNA was extracted and isolated using Trizol and cDNA was obtained by 
Reverse Transcription. mRNA for specific cell surface receptors was quantified by Real Time 
PCR relative to the housekeeping gene 18s mRNA. Levels of each receptor found in NOD 
BMDM" are expressed relative to C57BL/6 BMDM", 95% confidence intervals are shown. * 
p < 0.05, *** p < 0.001; NOD vs. C57BL/6; Student’s t test. 
















Figure 5- 2 mRNA production by NOD and C57BL/6 PM! 
Peritoneal cells NOD and C57BL/6 mice were harvested by peritoneal lavage with 5ml ice-
cold PBS. 9 mice of each strain were used. Lavages from the same strain were pooled 
together in groups of 3 and cells plated into wells of 6-well plates. PM" were purified by 
adhesion and mRNA was extracted and isolated using Trizol. cDNA was obtained by 
Reverse Transcription. mRNA for specific cell surface receptors was quantified by Real Time 
PCR relative to the housekeeping gene 18s mRNA. Levels of each receptor found in NOD 
PM" are expressed relative to C57BL/6 PM", 95% confidence intervals are shown. * p < 
0.05; NOD vs. C57BL/6; Student’s t test. 




5.2.2 No real differences were identified between NOD and C57BL/6 
PM! in the surface expression of several key phagocytic 
receptors  
 
Antibody availability limited the examination of the surface expression of receptors 
involved in phagocytosis to 5 key receptors involved in apoptotic cell ingestion: 
CD14, SRA, CD36, CD51 and CD61. Expression was assessed by flow cytometry as 
previously described (chapter 2.7). In brief, PM! were harvested by peritoneal 
lavage from either 5-week-old female NOD or age and sex matched C57BL/6 control 
mice. The harvested cells were kept on ice and aliquots from each mouse were 
immunolabelled for the murine M! marker F4/80 and each of the surface receptors in 
turn. The anti-F4/80 antibody was conjugated to APC to fluoresce in FL-4 whilst the 
anti-receptor antibodies were chosen to fluoresce in FL-1. Appropriate isotype 
controls were used. Levels of surface receptor expression were assessed on F4/80 
positive cells only to ensure specificity and measured as the geometric mean 
fluorescence in FL-1 (arbitrary units). Six mice of each strain were used and 
statistical analysis undertaken using the student’s t-test. 
Although the expression of CD14 by NOD PM! appeared significantly reduced 
compared to that of C57BL/6 PM! (14.2 ± 0.7 vs. 18.0 ± 0.7; NOD vs. C57BL/6; p 
< 0.01), the FL-1 shifts for PM! of both strains were small and this may have been 
secondary to limited efficiency of antibody binding (see figure 5.3). Thus, 2 
additional anti-murine CD14 antibodies (clones 4C6 and 61D3, kind gifts of John 
Hall, CIR, Edinburgh) were assessed. Unfortunately, despite using increasing 
concentrations of each antibody, these antibodies bound CD14 slightly more 
efficiently than the original antibody: 4C6 (24.4 ± 0.86 vs. 19.1 ± 0.26; NOD vs. 
C57BL/6; p < 0.001) and 61D3 (25.1 ± 1.0 vs. 21.3 ± 0.5; NOD vs. C57BL/6; p < 
0.01). Although the data regarding CD14 was consistent it remains tentative. Similar 
results were obtained with the anti-murine CD36 antibodies used. The shifts in FL-1 
achieved for both strains of PM! were very small and, although the differences 
between them reached statistical significance, the pathophysiological importance of 
the finding remains unclear (see figure 5.4). In order for this line of inquiry is to be 
pursued additional antibodies with increased binding to these receptors will be 
required. 




The surface expression of SRA by NOD PM! was significantly higher (see figure 
5.5) and was almost twice that of the control strain (35.6 ± 4.1 vs. 22.3 ± 0.8; NOD 
vs. C57BL/6; p<0.01). It is unlikely that increased expression of the SRA receptor 
would lead to diminished phagocytosis and this result may also be a statistically 
significant finding but not a key biological finding that sheds light upon the 
underlying mechanism of defective phagocytosis of NOD PM!.  
As expected, both strains of mice expressed high levels of CD61, with NOD PM! 
expressing slightly more than controls (79.7 ± 3.04 vs. 62.2 ± 2.89; NOD vs. 
C57BL/6; p < 0.01). Whilst this difference reached statistical significance, it was 
very small and again most unlikely to result in any altered physiological functions 
such as phagocytosis (see figure 5.6).  
Both NOD and C57BL/6 PM! expressed reasonably high levels of CD51 (32.2 ± 
0.54 vs. 31.0 ± 1.12; NOD vs. C57BL/6; ns), but no differences were evident 
between the 2 strains (see figure 5.7).  
The use of Real Time PCR and flow cytometry to assess mRNA production and 
surface expression of selected proteins had proved to be unfruitful. This could be 
because the relevant proteins had not been selected for analysis as study is limited by 
the availability of PCR probes, monoclonal antibodies and time. It might also reflect 
the fact that the defect lies in the functionality of a receptor rather than protein 
production or cell surface expression. Alternatively the defect could lie within the 
intracellular pathways necessary for efficient phagocytosis and not with cell surface 
receptors at all.  
Microarray technology, searching for relative differences between the strains in the 
expression of thousands of genes, was considered. However the opportunity arose to 
try the alternative strategy of using congenic NOD strains. This approach had 3 
advantages: (i) if successful it would highlight only a few candidate genes, (ii) it 
would prove that at least one of the implicated genes was responsible for the 
phagocytic defect and (iii) it would strongly implicate the defect in the aetiology of 
diabetes in NOD mice.  







Figure 5- 3 Representative histograms of CD14 expression of PM! 
PM" were harvested by peritoneal lavage and immunolabelled for F4/80 (conjugated to APC 
to fluoresce in FL-4) and CD14 or correct isotype antibody (conjugated to fluoresce in FL-1). 
The fluorescence in FL-1 of the F4/80 positive PM" was then assessed. Representative 
plots are shown above: unstained in blue, isotype control in red, C57BL/6 PM" with 
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Figure 5- 4 Representative histograms of CD36 expression of PM! 
PM" were harvested by peritoneal lavage and immunolabelled for F4/80 (conjugated to APC 
to fluoresce in FL-4) and CD36 or correct isotype antibody (conjugated to fluoresce in FL-1). 
The fluorescence in FL-1 of the F4/80 positive PM" was then assessed. A representative 
plot is shown above: unstained in blue, isotype control in red, C57BL/6 PM" with monoclonal 
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Figure 5- 5 Representative histograms of SRA expression of PM! 
PM" were harvested by peritoneal lavage and immunolabelled for F4/80 (conjugated to APC 
to fluoresce in FL-4) and SRA or correct isotype antibody (conjugated to fluoresce in FL-1). 
The fluorescence in FL-1 of the F4/80 positive PM" was then assessed. A representative 
plot is shown above: unstained in blue, isotype control in red, C57BL/6 PM" with monoclonal 
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Figure 5- 6 Representative histograms of CD61 expression of by PM! 
PM" were harvested by peritoneal lavage and immunolabelled for F4/80 (conjugated to APC 
to fluoresce in FL-4) and CD61 or correct isotype antibody (conjugated to fluoresce in FL-1). 
The fluorescence in FL-1 of the F4/80 positive PM" was then assessed. A representative 
plot is shown above: unstained in blue, isotype control in red, C57BL/6 PM" with monoclonal 
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Figure 5- 7 Representative histograms of CD51 expression of PM! 
PM" were harvested by peritoneal lavage and immunolabelled for F4/80 (conjugated to APC 
to fluoresce in FL-4) and CD51 or correct isotype (conjugated to fluoresce in FL-1). The 
fluorescence in FL-1 of the F4/80 positive PM" was then assessed. A representative plot is 
shown above: unstained in blue, isotype control in red, C57BL/6 PM" with monoclonal 
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5.2.3 Using congenic NOD strains, the in vivo phagocytic defect is 
localised first to idd 3/10/18 and subsequently to idd 18 
 
Idd loci within the NOD genome that convey susceptibility to type 1 diabetes 
mellitus have been identified through linkage studies.  NOD congenic strains have 
been developed with small sections of NOD genome within these idd loci replaced 
by chromosomal material from other strains of mice, usually C57BL/6 or C57BL/10. 
The R323 strain has C57BL/6 material on chromosome 3 replacing idd 3/10/18 
regions; R20 has C57BL/6 material only replacing idd 3/10; R905 has C57BL/10 
genetic material replacing idd 9 on chromosome 4 whilst the 1591 strain has 
C57BL/6 material replacing idd 3 on chromosome 3 and C57BL/10 material 
replacing idd 5 on chromosome 1 (see table 5.1).  
5.2.3.1 The phagocytic defect localises to idd 10/18 
 
In vivo phagocytosis assays were performed as previously described (chapter 2.5) at 
the University of Cambridge. Seven-week old female NOD mice were used with age 
and sex matched C57BL/6, R323 and 1591 mice. The number of time points 
examined was reduced in order to accommodate the simultaneous assessment of 4 
strains of mice. In brief, 5 million AC pre-labelled with cell-tracker green were 
injected ip and mice sacrificed 1 or 30 minutes later. Free AC and peritoneal cells 
were recovered by peritoneal lavage. Aliquots of lavage fluid were kept on ice and 
stained with anti-murine F4/80 antibodies conjugated to APC. Cells recovered were 
assessed by flow cytometry. Absolute numbers of AC and PM! were calculated by 
spiking the sample with a known number of fluorescent beads immediately prior to 
analysis. Four mice of each strain were used for the initial 1 minute time point and 6 
mice of each strain for the 30 minute time point. Statistical analysis was by 1 or 2 
way ANOVA with Bonferroni post tests as appropriate. 
There were similar numbers of PM! present in the peritoneal cavities of NOD and 
NOD congenic strains. As expected, fewer PM! were recovered from C57BL/6 mice 
than from NOD or either congenic strain assessed (see figure 5.8), although the 
differences between C57BL/6 and NOD mice did not reach statistical significance. In 
this experiment the C57BL/6 mice and the R323 congenic strain effectively cleared 




all AC from the peritoneal cavity in the allotted time scale. The NOD and 1591 
congenic strain failed to clear any AC, (see figure 5.9). 
This highlights certain subtle differences between different NOD colonies. The 
‘Edinburgh’ NOD mice were purchased from Charles River, France whilst the 
‘Cambridge’ NOD mice originated from the Taconic sub-strain in the USA. The two 
colonies were separated approximately 30 years ago. ‘Edinburgh’ NOD mice had 
increased numbers of PM! compared to C57BL/6 mice but cleared comparable 
numbers of AC such that the phagocytic defect was therefore implicit. In contrast 
‘Cambridge’ NOD mice had statistically comparable levels of PM! but had an 
explicit phagocytic defect in vivo with fewer AC cleared.  
As explained in chapter 2.4, the numbers of AC recovered by peritoneal lavage is 
affected by factors other than phagocytic clearance alone. For example, the size and 
complexity of the peritonea being lavaged may vary across different strains of mice. 
This can be controlled for to some extent by calculating the clearance of AC from 
peritonea i.e. the numbers of AC recovered at the later time point are compared to 
mean numbers recovered at baseline for that particular strain. The C57BL/6 and 
R323 strains cleared significantly more AC than either NOD or 1591 mice with no 
differences in AC clearance observed between C57BL/6 and R323 mice (figure 
5.10). 
The replacement of NOD chromosomal material on chromosome 3 across idd 
regions 3, 10 and 18 in R323 mice completely corrected the phagocytic defect. It is 
reasonable to hypothesis that any gene(s) responsible for the defect are located 
within this region. It is also reasonable to infer that since replacing both idd 3 and idd 
5 with C57BL/6 and C57BL/10 material respectively (the 1591 congenic strain) did 
not correct the phagocytic defect, that idd 3 is not involved and that the defect 
therefore localises to idd 10/18. 












C57BL/6 n/a n/a n/a NO 
NOD n/a n/a n/a YES 
R323 3/10/18 3 C57BL/6 NO 
R20 3/10 3 C57BL/6 YES 




R905 9 4 C57BL/10 YES 
 
Table 5- 1 Summary of NOD congenic strains used and the presence or absence 
of an apoptotic cell phagocytosis defect 
 

































Figure 5- 8 Analysis of the numbers of resident PM! recovered 
5 x 10
6
 AC were injected ip into 4 age and sex matched mice of each strain. Mice were 
sacrificed immediately by cervical dislocation and peritoneal cells recovered peritoneal 
lavage. Aliquots of lavage fluid were immunolabelled for the murine M" marker F4/80 to 
identify PM", spiked with Fowcheck
TM
 beads to enable counting of absolute cell numbers 
and assessed by flow cytometry. C57BL/6 mice have fewer resident peritoneal macrophages 
than the NOD congenic strains of mice, * p < 0.05, ** p < 0.01 vs. C57BL/6; 1 way ANOVA. 
No significant differences were elicited either between NOD and NOD congenic strains, or 
between NOD and C57BL/6 mice. 


































Figure 5- 9 Analysis of AC numbers recovered by different strains of mice 
5 x 10
6
 pre-labeled AC were injected ip into age and sex matched mice of each strain. Mice 
were sacrificed either immediately (n = 4 per group) or 30 minutes later (n = 6 per group) by 
cervical dislocation. Peritoneal cells were recovered peritoneal lavage. Aliquots of lavage 
fluid were spiked with Flowcheck
TM
 beads to enable counting of AC numbers and assessed 
by flow cytometry. Significant numbers of AC were cleared by C57BL/6 and R323 mice, in 
sharp contrast to NOD and 1591 mice. * p < 0.05, ** p < 0.01; 1 vs. 30 minute dwell times; 2 
way ANOVA with Bonferroni post tests.  
* ** 






































Figure 5- 10 Analysis of AC clearance by different strains of mice 
5 x 10
6
 pre-labeled AC were injected ip into age and sex matched mice of each strain. Mice 
were sacrificed either immediately (n = 4 per group) or 30 minutes later (n = 6 per group) by 
cervical dislocation. Peritoneal cells were recovered peritoneal lavage. Aliquots of lavage 
fluid were spiked with Fowcheck
TM
 beads to enable counting of AC numbers and assessed 
by flow cytometry. AC clearance was calculated by comparing numbers of AC recovered at 
30 minutes to baseline numbers recovered for that strain. C57BL/6 and R323 mice cleared 
significantly more AC than NOD and 1591 mice. * p < 0.05, ** p < 0.01; vs. NOD or 1591 
mice; no significant differences were identified between C57BL/6 and R323 mice; 1 way 
ANOVA with Bonferroni post tests.  




5.2.3.2 The phagocytic defect localises to idd 18 
A further series of in vivo phagocytosis assays was performed using a different panel 
of congenic mice for comparison: R20 (idd 3/10) and R905 (idd 9) strains. If the R20 
congenic did not exhibit a phagocytic defect, then the gene(s) underlying the 
defective AC clearance would localise to idd 10. Conversely, if the R20 congenic 
exhibited an AC phagocytic defect then gene(s) would be localise to idd 18. The 
R905 strain was included as a negative control with C57BL/6 remaining as a positive 
control for the experiment.  
Female NOD mice aged 6 to 7 weeks with age and sex matched controls were 
selected. Because the C57BL/6 mice had effectively cleared all available AC by 30 
minutes in the previous experiment, their clearance rates towards the end of the 
experiment were limited by AC availability. Rather than inject more AC, a shorter 
time point of 20 minutes was selected. Four mice were again used at the 1 minute 
time point and 6 mice were used at the 20 minute time point. Statistical analysis was 
by 1 or 2 way ANOVA as appropriate with Bonferroni post tests. 
On this occasion there were similar numbers of PM! present in all strains of mice 
(figure 5.11).  Nevertheless, only C57BL/6 mice cleared significant numbers of AC 
(figure 5.12), clearing significantly more than the NOD and congenic strains; AC 
clearance was similar between NOD mice and R20 and R905 congenic strains (figure 
5.13). Thus, the phagocytic defect was not corrected by replacement of idd 3/10 with 
C57BL/6 chromosomal material.  
From the previous experiment replacing idd 3, 10 and 18 on chromosome 3 with 
material from C57BL6 mice corrected the defective phagocytosis present in NOD 
mice to levels comparable to C57BL/6 mice. From this latter experiment, 
replacement of idd 3 and 10 alone with chromosomal material from C57BL/6 mice 
did not correct the phagocytic defect. These data suggest that the phagocytic defect 
localises to idd 18 although this specific experiment has yet to be undertaken: this 
would require importation of additional congenic mice from USA and was possible 
through lack of time. 
































Figure 5- 11 Analysis of resident PM! numbers recovered 
5 x 10
6
 AC were injected ip into 4 age and sex matched mice of each strain. Mice were 
sacrificed immediately by cervical dislocation and peritoneal cells recovered peritoneal 
lavage. Aliquots of lavage fluid were immunolabelled for the murine M" marker F4/80 to 
identify PM", spiked with Flowcheck
TM
 beads to enable counting of absolute cell numbers 
and assessed by flow cytometry. No significant differences were elicited between any of the 
strains of mice investigated. 





































Figure 5- 12 Analysis of AC numbers recovered by different strains of mice 
5 x 10
6
 pre-labeled AC were injected ip into age and sex matched mice of each strain. Mice 
were sacrificed either immediately (n = 4 per group) or 20 minutes later (n = 6 per group) by 
cervical dislocation. Peritoneal cells were recovered peritoneal lavage. Aliquots of lavage 
fluid were spiked with Flowcheck
TM
 beads to enable counting of AC numbers and assessed 
by flow cytometry. Significant numbers of AC were cleared by C57BL/6 mice, in contrast to 
NOD, R20 and R905 mice. *** p < 0.001; 1 minute vs. 20 minute dwell times; 2 way ANOVA 
with Bonferroni post tests.  







































Figure 5- 13 Analysis of AC clearance by different strains of mice 
5 x 10
6
 pre-labeled AC were injected ip into age and sex matched mice of each strain. Mice 
were sacrificed either immediately (n = 4 per group) or 20 minutes later (n = 6 per group) by 
cervical dislocation. Peritoneal cells were recovered peritoneal lavage. Aliquots of lavage 
fluid were spiked with Flowcheck
TM
 beads to enable counting of AC numbers and assessed 
by flow cytometry. AC clearance was calculated by comparing numbers of AC recovered at 
30 minutes to baseline numbers recovered for that strain. C57BL/6 cleared significantly more 
AC than NOD, R20 or R905 mice. ** p < 0.01; vs. NOD, R20 or R905 mice; 1 way ANOVA 
with Bonferroni post tests.  






Real Time PCR analysis of both BMDM! and PM! found no consistent difference 
between NOD and C57BL/6 mice in the mRNA production for CD36, C1q, TSP, 
CD61, CD51 and CD29. These molecules are unlikely candidates for the mechanism 
underlying defective AC phagocytosis by NOD M! 
PM! of mice possibly express less CD14 and CD36, but the cell surface antibody 
binding was extremely low for both strains of mice 
PM! of mice possibly express more SRA on their surface as assessed by flow 
cytometry, but again antibody binding was low for both strains of mice 
A key finding is that the NOD congenic strain R323 (idd 3/10/18) cleared AC from 
the peritoneal cavity with the same efficiency as C57BL/6 mice. The R20 congenic 
mice (idd 3/10) cleared AC from the peritoneal cavity at a similar rate to NOD mice. 
These results suggest that the genes underlying the defective peritoneal clearance of 
AC localise to idd 18 on chromosome 3. Analysis of the known genes within the idd 
18 locus yields only one functional gene that importantly has several single 
nucleotide polymorphisms: Vav3 (Maier and Wicker, 2005) a GEF that has been 
shown to be involved in phagocytosis (Hall et al., 2006). 
 









Chapter 6. In vitro analysis of 
the inflammatory phenotype 
of NOD macrophages  
 






Having demonstrated a clear phagocytic defect in M! from NOD mice in vitro and in 
vivo, it was felt important to examine other functions of NOD M!. An important 
function of resident M! is to act as sentinel cells that sample the microenvironment 
and, if required, initiate the inflammatory response by producing pro-inflammatory 
chemokines and cytokines (Cailhier et al., 2005; Cailhier et al., 2006). Although 
previous work has compared the responsiveness of NOD M! to M! from various 
control strains in vitro, there is no clear consensus in the literature.  
Jerrold Levine’s group from Boston, USA reported that, in the presence of either 
serum or opsonised AC, TG elicited PM! from NOD mice produced less pro-
inflammatory cytokines (principally IL-1#) than TG elicited PM! from either DBA 
or C57BL/6 control mice following stimulation with LPS (Fan et al., 2004). This was 
consistent with and extended their previous work with SLE prone strains of mice 
(Koh et al., 2000). It was, however, in stark contrast with 2 previously published 
papers by different groups that found various M! populations from NOD mice to be 
hyper-responsive to inflammatory stimuli. 
Sen et al in North Carolina, USA reported that the NF(B pathway in both BMDM! 
and splenic M! from NOD mice was hyperactive compared to M! from either 
BALB/c or NOR mice with a consequent increased production of pro-inflammatory 
cytokines (Sen et al., 2003). This extended their previously published work 
examining NOD derived DC in vitro (Poligone et al., 2002).   
Stoffels et al (Stoffels et al., 2004) in Leuven, Belgium reported that resident PM! 
from NOD mice produced significantly more pro-inflammatory cytokines (IL-1# and 
TNF$) in response to necrotic cells or LPS compared to M! from either C57BL/6 or 
NOR mice Also, unlike M! from either C57BL/6 or NOR control strains, resident 
PM! from NOD mice failed to downregulate cytokine production in the presence of 
AC. In contrast the pro-inflammatory response of NOD M! to IFN" was diminished 
compared to control strains. Consistent with these findings they demonstrated 
hyperactivity of the NF(B signalling pathway and reduced STAT1$ activity.  
As the literature regarding an important aspect of M! function was controversial, it 
was felt crucial to examine the inflammatory phenotype of different NOD M! 




populations in vitro and in vivo. BMDM! and 2 resident M! populations (PM! and 
PLM!) were used in the in vitro experiments and TG peritonitis and CG pleurisy 
were utilised as 2 models of in vivo inflammation. These models had been well 
established within our laboratory and previously shown to be M!-dependent 
(Cailhier et al., 2005; Cailhier et al., 2006). Lastly, the DTH model of pleurisy, a less 
M!-dependent in vivo model of inflammation, was used. 
C57BL/6 mice were used as the control strain for similar reasons as outlined in 
previous chapters. They are widely used in the literature as a control strain for NOD 
mice and both strains are considered to lean more towards a Th1 inflammatory 
response. Also, for any work undertaken with NOD congenic strains most of the 
transgenic material comes from C57BL/6 mice. 
 
6.2 RESULTS: BMDM" 
 
6.2.1 BMDM! derived from NOD and C57BL/6 mice are comparable 
 
Nikolic et al, working in the Netherlands, suggested that when bone marrow 
precursor cells are matured in the presence of GM-CSF, those from NOD mice 
preferentially differentiate into M!, with defective maturation into DC, compared to 
those of C57BL origin (Nikolic et al., 2005). Prior to comparing chemokine and 
cytokine production from NOD and C57BL/6 BMDM!, it was therefore essential to 
demonstrate equal levels of maturity between the 2 strains of BMDM! when used at 
day 7. 
Femurs were harvested from 4 male NOD mice aged 8 weeks together with age and 
sex matched C57BL/6 controls. BMDM! were matured in Teflon pots as previously 
described (chapter 2.2) until day 7. The cells were resuspended by vigorous agitation 
using a Pasteur pipette, following which 10µl aliquots were removed and cell 
numbers counted by haemocytometer. Aliquots of containing 2 x 10
5
 cells were then 
placed in chilled FACS tubes on ice, washed in PBS and triple stained for CD11b 
conjugated to FITC, F4/80 conjugated to PE and CD11c conjugated to APC (see 
table 2.6) for full details of monoclonal antibodies used) as previously described. The 
cells were then analysed by flow cytometry. 




No differences were seen in the number of the cells yielded from a single femur of 
each strain of mice at day 7 (13 ± 1.1 x 10
6
 vs. 12.6 ± 1.5 x 10
6
; C57BL/6 vs. NOD; 





 cells (91.5 ± 4.9% vs. 87.0 ± 9.5%; C57BL/6 vs. NOD; ns). 
Geometric mean fluorescence in each channel was used as a measure of protein 
expression. No differences between the strains were seen in CD11b, F4/80 or CD11c 
expression by the cell populations recovered at day 7 (see figure 6.1).  
It was therefore considered reasonable to compare cytokine and chemokine 
production between day 7 BMDM! derived from NOD and C57BL/6 mice in 
response to a variety of stimuli. 






Figure 6- 1 M! derived from the bone marrow of NOD and C57BL/6 mice exhibit 
comparable surface expression of macrophage markers 
BMDM" from NOD and C57BL/6 mice were matured for 7days in Teflon pots in the 
presence of 20% L929 supernatant. Aliquots were removed on day 7, stained for CD11b, 
F4/80 and CD11c and examined by flow cytometry. Whilst the majority of cells from both 
strains expressed high levels of CD11b (A) and F4/80 (B), few cells expressed significant 
levels of CD11c (C). No differences were seen between the strains in the expression of each 
protein as assessed by the geometric mean fluorescence (D). 




6.2.2 NOD BMDM! exhibit a marked hyper-inflammatory response 
12 male NOD mice aged 8 to 12 weeks, together with 15 age and sex matched 
C57BL/6 controls were sacrificed by rising levels of CO2. Resident pleural and 
peritoneal cells were harvested by lavage, pooled according to strain and kept on ice 
pending further analysis (chapters 6.3 and 6.4). A femur was harvested from the first 
6 mice of each group and BMDM! were matured in Teflon pots for 7 days as 
previously described using media supplemented with 10% FBS and 20% L929 
supernatant (chapter 2.2). Mature BMDM! were pooled according to strain and 0.5 x 
10
6
 cells were plated into the wells of 12-well plates. Non-adherent cells were 
removed after 1 hour by gentle washing and the remaining cells were incubated in 
0.5ml of either standard media (quiescent control) or media containing either 1µg/ml 
LPS, 0.25% CG or 0.5% TG.  
Cells were inspected visually by light microscopy (x 400 magnification) and the 
supernatants from each well were aspirated after 1, 4 or 24 hours. Supernatants were 
centrifuged and stored at -80
o
C prior to analysis of cytokine and chemokine levels. 4 
wells were used for each condition. The concentrations of MIP-2 and KC were 
measured by ELISA whilst MCP-1, TNF$, IL-6, IFN" and IL-10 levels were 
measured by CBA as described in chapter 2.8 
Following the aspiration of supernatants, all remaining cells were lysed using 0.5ml 
lysis buffer and the protein concentration was measured for each well and used as a 
surrogate for cell number. Cytokine and chemokine levels recorded in each well were 
then adjusted, to take into account the protein content of the well. Mean protein 
levels extracted from the wells were not significantly different across the 2 strains 
(613 ± 12µg/ml vs. 580 ± 13µg/ml; NOD vs. C57BL/6; p = ns). 
6.2.2.1 Quiescent BMDM! produce negligible levels of chemokines or 
cytokines 
BMDM! incubated in standard M! media, without stimulation, produced very low 
levels of all chemokines and cytokines measured. Although, as expected levels 
increased with time in culture and differences were observed in the levels of KC 
detected between the strains. It should be noted, however, that the production of all 
chemokines and cytokines examined (including KC) remained negligible compared 
to stimulated M! (data from the 24 hour time point is displayed in table 6.1, data 




from other time points is not shown). This confirmed the non-stimulatory quiescent 
nature of the media used throughout the experiment. 
6.2.2.2 Neither NOD nor C57BL/6 BMDM! produce IFN# 
 
Since M! are not thought to produce IFN", this was a useful negative control, and 
indeed no significant production of IFN" was detected at any time point (see table 
6.2) irrespective of the stimulus used. 
6.2.2.3 BMDM! from NOD mice are hyper-inflammatory in response to 
LPS 
No differences in the production of any chemokine or cytokine measured were 
apparent at the 1 hour time point (see table 6.3). At the 4 hour time point NOD 
BMDM! produced significantly more KC and MIP-2 (both CC chemokines) and 
MCP-1 (CXC chemokine) compared to control M!. However, the production of 
MIP-2 was comparable between the 2 strains at the 24 hour time point with 
production by C57BL/6 BMDM! apparently having ‘caught up’ (see figure 6.2).  
Similarly, by 4 hours BMDM! from NOD mice produced considerably increased 
levels of the pro-inflammatory cytokines TNF$ and IL-6 compared to the C57BL/6 
controls as well as less of the anti-inflammatory cytokine IL-10. These differences 
were either maintained or increased at the 24 hour time point (see figure 6.3). 
This pattern is entirely consistent with NOD BMDM! exhibiting an exaggerated pro-
inflammatory phenotype compared with C57BL/6 controls, in keeping with the 
published work of Sen et al ((Sen et al., 2003). 





NOD BMDM! C57BL/6 BMDM! 
 
pg/ml (sem) pg/ml (sem) 
     
MIP-2 667.6 (66.7) 542.9 (82.3) 
KC 1,064*** (108.3) 342.7 (66.5) 
MCP-1 65.6 (9.9) 50.9 (12.4) 
TNF# 0.0 (0.0) 8.0 (9.8) 
IL-6 12.7 (4.5) 11.0 (4.4) 
IFN ! 1.0 (1.2) 0.0 (0.0) 
IL-10 3.8 (2.3) 3.0 (3.7) 
     
 
 
Table 6- 1 Chemokine and cytokine production by quiescent non-activated 
BMDM! after 24 hours 
BMDM" from NOD mice and C57BL/6 control mice were matured for 7 days in Teflon pots 
with media supplemented with 20% L929 medium. 0.5 x 10
6
 BMDM" were seeded into 12-
well plastic plates, gently washed and incubated in 0.5ml quiescent media for 24 hours. 
Supernatants were harvested and the remaining cells washed with PBS, lysed and the 
protein content of each well measured. Levels of chemokines and cytokines measured in the 
supernatants of individual wells were adjusted for the protein contents extracted from each 
well. Data shown are the mean levels of 4 wells. Trivial levels of all chemokines and 
cytokines were detected in the supernatants. *** p < 0.001, NOD vs. C57BL/6 by 2-way 
ANOVA across the whole time course. No other differences were significant. 





Time NOD BMDM! C57BL/6 BMDM! 
(hours) pg/ml (sem) pg/ml (sem) 
 LPS STIMULATION 
     
1 0.0 (0.0) 0.7 (0.8) 
4 2.4 (1.7) 3.9 (2.9) 
24 1.0 (1.2) 0.0 (0.0) 
     
 CG STIMULATION 
     
1 1.5 (1.0) 1.6 (1.0) 
4 10.7 (7.1) 5.2 (6.0) 
24 5.2 (6.0) 19.1 (7.4) 
     
 TG STIMULATION 
     
1 0.0 (0.0) 0.5 (0.0) 
4 9.5 (0.0) 6.1 (0.7) 
24 0.0 (7.0) 10.9 (7.0) 
     
 
Table 6- 2 Negligible interferon # production by BMDM! stimulated with either 
LPS, CG or TG  
BMDM" from NOD mice and C57BL/6 control mice were matured for 7 days in Teflon pots 
with media supplemented with 20% L929 medium. 0.5 x 10
6
 BMDM" were seeded into 12-
well plastic plates, gently washed and incubated in 0.5ml media containing either 1µg/ml 
LPS, 0.25% CG or 0.5% TG for 1, 4 or 24 hours. Supernatants were harvested and the 
remaining cells washed with PBS, lysed and the protein content of each well measured. 
Levels of interferon-! measured in the supernatants were adjusted for the protein content of 
each well. Data shown are the mean levels of 4 wells. No significant differences identified 
between NOD and C57BL/6 mice by 2-way ANOVA. 







NOD BMDM! C57BL/6 BMDM! 
 
 
pg/ml (sem) pg/ml (sem) 
 LPS STIMULATION at 1 hour 
     
MIP-2 1325.8 (54.4) 859.4 (53.0) 
KC 2320.5 (83.9) 738.8 (31.8) 
MCP-1 510.5 (117.7) 280.2 (67.1) 
TNF# 642.4 (37.3) 372.9 (40.7) 
IL-6 60.4 (24.3) 66.3 (28.4) 
IL-10 110.7 (80.2) 83.0 (23.4) 
     
 CG STIMULATION at 1 hour 
     
MIP-2 193.1 (28.3) 132.3 (29.2) 
KC 127.7 (27.5) 19.1 (11.1) 
MCP-1 55.3 (12.2) 20.3 (16.7) 
TNF# 7.0 (8.5) 12.5 (9.2) 
IL-6 5.6 (3.5) 7.8 (7.0) 
IL-10 13.5 (8.3) 16.7 (20.5) 
     
 TG STIMULATION at 1 hour 
     
MIP-2 60.5 (4.1) 94.8 (41.1) 
KC 0.0 (1.8) 0.0 (15.6) 
MCP-1 27.1 (9.9) 15.3 (9.6) 
TNF# 0.0 (0.0) 0.0 (0.0) 
IL-6 6.7 (1.1) 4.5 (1.4) 
IL-10 6.1 (6.2) 0.7 (0.9) 
     
 
Table 6- 3 Chemokine and cytokine production by stimulated BMDM! after 1 hour 
BMDM" from NOD mice and C57BL/6 control mice were matured for 7 days in Teflon pots 
with media supplemented with 20% L929 medium. 0.5 x 10
6
 cells were seeded into 24-well 
plastic plates, gently washed and incubated in 0.5ml media containing either 1µg/ml LPS, 
0.25% CG or 0.5% TG for 1 hour. Supernatants were harvested and the remaining cells 
washed with PBS, lysed and the protein content of each well measured. Levels of 
chemokine and cytokine measured in the supernatants were adjusted for the protein content 
of each well. Data shown are the mean levels of 4 wells. No significant differences identified 
between NOD and C57BL/6 mice by 2-way ANOVA. 






Figure 6- 2 Chemokine levels produced by BMDM! stimulated with LPS 
BMDM" from NOD mice and C57BL/6 control mice were matured for 7 days in Teflon pots 
with media supplemented with 20% L929 medium. 0.5 x 10
6
 cells were seeded into 12-well 
plastic plates, gently washed and incubated in 0.5ml media containing 1µg/ml LPS. 
Supernatants were harvested and the remaining cells washed with PBS, lysed and the 
protein content of each well measured. Levels of chemokines measured in the supernatants 
were adjusted for the protein content of each well. Data shown are the mean levels of 4 
wells. Histograms show the normalised levels; NOD in polka dots, C57BL/6 in solid bars. (A) 
Chemokines at 4 hours. (B) Chemokines at 24 hours. *** p < 0.001; NOD vs. C57BL/6; 2-













Figure 6- 3 Cytokine levels produced by BMDM! stimulated with LPS 
BMDM" from NOD mice and C57BL/6 control mice were matured for 7 days in Teflon pots 
with media supplemented with 20% L929 medium. 0.5 x 10
6
 cells were seeded into 12-well 
plastic plates, gently washed and incubated in 0.5ml media containing 1µg/ml LPS. 
Supernatants were harvested and the remaining cells washed with PBS, lysed and the 
protein content of each well measured. Levels of cytookines measured in the supernatants 
were adjusted for the protein content of each well. Data shown are the mean levels of 4 
wells. Histograms show the normalised levels; NOD in polka dots, C57BL/6 in solid bars. (A) 
Cytokines at 4 hours. (B) Cytokines at 24 hours. *** p < 0.001, * p < 0.05; NOD vs. C57BL/6; 











6.2.2.4 BMDM! from NOD mice are hyper-inflammatory in response to 
Carrageenan  
 
Once again no significant production of IFN" was detected at any time point (see 
table 6.2), and no differences in chemokine or cytokine production were apparent by 
1 hour (see table 6.3). However, at the 4 and 24 hour time points, the broad pattern of 
hyper-inflammatory increased chemokine and cytokine production by NOD 
BMDM! compared to CB57BL/6 BMDM! in response to CG was similar or even 
more exaggerated to that exhibited in response to LPS (see figures 6.4 and 6.5).  
6.2.2.5 BMDM! from NOD mice secrete higher levels of MIP-2, KC and 
TNF" in response to Thioglycollate 
 
The overall levels of stimulation achieved with 0.5% TG appeared significantly less 
than that obtained with 1µg/ml LPS or 0.25% CG as the levels of all cytokines and 
chemokines measured were significantly lower. Nevertheless although no differences 
in chemokine or cytokine production were apparent at 1 hour (see table 6.2), the 
differences increased with time and by 24 hours a broadly similar pattern emerged. 
NOD derived BMDM! produced higher levels of MIP-2, KC and TNF$ than 
CB57BL/6 BMDM! although similar (but very low) levels of MCP-1, IL-6 and IL-
10 were noted (see figures 6.6 and 6.7). 






Figure 6- 4 Chemokine levels produced by BMDM! stimulated with CG 
BMDM" from NOD mice and C57BL/6 control mice were matured for 7 days in Teflon pots 
with media supplemented with 20% L929 medium. 0.5 x 10
6
 cells were seeded into 12-well 
plastic plates, gently washed and incubated in 0.5ml media containing 0.25% CG. 
Supernatants were harvested and the remaining cells washed with PBS, lysed and the 
protein content of each well measured. Levels of chemokines measured in the supernatants 
were adjusted for the protein content of each well. Data shown are the mean levels of 4 
wells. Histograms show the normalised levels; NOD in polka dots, C57BL/6 in solid bars. (A) 
Chemokines at 4 hours. (B) Chemokines at 24 hours. *** p < 0.001; NOD vs. C57BL/6; 2-












Figure 6- 5 Cytokine levels produced by BMDM! stimulated with CG 
BMDM" from NOD mice and C57BL/6 control mice were matured for 7 days in Teflon pots 
with media supplemented with 20% L929 medium. 0.5 x 10
6
 cells were seeded into 12-well 
plastic plates, gently washed and incubated in 0.5ml media containing 0.25% CG. 
Supernatants were harvested and the remaining cells washed with PBS, lysed and the 
protein content of each well measured. Levels of cytokines measured in the supernatants 
were adjusted for the protein content of each well. Data shown are the mean levels of 4 
wells. Histograms show the normalised levels; NOD in polka dots, C57BL/6 in solid bars. (A) 
Cytokines at 4 hours. (B) Cytokines at 24 hours. *** p < 0.001, ** p < 0.01; NOD vs. 













Figure 6- 6 Chemokine levels produced by BMDM! stimulated with TG 
BMDM" from NOD mice and C57BL/6 control mice were matured for 7 days in Teflon pots 
with media supplemented with 20% L929 medium. 0.5 x 10
6
 cells were seeded into 12-well 
plastic plate, gently washed and incubated in 0.5ml media containing 0.5% TG. 
Supernatants were harvested and the remaining cells washed with PBS, lysed and the 
protein content of each well measured. Levels of chemokines measured in the supernatants 
were adjusted for the protein content of each well. Data shown are the mean levels of 4 
wells. Histograms show the normalised levels; NOD in polka dots, C57BL/6 in solid bars. (A) 
Chemokines at 4 hours. (B) Chemokines at 24 hours. *** p < 0.001; NOD vs. C57BL/6; 2-










Figure 6- 7 Cytokine levels produced by BMDM! stimulated with TG 
BMDM" from NOD mice and C57BL/6 control mice were matured for 7 days in Teflon pots 
with media supplemented with 20% L929 medium. 0.5 x 10
6
 cells were seeded into 12-well 
plastic plates, gently washed and incubated in 0.5ml media containing 0.5% TG. 
Supernatants were harvested and the remaining cells washed with PBS, lysed and the 
protein content of each well measured. Levels of cytokines measured in the supernatants 
were adjusted for the protein content of each well. Data shown are the mean levels of 4 
wells. Histograms show the normalised levels; NOD in polka dots, C57BL/6 in solid bars. (A) 
Cytokines at 4 hours. (B) Cytokines at 24 hours. *** p < 0.001; NOD vs. C57BL/6; 2-way 








6.3 RESULTS: RESIDENT PLEURAL MACROPHAGES 
 
6.3.1 NOD PLM! are strikingly hypo-responsive compared to C57BL/6 
PLM! 
 
Resident pleural cells were obtained by pleural lavage from the same mice as those 
sacrificed for the BMDM! used above (chapter 6.2.2) i.e. 12 male NOD mice aged 8 
to 12 weeks and 15 age and sex matched C57BL/6 controls. 0.25 x 10
6
 cells were 
plated into plastic wells of 12-well plates and non-adherent cells removed after 1 
hour by gentle washing with warm media. The remaining PLM! were incubated in 
0.5ml of either standard media (quiescent non-stimulatory) or media containing 
1µg/ml LPS or 0.25% CG. As above, cells were inspected visually by light 
microscopy (x 400). Supernatants from each well aspirated at 1, 4 or 24 hours and 
analysed in an identical fashion to those above. The cells were lysed and the protein 
content of each well analysed as before. Individual cytokine and chemokine levels 
recorded in each well were again adjusted for the protein to compensate for 
differences in cell numbers across conditions and time points. Protein levels were 
significantly higher in the wells seeded with resident pleural cells from NOD mice 
compared to C57BL/6 controls (214 ± 18µg/ml vs. 135 ± 5.8µg/ml; NOD vs. 
C57BL/6; p < 0.001 student’s t test). For this experiment, leukocyte numbers were 
counted by haemocytometer and a set number of leukocytes (0.25 x 10
6
) plated into 
each well. Although this might reflect increased cell loss amongst the C57BL/6 
PLM!, an alternative explanation is more likely. In a series of pleural lavages from 
male mice, aged 8 to 12 weeks (6 per group), analysed by flow cytometry (chapter 
7.3), NOD mice had a much higher proportion of PLM! among their resident pleural 
cells (74.5 ± 4.1% vs. 53.5 ± 2.0%; NOD vs. C57BL/6; p < 0.001 student’s t test).  
This is sufficient to explain the difference in protein levels and reinforces the 
importance of adjusting recorded levels of cytokines and chemokines for either the 
adherent cell number or a surrogate marker such as protein levels.  
6.3.1.1 Quiescent PLM! produce low levels of chemokines and 
cytokines  
As previously, the levels of all chemokines and cytokines produced by PLM! 
incubated in quiescent non-inflammatory M! media increased over time. The levels 
produced were, however, extremely low compared to the stimulated groups, once 




again confirming the non-inflammatory nature of both cells and the quiescent M! 
media (see table 6.4).  
6.3.1.2 PLM! from NOD mice are hypo-responsive to both LPS and CG 
Once again, no significant production of IFN" was detected at any time point 
regardless of stimulation (table 6.5).  
Although no differences in the production of any chemokine or cytokine measured 
were apparent at the 1 hour time point (see table 6.6), striking differences emerged 
between NOD and C57BL/6 PLM! by the 4 hour time point. In response to LPS, 
PLM! harvested from NOD mice produced significantly less of all chemokines and 
cytokines than the C57BL/6 controls (see figures 6.8 and 6.9 respectively), although 
the difference in MCP-1 levels in response to LPS (figure 6.8 (B)) did not reach 
statistical significance at the 4 hour time point by 2-way ANOVA with Bonferroni 
post hoc tests due to the variance at later time points within the time course. 
Similarly, in response to CG, PLM! harvested from NOD mice produced 
significantly less of the chemokines and cytokines measured than the C57BL/6 
controls (see figures 6.10 and 6.11 respectively). There were no obvious differences 
in the state of the cells on inspection by light microscopy between the 2 strains of 
mice used to explain this dramatic difference with the PLM! from each strain being 
uniform in size and appearance. This pattern, in stark contrast to that seen with 
BMDM! above, is thought to reflect the hypo-responsive nature of NOD derived 
resident M! populations compared to C57BL/6 derived controls. 
Although levels of MCP-1 and KC produced by PLM! continued to accumulate up 
to the 24 hour time point, as seen with the BMDM! preparations above, levels of 
MIP-2, TNF$, IL-10 and IL-6 appeared to fall dramatically (see table 6.7). Since no 
supernatant (and therefore no chemokine or cytokine) was removed from the wells it 
is thought this may reflect degradation of chemokines and cytokines by enzymes 
specifically produced by the resident cells ex vivo and not BMDM! in vitro.





NOD PLM" C57BL/6 PLM" 
 
pg/ml (sem) pg/ml (sem) 
     
MIP-2 4,249*** (723) 6,755 (873) 
KC 3,528 (504) 2,665 (482) 
MCP-1 58.9 (38.1) 45.9 (65.0) 
TNF# 12.4 (7.7) 26.4 (3.2) 
IL-6 769.4 (415.4) 439.8 (75.6) 
IFN ! 1.2 (1.5) 2.9 (2.0) 
IL-10 29.6 (20.1) 72.3 (59.0) 
     
 
 
Table 6- 4 Chemokine and cytokine levels produced by quiescent PLM! after 24 
hours  
Pleural cells from NOD mice and C57BL/6 control mice were harvested by pleural lavage. 
0.25 x 10
6
 cells were seeded into 12-well plastic plates and the PLM" purified by adhesion 
and incubated in 0.5ml media for 24 hours. Supernatants were harvested and the remaining 
cells washed with PBS, lysed and the protein content of each well measured. Levels of 
chemokines and cytokines measured in the supernatants were adjusted for the protein 
content of each well. Extremely low levels of all chemokines and cytokines measured were 
detected. Data shown are the mean levels of 4 wells, *** p < 0.001, NOD PLM" vs. C57BL/6 
PLM" by 2-way ANOVA across the whole time course. All other differences were not 
significant. 
 






Time NOD PLM" C57BL/6 PLM" 
(hours) pg/ml (sem) pg/ml (sem) 
 LPS STIMULATION 
     
1 0.9 (0.7) 1.3 (0.5) 
4 0.9 (0.4) 0.0 (0.0) 
24 0.0 (0.0) 0.0 (0.0) 
     
 CG STIMULATION 
     
1 1.8 (0.7) 1.9 (0.3) 
4 0.6 (0.5) 6.5 (1.6) 
24 0.7 (0.5) 1.8 (2.0) 
     
 
Table 6- 5 Negligible amount of interferon # levels are produced by PLM! 
Pleural cells from NOD mice and C57BL/6 control mice were harvested by pleural lavage. 
0.25 x 10
6
 cells were seeded into 12-well plastic plates and the PLM" purified by adhesion 
and incubated in 0.5ml M" media containing either 1µg/ml LPS, or 0.25% CG for 1, 4 or 24 
hours. Supernatants were harvested and the remaining cells washed with PBS, lysed and 
the protein content of each well measured. Levels of interferon-! measured in each 
supernatant were adjusted for the protein content of each well. Data shown are the mean 
levels of 4 wells, no significant differences identified between PLM" from NOD mice and 
C57BL/6 mice, 2 way ANOVA. 







NOD PLM" C57BL/6 PLM" 
 
 
pg/ml (sem) pg/ml (sem) 
 LPS STIMULATION at 1 hour 
     
MIP-2 58.3 (7.4) 374.9 (57.5) 
KC 90.4 (7.5) 841.3 (92.6) 
MCP-1 0.0 (0.0) 22.8 (26.4) 
TNF# 2.2 (1.6) 35.1 (3.7) 
IL-6 15.0 (0.6) 107.3 (13.7) 
IL-10 3.9 (4.5) 18.5 (9.3) 
     
 CG STIMULATION at 1 hour 
     
MIP-2 70.5 (7.7) 55.2 (4.9) 
KC 99.3 (6.6) 87.8 (20.3) 
MCP-1 0.0 (0.0) 0.0 (0.0) 
TNF# 5.5 (2.4) 7.5 (1.4) 
IL-6 23.1 (2.2) 14.8 (1.4) 
IL-10 23.1 (7.9) 26.6 (6.3) 
     
 
Table 6- 6 Chemokine and cytokine production by PLM! after 1 hour of 
stimulation 
Pleural cells from NOD mice and C57BL/6 control mice were harvested by pleural lavage. 
0.25 x 106 cells were seeded into 12-well plastic plates and the PLM" purified by adhesion 
and incubated in 0.5ml M" media containing either 1µg/ml LPS or 0.25% CG for 1 hour. 
Supernatants were harvested and the remaining cells washed with PBS, lysed and the 
protein content of each well measured. Levels of chemokines and cytokines measured in the 
supernatants were adjusted for the protein content of each well. Data shown are the mean 
levels of 4 wells, no significant differences identified between PLM" from NOD mice and 
C57BL/6 mice, 2-way ANOVA. 






Figure 6- 8 Chemokine levels produced by PLM! after 4 hours stimulation with 
LPS 
Pleural cells from NOD mice and C57BL/6 control mice were harvested by pleural lavage, 
0.25 x 106 cells were seeded into 12-well plastic plates and the PLM" purified by adhesion 
and incubated in 0.5ml M" media containing 1µg/ml LPS for 4 hours. Supernatants were 
harvested, the remaining cells washed with PBS, lysed and the protein content of each well 
measured. Levels of chemokine measured in the supernatants were adjusted for the protein 
content of each well. Data shown are the mean levels of 4 wells. Histograms show the 
adjusted levels, NOD PLM" in polka dots, C57BL/6 PLM" in solid bars. (A) MIP-2 and KC 









Figure 6- 9 Cytokine levels produced by PLM! after 4 hours stimulation with LPS 
Pleural cells from NOD mice and C57BL/6 control mice were harvested by pleural lavage, 
0.25 x 106 cells were seeded into 12-well plastic plates and the PLM" purified by adhesion 
and incubated in 0.5ml M" media containing 1µg/ml LPS for 4 hours. Supernatants were 
harvested, the remaining cells washed with PBS, lysed and the protein content of each well 
measured. Levels of chemokine measured in the supernatants were adjusted for the protein 
content of each well. Data shown are the mean levels of 4 wells. Histograms show the 
adjusted levels, NOD PLM" in polka dots, C57BL/6 PLM" in solid bars. (A) TNF# and IL-10 
levels. (B). IL-6 levels. *** p < 0.001, **p < 0.01; NOD vs. C57BL/6; 2-way ANOVA across 










Figure 6- 10 Chemokine levels produced by PLM! after 4 hours stimulation with CG 
Pleural cells from NOD mice and C57BL/6 control mice were harvested by pleural lavage, 
0.25 x 106 cells were seeded into 12-well plastic plates and the PLM" purified by adhesion 
and incubated in 0.5ml M" media containing 0.25% CG for 4 hours. Supernatants were 
harvested, the remaining cells washed with PBS, lysed and the protein content of each well 
measured. Levels of chemokine measured in the supernatants were adjusted for the protein 
content of each well. Data shown are the mean levels of 4 wells. Histograms show the 
adjusted levels, NOD PLM" in polka dots, C57BL/6 PLM" in solid bars. (A) MIP-2 and KC 
levels. (B). MCP-1 levels. *** p < 0.001, **p < 0.01; NOD vs. C57BL/6; 2-way ANOVA across 
each time course. 
 
 
** *** *** 





Figure 6- 11 Cytokine levels produced by PLM! after 4 hours stimulation with CG 
Pleural cells from NOD mice and C57BL/6 control mice were harvested by pleural lavage, 
0.25 x 106 cells were seeded into 12-well plastic plates and the PLM" purified by adhesion 
and incubated in 0.5ml M" media containing 0.25% CG for 4 hours. Supernatants were 
harvested, the remaining cells washed with PBS, lysed and the protein content of each well 
measured. Levels of cytokine measured in the supernatants were adjusted for the protein 
content of each well. Data shown are the mean levels of 4 wells. Histograms show the 
adjusted levels, NOD PLM" in polka dots, C57BL/6 PLM" in solid bars. (A) TNF# and IL-10 











NOD PLM" C57BL/6 PLM" 
 
 
pg/ml (sem) pg/ml (sem) 
 LPS STIMULATION at 24 hours 
     
MIP-2 3,788 (416) 4,314 (588) 
KC 18,165*** (2,746) 51,115 (10,039) 
MCP-1 690 (166) 976 (80) 
TNF# 26 (4) 85 (9) 
IL-6 4256* (506) 8185 (926) 
IL-10 101* (35) 231 (26) 
     
 CG STIMULATION at 24 hours 
     
MIP-2 3,915 (444) 6,170 (1,612) 
KC 12,531** (1,184) 19,752 (2,070) 
MCP-1 204*** (23) 414 (33) 
TNF# 44 (7) 124 (47) 
IL-6 1354** (134) 2931 (406) 
IL-10 291 (31) 542 (50) 
     
 
Table 6- 7 Chemokine and cytokine levels produced by PLM! after 24 hours 
stimulation 
Pleural cells from NOD mice and C57BL/6 control mice were harvested by pleural lavage, 
0.25 x 106 cells were seeded into 12-well plastic plates and the PLM" purified by adhesion 
and incubated in 0.5ml M" media containing either 1µg/ml LPS or 0.25% CG for 24 hours. 
Supernatants were harvested, the remaining cells washed with PBS, lysed and the protein 
content of each well measured. Levels of chemokine and cytokine measured in the 
supernatants were adjusted for the protein content of each well. Data shown are the mean 
levels of 4 wells. *** p < 0.001, **p < 0.01, * p < 0.05; NOD PLM" vs. C57BL/6 PLM"; 2-way 
ANOVA across each time course. 
 




6.4 RESULTS: RESIDENT PERITONEAL MACROPHAGES 
 
6.4.1 NOD PM! are hypo-responsive compared to C57BL/6 
Resident peritoneal cells were obtained by peritoneal lavage from the same mice as 
those sacrificed for the PLM! and BMDM! used above (chapter 6.2 and 6.3) i.e. 12 
male NOD mice aged 8 to 12 weeks and 15 age and sex matched C57BL/6 controls. 
Once again 0.25 x 10
6
 cells were plated into plastic wells of 24-well plates and non-
adherent cells removed after 1 hour by gentle washing with warm media. Remaining 
PM! were incubated in 0.5ml of either standard media (quiescent) or media 
containing 1µg/ml LPS or 0.5% TG. As above, cells were inspected visually by light 
microscopy (x 400). Supernatants from each well were aspirated after 1, 4 or 24 
hours and analysed in an identical fashion to those above. Remaining cells were 
lysed and the protein content of each well analysed as before. Individual cytokine 
and chemokine levels recorded in each well were again normalised to the mean 
protein content to compensate for differences in cell numbers across conditions and 
time points. 
The mean protein level measured across all wells was 145 ± 5.8µg/ml.  No 
differences were identified between the 2 strains (166 ± 8.1µg/ml vs. 153 ± 8.2µg/ml; 
NOD vs. C57BL/6; p = ns) 
6.4.1.1 Quiescent PM! produce low levels of chemokines and cytokines  
It was noted once again that levels of all chemokines and cytokines produced by 
PM! bathed in M! media without stimulation increased with time. Although the 
levels produced were noted to be extremely low compared to the LPS stimulated 
wells, (see table 6.8) the levels were perhaps higher than those achieved with 
quiescent BMDM! or PLM! and similar to the TG stimulated wells (tables 6.1 6.4 
and 6.10 respectively). Whilst it is possible this was due to contamination of the 
media with LPS the same batch of M! media was used throughout the experiment 
for all 3 different M! phenotypes examined. In addition, sterile needles and sterile 
PBS were used for all peritoneal lavages.  Alternatively it may reflect the increased 
sensitivity of PM! to stimulation by their external environment and the low 
stimulatory capacity of the 0.5% TG used. 





NOD PM" C57BL/6 PM" 
 
pg/ml (sem) pg/ml (sem) 
     
MIP-2 10,375 (1,597) 9,043 (1,876) 
KC 3,772 (956.2) 7,199 (1,385) 
MCP-1 165.7 (13.5) 726.5 (632.8) 
TNF# 60.4 (7.2) 416.7 (113.5) 
IL-6 3,116 (29.4) 1,310 (145.2) 
IFN ! 3.43 (0.75) 2.28 (1.12) 
IL-10 55.2 (16.4) 73.2 (20.9) 
     
 
 
Table 6- 8 Chemokine and cytokine levels produced by quiescent PM! after 24 
hours  
PM" from NOD and C57BL/6 controls were harvested by peritoneal lavage and 0.25 x 10
6
 
cells were seeded into 12-well plastic plates, purified by adhesion and incubated in 0.5ml 
media for 24 hours. Supernatants were harvested and the remaining cells washed with PBS, 
lysed and the protein content of each well measured. Levels of chemokines and cytokines 
measured in the supernatants were adjusted for the protein content of each well. Low levels 
were detected of all chemokines and cytokines measured. Data shown are the mean levels 
of 4 wells. 




6.4.1.2 PM! from NOD mice are hypo-responsive to LPS in comparison 
to C57BL/6 PM! 
Once again, no significant production of IFN" was detected at any time point 
regardless of stimulation (table 6.9).  
Unfortunately, as mentioned previously, the 0.5% TG stimulation failed to elicit an 
inflammatory response from PM! of either strain. Levels of all chemokines or 
cytokines measured were equal to, or even below, those achieved by quiescent PM! 
(data from the 24 hour time point is displayed in table 6.10; data from earlier time 
points is not shown). Although the explanation is unclear, the inflammatory response 
achieved by stimulation of BMDM! by 0.5% TG was far less than achieved with 
0.25% CG or 1µg/ml LPS. Thus it is possible that on this occasion 0.5% TG was too 
dilute to be an effective an in vitro stimulus. No further analysis of these data was 
attempted. 
Whilst 1µg/ml LPS was sufficient to provoke a significant inflammatory response 
from PM!, no significant production of any of the chemokines or cytokines 
measured was apparent until the 24 hour time point (see table 6.11). At 24 hours a 
broadly similar pattern to that obtained from PLM! emerged with PM! from NOD 
mice appearing hyporesponsive compared to the C57BL/6 controls (see figures 6.12 
and 6.13).  





Time NOD PM" C57BL/6 PM" 
(hours) pg/ml (sem) pg/ml (sem) 
 LPS STIMULATION 
     
1 0.0 (0.0) 2.4 (2.3) 
4 0.0 (0.0) 0.0 (0.0) 
24 2.6 (2.0) 1.7 (1.1) 
     
 TG STIMULATION 
     
1 0.0 (0.0) 0.0 (0.0) 
4 0.0 (0.0) 0.0 (0.0) 
24 3.2 (1.0) 5.8 (1.5) 
     
 
Table 6- 9 Negligible interferon # levels produced by PM!   
PM" from NOD and C57BL/6 controls were harvested by peritoneal lavage and 0.25 x 10
6
 
cells were seeded into 12-well plastic plates, purified by adhesion and incubated in 0.5ml 
media containing either 1µg/ml LPS, or 0.5% TG for 1, 4 or 24 hours. Supernatants were 
harvested and the remaining cells washed with PBS, lysed and the protein content of each 
well measured. Levels of interferon-! measured in the supernatants were adjusted for the 
protein content of each well. Data shown are the mean levels of 4 wells; no significant 
differences identified between NOD and C57BL/6 mice, 2-way ANOVA. 
.





NOD PM" C57BL/6 PM" 
 
pg/ml (sem) pg/ml (sem) 
     
MIP-2 1,757 (154) 2,291 (325) 
KC 1,467 (218) 1,721 (272) 
MCP-1 87 (43) 89 (41) 
TNF# 53 (13) 71 (19) 
IL-6 42 (14) 125 (44) 
IFN ! 106 (15) 126 (8) 
IL-10 1,757 (154) 2,291 (325) 
     
 
Table 6- 10 Chemokine and cytokine production by PM! after 24 hours TG 
stimulation 
PM" from NOD and C57BL/6 controls were harvested by peritoneal lavage and 0.25 x 10
6
 
cells were seeded into 12-well plastic plates, purified by adhesion and incubated in 0.5ml 
media supplemented with 0.5% TG for 24 hours. Supernatants were harvested and the 
remaining cells washed with PBS, lysed and the protein content of each well measured. 
Levels of chemokines and cytokines measured in the supernatants were adjusted for the 
protein content of each well. Data shown are the mean levels of 4 wells; no significant 
differences identified between NOD and C57BL/6 mice, 2-way ANOVA. 
. 







NOD PM" C57BL/6 PM" 
 
 
pg/ml (sem) pg/ml (sem) 
 LPS STIMULATION at 1 hour 
     
MIP-2 1,162 (154.9) 991.9 (103.5) 
KC 1,115 (202.9) 1,311 (237.7) 
MCP-1 0.0 (0.0) 139.8 (141.2) 
TNF# 92.3 (14.3) 135.0 (16.1) 
IL-6 376.2 (53.0) 252.9 (25.3) 
IL-10 22.9 (26.4) 73.5 (71.0) 
     
 LPS STIMULATION at 4 hours 
     
MIP-2 9,131 (871) 5,998 (699) 
KC 13,659 (986) 5,088 (556) 
MCP-1 113 (22) 74 (11) 
TNF# 46 (5) 52 (4) 
IL-6 325 (71) 335 (56) 
IL-10 2,521 (370) 1,533 (178) 
     
 
Table 6- 11 Chemokine and cytokine production by PM! after 1 or 4 hours LPS 
stimulation 
PM" from NOD and C57BL/6 controls were harvested by peritoneal lavage and 0.25 x 10
6
 
cells seeded, purified by adhesion and incubated in 0.5ml media containing either 1µg/ml 
LPS for 1 or 4 hous. Supernatants were harvested and the remaining cells washed with 
PBS, lysed and the protein content of each well measured. Levels of chemokines and 
cytokines measured in the supernatants were adjusted for the protein content of each well. 
Data shown are the mean levels of 4 wells; no significant differences identified between 
NOD and C57BL/6 mice, 2-way ANOVA across time course. 





Figure 6- 12 Chemokine production by PM! after 24 hours of LPS stimulation 
PM" from NOD and C57BL/6 controls were harvested by peritoneal lavage and 0.25 x 10
6
 
cells were seeded into 12-well plastic plates, purified by adhesion and incubated in media 
containing 1µg/ml LPS for 24 hours. Supernatants were harvested, the remaining cells 
washed with PBS, lysed and the protein content of each well measured. Levels of 
chemokine measured in the supernatants were adjusted for the protein content of each well. 
Data shown are the mean levels of 4 wells Histograms show the adjusted levels, NOD PM" 
in polka dots, C57BL/6 PM" in solid bars. (A) MIP-2 and KC levels. (B) MCP-1 levels. * p < 
.05; 2-way ANOVA across each time course. 
* 





Figure 6- 13 Cytokine production by PM! after 24 hours of LPS stimulation 
PM" from NOD and C57BL/6 controls were harvested by peritoneal lavage and 0.25 x 10
6
 
cells were seeded into 12-well plastic plates, purified by adhesion and incubated in media 
containing 1µg/ml LPS for 24 hours. Supernatants were harvested, the remaining cells 
washed with PBS, lysed and the protein content of each well measured. Levels of cytokine 
measured in the supernatants were adjusted for the protein content of each well. Data 
shown are the mean levels of 4 wells Histograms show the adjusted levels, NOD PM" in 
polka dots, C57BL/6 PM" in solid bars. (A) TNF# and IL-10 levels. (B) IL-6 levels. *** p < 








6.4.2 NOD PM! are hyporesponsive compared to C57BL/6 PM! 
 
Although the above experiment with TG stimulation of PM! failed to achieve levels 
of chemokines and cytokines over and above those produced by quiescent PM!, the 
data is reminiscent of an earlier, smaller study that examined the effect on PM! 
phenotype of stimulation with TG and LPS for 4 hours in vitro.  
PM! were harvested from 5 female NOD mice aged 6 weeks together with 8 age and 
sex matched C57BL/6 control mice. Cells were pooled according to strain and 1 x 
10
6
 resident peritoneal cells were plated into wells of 12 well plates. PM! were 
purified by adhesion, with non-adherent cells removed by gentle washing after 1 
hour. The remaining PM! were incubated for 4 hours in 1ml of standard media 
(quiescent) or media containing either 1µg/ml LPS or 0.5% TG (this experiment used 
the same batch but a different aliquot of 10% TG from the experiment above). 
Cytokine and chemokine levels were determined by ELISA according to the 
manufacturer’s instructions but IL-6 was not measured. The remaining cells were 
lysed with cell lysis buffer and protein levels in the buffer were assessed as in the 
experiment above. Levels of all cytokines and chemokines were adjusted to the mean 
protein level for all wells (314µg/ml). No differences were noted in the protein levels 
assessed from wells seeded with NOD PM! as opposed to C57BL/6 PM! (318 ± 
27µg/ml vs. 311 ± 22µg/ml; NOD vs. C57BL/6; p = ns) 
On this occasion, quiescent PM! produced much less cytokines or chemokines than 
PM! stimulated with either TG or LPS (levels shown in table 6.12). Production of 
the CXC chemokines, MIP-2 and KC in response to LPS was similar between the 2 
strains although surprisingly, MCP-1 production was actually higher by NOD PM! 
(see figure 6.14).  Both TNF$ and IL-10 production by NOD PM! in response to 
LPS was markedly reduced in comparison to PM! derived from C57BL/6 mice (see 
figure 6.15). NOD PM! produced less of all and cytokines measured than C57BL/6 
PM! in response to TG (see figure 6.8).  





NOD PM" C57BL/6 PM" 
 
pg/ml (sem) pg/ml (sem) 
     
MIP-2 2,778 (232.2) 2,413 (252.3) 
KC 1,582** (162.7) 671 (99.1) 
MCP-1 5 (0.3) 3 (1.6) 
TNF# 46 (1.4) 50 (3.7) 
IL-10 56 (37.1) 43 (10.7) 
     
 
Table 6- 12 Chemokine and cytokine production by quiescent PM!  
Peritoneal cells from NOD mice and C57BL/6 mice were harvested by peritoneal lavage and 
0.25 x 10
6
 cells were seeded into 12-well plastic plates. PM" were purified by adhesion and 
incubated in 0.5ml media for 4 hours. Supernatants were harvested and the remaining cells 
washed with PBS, lysed and the protein content of each well measured. Levels of 
chemokines and cytokines measured in the supernatants were adjusted for the protein 
content of each well. Data shown are the mean levels of 4 wells. ** p < 0.01 NOD PM" vs. 
C57BL/6 PM"; student’s t test. 





Figure 6- 14 Chemokine production by PM! after 4 hours of LPS stimulation 
Peritoneal cells from NOD mice and C57BL/6 control mice were harvested by peritoneal 
lavage. 0.25 x 10
6
 cells were seeded into 12-well plastic plates. PM" were purified by 
adhesion and incubated in media containing 1µg/ml LPS for 4 hours. Supernatants were 
harvested, the remaining cells washed with PBS, lysed and the protein content of each well 
determined. Chemokine levels measured in the supernatants were adjusted for the protein 
content of each well. Data shown are the mean levels of 4 wells. Histograms show the 
adjusted levels, NOD PM" in polka dots, C57BL/6 PM" in solid bars. (A) MIP-2 and KC 
levels. (B) MCP-1 levels. **p < 0.01; NOD PM" vs. C57BL/6 PM"; student’s t test. 
** 






Figure 6- 15 Cytokine production by PM! after 4 hours of LPS stimulation 
Peritoneal cells from NOD mice and C57BL/6 control mice were harvested by peritoneal 
lavage. 0.25 x 10
6
 cells were seeded into 12-well plastic plates. PM" were purified by 
adhesion and incubated in media containing 1µg/ml LPS for 4 hours. Supernatants were 
harvested, the remaining cells washed with PBS, lysed and the protein content of each well 
determined. Cytokine levels measured in the supernatants were adjusted for the protein 
content of each well. Data shown are the mean levels of 4 wells. Histograms show the 
adjusted levels, NOD PM" in polka dots, C57BL/6 PM" in solid bars. (A) TNF# levels. (B) IL-
10 levels. ***p < 0.001; NOD PM" vs. C57BL/6 PM"; student’s t test. 
 
*** *** 





Figure 6- 16 Chemokine production by PM! after 4 hours of TG stimulation 
Peritoneal cells from NOD mice and C57BL/6 control mice were harvested by peritoneal 
lavage. 0.25 x 10
6
 cells were seeded into 12-well plastic plates. PM" were purified by 
adhesion and incubated in media containing 0.5% TG for 4 hours. Supernatants were 
harvested, the remaining cells washed with PBS, lysed and the protein content of each well 
determined. Chemokine levels measured in the supernatants were adjusted for the protein 
content of each well. Data shown are the mean levels of 4 wells. Histograms show the 
adjusted levels, NOD PM" in polka dots, C57BL/6 PM" in solid bars. (A) MIP-2 and KC 









Figure 6- 17 Cytokine production by PM! after 4 hours of TG stimulation 
Peritoneal cells from NOD mice and C57BL/6 control mice were harvested by peritoneal 
lavage. 0.25 x 106 cells were seeded into 12-well plastic plates. PM" were purified by 
adhesion and incubated in media containing 0.5% TG for 4 hours. Supernatants were 
harvested, the remaining cells washed with PBS, lysed and the protein content of each well 
determined. Cytokine levels measured in the supernatants were adjusted for the protein 
content of each well. Data shown are the mean levels of 4 wells. Histograms show the 
adjusted levels, NOD PM" in polka dots, C57BL/6 PM" in solid bars. (A) TNF# levels. (B) IL-
10 levels. ***p < 0.001; NOD PM" vs. C57BL/6 PM"; student’s t test. 
 
*** *** 






In this chapter, it was demonstrated that NOD BMDM! are pro-inflammatory in 
comparison to C57BL/6 controls following stimulation with LPS, TG or CG.  
In contrast, PM! and PLM! from NOD mice were significantly less responsive than 
C57BL/6 control M! to LPS, and either TG or CG stimulation. 
It should be noted, however, that the pattern was less consistent and less clear with 
ex-vivo resident M! than with the BMDM!. This may reflect the greater cellular 
heterogeneity in ex-vivo M! populations or perhaps greater sensitivity to their 
external environment and therefore any inadvertent contamination of tissue culture 
media.  
This divergent response between ex-vivo M! and BMDM! may help explain the 
apparent discord between data published by different research groups. 
The next important question was to determine which phenotype appeared to 
influence the inflammatory process in vivo? 
























Chapter 7. Analysis of the 
NOD inflammatory response in 
vivo 
  





Following examination of the patterns of chemokine and cytokine production by 
NOD and C57BL/6 M! in vitro, it was important to examine the inflammatory 
responses of these mice in vivo. Three models of inflammation were chosen for 
analysis: TG peritonitis, CG pleurisy and DTH pleurisy. 
 
7.2 THIOGLYCOLLATE PERITONITIS 
TG peritonitis is a well characterised model of sterile inflammation, frequently used 
to elicit inflammatory M! for ex vivo experimentation (Fan et al., 2004). Our group 
has previously demonstrated that TG peritonitis is markedly dependent on the 
function of resident peritoneal M! (Cailhier et al., 2005). From the hyper-responsive, 
pro-inflammatory phenotype of NOD BMDM! in vitro, it could be hypothesised that 
NOD mice would exhibit an exaggerated inflammatory response and greater 
leukocyte recruitment. Conversely, the hypo-responsive phenotype of NOD PM! 
would suggest a diminished inflammatory response with reduced PMN and M! 
recruitment as a result of reduced production of key chemokines and cytokines. 
Indeed, Potter et al reported that several ‘autoimmune prone’ strains of mice exhibit 
a muted inflammatory response in TG peritonitis (Potter et al., 2003).  In addition, 
Bouma et al (Bouma et al., 2005) reported that NOD mice exhibited markedly 
impaired leukocyte recruitment to TG peritonitis that was more marked than that 
evident in lupus-prone strains. The mechanism was unexplained by either group 
although Bouma et al suggested that an impaired migratory ability of NOD PMN 
may underlie the defect.  
It was decided to explore the inflammatory response of NOD mice to TG peritonitis 
in greater detail. The study of similar time points to previous reports would 
corroborate (or refute) the reported muted inflammatory phenotype exhibited by 
NOD mice. In addition, focus on the first 24 hours would facilitate study of the levels 
of important chemokine and cytokines at time points previously shown to be 
important for leukocyte recruitment in order to determine whether the PM! of NOD 
mice exhibited an abnormal pattern of chemokine and cytokine production in vivo. 
 




7.2.1 NOD mice recruit fewer leukocytes in thioglycollate peritonitis  
 
Peritonitis was initiated with TG in male NOD mice aged 8 to 12 weeks and age and 
sex matched C57BL/6 controls as previously described (chapter 2.9.1). In brief, 1ml 
of TG (3% w/v in sterile distilled water) was injected ip to all mice with the 
exception of those selected for the zero hour (naïve) time point. Mice were sacrificed 
at baseline (naïve) and 24 (n=8 mice), 48 (n=5 mice) and 96 (n=5 mice) hours 
following TG administration. Mice underwent peritoneal lavage with 5ml ice-cold 
PBS immediately after death. Aliquots were removed from each sample and placed 
in chilled FACS tubes. After immunolabeling with various leukocyte markers (F4/80 
[M!], GR1 [PMN], B220 [B cells] and CD3 [T cells]) peritoneal cells were analysed 
by flow cytometry as described in chapter 2.9.1.1. The remaining fluid was 
centrifuged to remove cells and aliquots frozen at -80
o
C pending further analysis. 
Analysis of the peritoneal cells recovered revealed a striking reduction in the total 
numbers of leukocytes recruited by NOD mice during TG peritonitis (see figure 
7.1A) despite increased numbers of PM! present in the naïve peritoneum at baseline 
(1.16 ± 0.26 x 10
6
 vs. 0.52 ± 0.08 x 10
6
; NOD vs. C57BL/6; p < 0.02 by student’s t 
test of individual time point although not significant in context of the full 
experimental time course and analysis by 2 way ANOVA). A marked reduction in 
the numbers of M! and PMN was evident in NOD mice compared to C57BL/6 
control mice (figure 7.1B and C). 
In a pattern highly reminiscent of the lupus-prone mice strains (Potter et al., 2003), 
NOD mice recruited markedly fewer M! overall. Whilst M! numbers peaked at 48 
hours and started to fall by 96 hours in C57BL/6 mice, they were still increasing in 
NOD mice by the end of the experimental time course (figure 7.1B). The peak in 
PMN numbers occurred at 24 hours in both strains with numbers markedly reduced 
by 48 hours. Although the profile of PMN infiltration was similar between NOD and 
C57BL/6 mice, the peak PMN number was significantly lower in NOD mice (figure 
7.1C). In addition, NOD mice recruited fewer B and T lymphocytes figure 7.2). 
Indeed, unlike C57BL/6 mice, NOD mice did not exhibit a significant increase in 
either B or T lymphocyte numbers at any time point. 







Figure 7- 1 NOD mice recruit fewer leukocytes during thioglycollate peritonitis 
Peritonitis was induced with an ip injection of 1ml 3% TG. Peritoneal cells were recovered by 
lavage, immunolabeled and then analysed by flow cytometry. 8 mice were used for the 24-
hour time point, 5 mice per strain for all other time points. C57BL/6 mice in solid lines, NOD 
in dashed lines. NOD mice exhibit a marked defect in the recruitment of leukocytes to the 
peritoneum (A). The defective recruitment was most striking for M" (B), although reduced 
recruitment of PMN (C) is also clearly apparent. *** p < 0.001, ** p < 0.01, * p < 0.05; 
C57BL/6 vs. NOD; 2-way ANOVA. 






Figure 7- 2 NOD mice recruit fewer lymphocytes during thioglycollate peritonitis 
Peritonitis was induced with an ip injection of 1ml 3% TG. Peritoneal cells were recovered by 
lavage, immunolabeled and then analysed by flow cytometry. 8 mice were used for the 24-
hour time point, 5 mice per strain for all other time points. C57BL/6 mice in solid lines, NOD 
in dashed lines. NOD mice exhibited a defect in the recruitment of B lymphocytes (A) and T 
lymphocytes (B) to the peritoneum compared to C57BL/6 controls. *** p < 0.001, ** p < 0.01; 
C57BL/6 vs. NOD; 2-way ANOVA. 




7.2.2 Defective recruitment of leukocytes by NOD mice is apparent by 4 
hours 
Having demonstrated a similar pattern of leukocyte recruitment in NOD mice over 
the course of 96 hours to that published by Paul Potter (Potter et al., 2003) , it was 
decided to investigate the first 24 hours in greater detail. Jean-Francois Cailhier 
(Cailhier et al., 2005)demonstrated that events early occurring within the first 4 hours 
of TG peritonitis set the pattern of PMN recruitment with MIP-2 (CXCL2) 
production by resident peritoneal M! being critical.  
Twenty female NOD mice aged 8 to 12 weeks were selected together with age and 
sex matched C57BL/6 controls. Due to changes in the project license peritonitis was 
initiated with 0.5ml of TG 10% w/v injected ip instead of 1ml 3% w/v. Mice were 
sacrificed at zero (naïve), 1, 4, 8 and 24 hours (4 per group) and samples were 
collected, prepared and stained for flow cytometry as previously described. Defective 
recruitment of leukocytes by NOD mice was evident by 4 hours and was more 
marked at 24 hours (figure 7.3). Reassuringly, despite using female mice and 0.5ml 
of 10% TG, the number of leukocytes recruited to the peritoneum at 24 hours was 
similar to the previous experiment with male mice and 1ml of 3% TG (see figure 
7.4).  




 and quite distinct 




. Within the first 
hour following TG administration there were clear differences in the peritoneal M! 
populations of NOD mice compared to C57BL/6 mice (figure 7.5). NOD mice 
retained their mature PM!, whilst they largely disappeared in the C57BL/6 strain in a 
manner reminiscent of the MDR (Tomazic et al., 1977). Conversely, recruitment of 
infiltrating monocytes/M! was much brisker in C57BL/6 mice. As a result of these 
differences, the total numbers of M! varied little between the 2 strains of mice until 
the 4 hour time point by which time the reduced M! infiltration resulted in reduced 
numbers being evident in NOD mice (figure 7.5). PMN recruitment was comparable 
between NOD and control mice for the first 4 hours of TG peritonitis. No further 
increase in PMN infiltration was evident in NOD mice whilst PMN numbers 
continued to climb in C57BL/6 mice and peaked at 24 hours (figure 7.6). 






Figure 7- 3 Analysis of leukocyte numbers during TG peritonitis 
Peritonitis was induced with an ip injection of 0.5ml 10% TG. Peritoneal cells were recovered 
by lavage, stained and analysed by flow cytometry. 4 mice were used per time point. 
C57BL/6 mice in solid lines, NOD in dashed lines. The marked defect in the recruitment of 
leukocytes exhibited by NOD mice was evident by 4 hours. *** p < 0.001, * p < 0.05; 
C57BL/6 vs. NOD; 2-way ANOVA.  





Figure 7- 4 Comparable leukocyte infiltration at 24 hours in male administered 1ml 
of 3% TG and female mice administered 0.5ml of 10% TG 
Peritonitis was induced with an ip injection of either 1ml of 3% TG (males) or 0.5ml of 10% 
TG (females). Mice were sacrificed 24 hours later, peritoneal cells were recovered by lavage, 
stained and then analysed by flow cytometry. Male mice are in solid bars, female mice in 
chequered bars. Total leukocyte numbers recovered at this time point were strikingly similar 
between males and females of each strain. 






Figure 7- 5 Analysis of infiltrating monocytes/macrophages and mature 
macrophages during the first 24 hours of TG peritonitis.  
Peritonitis was induced with an ip injection of 0.5ml 10% TG. Peritoneal cells were recovered 
by lavage, immunolabeled and then analysed by flow cytometry. 4 mice were used per time 









were gated as illustrated in figure 2.22. C57BL/6 mice in solid lines, NOD in dashed lines. 
NOD mice exhibited a marked defect in the total recruitment of PM" by 4 hours (A). Unlike 
C57BL/6 mice, the numbers of mature PM" in NOD mice did not appear to fall following the 
injection of TG (B) and the low total M" count was primarily attributable to fewer F4/80
MED
 
infiltrating monocytes/macrophages (C). *** p < 0.001, ** p < 0.01, * p < 0.05; C57BL/6 vs. 
NOD; 2-way ANOVA 





Figure 7- 6 Analysis of PMN recruitment during TG peritonitis 
Peritonitis was induced with an ip injection of 0.5ml 10% TG. Peritoneal cells were recovered 
by lavage, immunolabeled and then analysed by flow cytometry. 4 mice were used per time 
point. C57BL/6 mice in solid lines, NOD in dashed lines. NOD recruitment of PMN was 
comparable to C57BL/6 mice until the 4-hour time point; thereafter PMN numbers failed to 
increase in NOD mice, but continued to rise in C57BL/6 mice. *** p < 0.001; C57BL/6 vs. 
NOD; 2-way ANOVA 




7.2.3 NOD and C57BL/6 mice exhibit comparable levels of chemokines 
and cytokines  
 
In vitro work examining chemokine and cytokine production in response to LPS and 
TG indicated that NOD BMDM! were pro-inflammatory whilst PM! were hypo-
responsive compared to C57BL/6 controls. Since reduced secretion of key 
chemokines or cytokines in vivo represented a potential mechanism for the defective 
leukocyte recruitment in TG peritonitis, the levels of MIP-2, KC, MCP-1, TNF$, 
IL10 and IFN" were analysed by specific ELISA in cell free aliquots of lavage fluid 
stored at -80
o
C until analysis.  
The levels of MIP-2 were comparable with both NOD and C57BL/6 mice mounting 
a robust peak at 1 hour that returned to baseline by 4 hours (figure 7.7A). The levels 
of KC in NOD mice peaked at 4 hours but levels were not statistically significant 
differences to those in C57BL/6 mice (figure 7.7B). Levels of the important CC 
chemokine MCP-1 were comparable between the 2 strains (figure 7.7C). Consistent 
with the in vitro studies of BMDM!, NOD mice exhibited a trend to produce a more 
pro-inflammatory milieu with more TNF$ and less IL-10 production but the 
differences did not reach statistical significance (figure 7.7D and E). Neither strain 
produced significant levels of IFN", consistent with this being a M! dependent 
model of inflammation (figure 7.7F). 
Even though the list of chemokines and cytokines examined was not exhaustive, the 
explanation for the diminished leukocyte recruitment evident in NOD mice was 
unlikely to lie in the peritoneal levels of these mediators Rather than continued 
chemokine and cytokine analysis, it was decided to address whether the defective 
leukocyte recruitment could be localised to the same idd locus as the phagocytic 
defect (see chapter 5).  
 
7.2.4 Defective recruitment of leukocytes did not localise to idd18 
Bouma et al suggested that impaired leukocyte migration towards inflamed sites 
might underlie the defective cell recruitment evident in NOD mice (Bouma et al., 
2005). Evidence presented in chapter 5 suggested that the in vivo phagocytic defect 
localised to idd18, and by inference to vav3, might involve a gene that plays a role in 
cytoskeletal rearrangement. Clearly such a gene could also be responsible for 
impaired migratory responses and hence defective leukocyte recruitment. To test this 




hypothesis TG peritonitis was initiated in the same congenic NOD strains used to 
localise the in vivo phagocytic defect to idd18. In these studies R323 has idd3/10/18 
replaced, R20 has just idd3/10 replaced, R905 has idd9 replaced and 1591 has idd3/5 
replaced (see table 5.1 for more details). 
The experiment was conducted in 2 stages with each stage comprising 4 NOD mice, 
4 C57BL/6 control mice and 4 mice from 2 of the congenic strains. All mice were 
male and aged 6 to 8 weeks. Peritonitis was initiated by an ip injection of 0.5ml 10% 
TG and mice were sacrificed 24 hours later by cervical dislocation and peritoneal 
cells recovered by lavage using ice-cold PBS. Aliquots of lavage fluid from each 
mouse were stained and analysed by flow cytometry as above. Data from the 2 
experiments were combined (resulting in n = 8 for NOD and C57BL/6 mice and n = 
4 for all congenic strains) and analysed together. 
At the 24 hour time point, C57BL/6 mice exhibited significantly increased numbers 
of total leukocytes, M! and PMN than either the NOD mice or any of the NOD 
congenic strains. No differences were evident between the NOD mice and any of the 
congenic strains with respect to numbers of leukocytes recruited (see figure 7.8). 
Clearly the defective recruitment does not correct by replacing NOD genes in any of 
the idd loci 3, 5, 9, 10 or 18 and certainly did not correct by replacing the NOD vav3 
gene with a copy of the C57BL/6 Vav3 gene. The next question examined was 
whether defective leukocyte recruitment in NOD mice was restricted to peritonitis or 
also present in other M! dependent models of inflammation such as carrageenan 
(CG) pleurisy. 






Figure 7- 7 Analysis of chemokine and cytokine levels during TG peritonitis 
Peritonitis was induced with an ip injection of 0.5ml 10% TG. Peritoneal lavage was 
performed a various time points to 24 hours. Samples were centrifuged and supernatants 
decanted for analysis. 4 mice were used per time point. C57BL/6 mice in solid lines, NOD in 
dashed lines. No differences were seen between NOD and control mice in the 
concentrations of any chemokines or cytokines investigated.  





Figure 7- 8 Analysis of leukocyte numbers 24 hours after the initiation of TG 
peritonitis in C57BL/6, NOD and 4 congenic strains of NOD mice 
Peritonitis was initiated by i.p injection of 0.5ml 10% TG, the mice were sacrificed 24 hours 
later and peritoneal cells recovered  by lavage, immunolabeled and analysed by flow 
cytometry.  Total leukocyte counts in graph (A), M" counts in graph (B) and PMN counts in 
graph (C). *** p < 0.001, ** p < 0.01, * p < 0.05; NOD or congenic vs. C57BL/6; ANOVA. 




7.3 CARRAGEENAN PLEURISY 
Having corroborated defective leukocyte recruitment in one M! dependent model of 
inflammation it was decided to examine the inflammatory response of NOD mice 
using a different experimental model in a different system in order to determine 
whether a similar response was seen. CG pleurisy was selected over more 
‘physiologically relevant’ models of inflammation such as bacterial or LPS induced 
pleurisy because, like TG peritonitis, it is a reproducible model of sterile 
inflammation characterised by brisk leukocyte recruitment and has previously been 
demonstrated to be dependent upon resident M! function (Cailhier et al., 2005). It 
was hypothesised that once again NOD mice would exhibit impaired recruitment of 
leukocytes to the site of inflammation. 
 
7.3.1 Male NOD mice exhibit reduced leukocyte recruitment during CG 
pleurisy  
24 male NOD mice, aged 8 to 12 weeks, together with age and sex matched 
C57BL/6 controls were divided between 4 time points: zero (naïve), 24, 48 and 72 
hours. CG pleurisy was initiated as previously described. In brief, all mice were 
anaesthetised and 0.1ml 1% CG injected intrapleurally (i.pl.). Mice were sacrificed 
by exsanguination under general anaesthesia and pleural lavage performed with 1ml 
3.88% sodium citrate. The recovered pleural lavage was accurately weighed to gauge 
volume and aliquots were then transferred to chilled FACS tubes, immunolabeled 
and analysed as previously described in chapter 2.9.2. The remaining lavage fluid 
and blood samples were centrifuged to remove cells and the supernatants and serum 
samples were decanted and frozen at -80
o
C pending analysis. 
Since smaller volumes are used for pleural compared to peritoneal lavage (1ml vs. 
5ml) it is possible to use the volume of retrieved lavage fluid to directly gauge the 
volume of inflammatory exudate. The volumes of inflammatory exudate produced by 
NOD and C57BL/6 mice during CG pleurisy were similar at all time points 
examined (figure 7.9). Similar to TG peritonitis, NOD mice again recruited fewer 
total leukocytes over the time course (figure 7.10A) although the cell numbers at 24 
hours were comparable. A striking reduction in recruited M! numbers was evident in 
NOD mice compared to controls (figure 7.10B), despite initially having significantly 
higher resident PLM! numbers (0.73 ± 0.09 x 10
6 
vs. 0.27 ± 0.03 x 10
6
; NOD vs. 
C57BL/6; p < 0.001 by student’s t test of individual time point although not 




significant in context of the whole experimental time course and 2 way ANOVA). In 
contrast to TG peritonitis, the peak numbers of PMN at 24 hours were similar. 
Interestingly, C57BL/6 mice exhibited rapid clearance of significant numbers of 
PMN at 48 hours whereas NOD mice had a significantly increased PMN infiltrate at 
this time point (figure 7.10C). It is tempting to argue that the increased numbers of 
PMN present at 48 hours resulted from the combination of fewer M! to remove 
senescent apoptotic PMNs and an impaired AC phagocytic capacity of M! in NOD 
mice. Unfortunately, no free AC, necessary to prove defective clearance, were 
identified during examination of cytospins of the lavage fluid of either strain. 
Nikolic et al argued that bone-marrow precursors from NOD mice exhibit defective 
DC maturation in vitro (with maturation skewed towards M! generation (Nikolic et 
al., 2005) and the numbers of pleural CD11c
HI
 cells was thus measured in both 
strains. Fewer pleural DC were identified in NOD mice. Although this result is 
consistent with diminished maturation of NOD myeloid precursors into DC, the ratio 
of DC to M! in the 2 strains was remarkably similar at all time points (figure 7.11), 
suggesting that the in vitro phenomenon was probably not relevant to this model of 
inflammation in vivo. 
 
7.3.2 Female NOD mice exhibit reduced recruitment of M! and PMN 24 
hours after initiation of CG pleurisy 
 
As shown earlier, male and female NOD mice exhibited remarkably similar levels of 
leukocyte recruitment during TG peritonitis at the 24 hour time point although the 
dose of TG was different. It was hypothesised that the defective recruitment of 
leukocytes to CG pleurisy would also be independent of gender. CG pleurisy was 
initiated in 6 female NOD mice aged 6 weeks and 6 age and sex matched C57BL/6 
controls. Samples were collected and analysed for leukocytes as described 
previously. Somewhat surprisingly, in addition to the reduced numbers of total 
leukocytes and M! as seen previously with NOD mice, fewer PMN were also 
recovered (see figure 7.12). Further work, clarifying the phenotype is required. 
 
 




7.3.3 NOD mice produce significantly less MCP-1 during CG pleurisy 
Following the removal of aliquots for analysis of cell kinetics, lavage samples from 
the original experiment (using male mice) were spun down and supernatants 
decanted for analysis. The collection of serum from mice at each time point also 
enabled the analysis of chemokines and cytokines within the circulation enabling the 
gradient of chemokine, from serum to exudate to be calculated as this gradient, rather 
than absolute levels,  drives leukocyte recruitment. A range of chemokines and 
cytokines were examined: KC and MIP-2 by ELISA whilst MCP-1, TNF$, IL-6, IL-
10 and IFN" were analysed by CBA. 
Whilst NOD mice exhibited a significantly lower peak of MCP-1 within the pleural 
lavage fluid and the serum (figure 7.13), suggesting a possible mechanism for the 
markedly defective recruitment of M! seen in this model of inflammation. However, 
the gradient of MCP-1 from exudate to serum was strikingly similar between the 2 
strains (5.8 ± 1.4 vs. 6.5 ± 0.40; NOD vs. C57BL/6; p = ns, student’s t test ).  
It was previously noted with TG peritonitis and from the work of Jean-Francois 
Cailhier (Cailhier et al., 2005) that most chemokines and cytokines peaked early, 
within 4 hours with levels falling to baseline by 24 hours (figure 7.7). It was 
therefore not surprising to find no significant levels of most of these chemokines and 
cytokines within either the exudate or the serum at the 24 hour time point or later 
(see 24 hour data displayed in table 7.1; other time points not shown). One notable 
exception was KC (figure 7.14): NOD mice exhibited significantly higher levels in 
pleural exudates, lower levels in the serum and as a consequence a much greater 
gradient of KC from exudate to serum (3.2 ± 0.8 vs. 0.6 ± 0.1; NOD vs. C57BL/6; p 
< 0.05, student’s t test). This is interesting and rather unexpected, since peak PMN 
recruitment at 24 hours was similar between the 2 strains. There are a number of 
potential explanations for this anomaly. It could be explained by defective migratory 
ability of NOD PMN in response to chemokines or a reduced responsiveness of NOD 
PMN to KC. However, an alternative explanation may be that KC levels at 24 hours 
are less critical than at earlier time points: Jean-Frncois Cailhier (Cailhier et al., 
2006) found that KC levels peaked at 3 hours in CG pleurisy.  
In order to obtain a more complete picture of the cytokine and chemokine kinetics, it 
would be critical to examine levels at earlier time points in CG pleurisy. However, 
bearing in mind that the chemokine and cytokine responses in vivo during TG 




peritonitis did not give a clear mechanism for the diminished recruitment of 
leukocytes, additional mechanisms may be involved during CG pleurisy. The 
numbers of circulating leukocytes were determined and experiments were undertaken 
to determine whether NOD mice are capable of mounting a vigorous inflammatory 
response in a less M! dependent model of inflammation.  
  







Figure 7- 9 Analysis of volumes of recovered pleural lavage fluid 
Pleurisy was induced with an intra-pleural injection of 0.1ml 1% CG. Pleural lavage was 
performed with 1ml 3.88% sodium citrate. Volumes of fluid recovered were accurately 
weighed to measure of the volume present. 6 mice were used per time point; C57BL/6 mice 
in solid lines, NOD in dashed. There were no significant differences in the volumes of fluid 
recovered at any time point examined; C57BL/6 vs. NOD; 2-way ANOVA 






Figure 7- 10 Analysis of leukocyte numbers in CG pleurisy 
Pleurisy was induced with an intra-pleural injection of 0.1ml 1% CG. Pleural cells were 
recovered by lavage, immunolabeled and analysed by flow cytometry. 6 mice were used per 
time point; C57BL/6 mice in solid lines, NOD in dashed. NOD recruitment of leukocytes was 
reduced compared to C57BL/6 controls (A), with a striking failure to recruit M" (B). In 
contrast to TG peritonitis, PMN recruitment was similar in both strains, although PMN 
clearance was less rapid in NOD mice (C). *** p < 0.001, * p < 0.05; C57BL/6 vs. NOD; 2-
way ANOVA 
 







Figure 7- 11 Analysis of DC numbers and comparison to M! numbers in CG 
pleurisy 
Pleurisy was induced with an intra-pleural injection of 0.1ml 1% CG. Pleural cells were 
recovered by lavage, immunolabeled for CD11c and then analysed by flow cytometry. 6 mice 
were used per time point; C57BL/6 mice in solid lines, NOD in dashed lines. Numbers of DC 
within the inflammatory milieu were diminished in NOD mice compared to C57BL/6 controls 
(A). However the reduction in DC numbers was proportional to M" numbers, with a similar 
DC:M" ratio as control mice at all time points examined (B).  ** p < 0.01; C57BL/6 vs. NOD; 
2-way ANOVA 





Figure 7- 12 Analysis of leukocyte numbers in CG pleurisy in female mice at 24 
hours 
Pleurisy was induced with an intra-pleural injection of 0.1ml 1% CG. 24 hours later pleural 
cells were recovered by lavage, immunolabeled and analysed by flow cytometry. 6 mice per 
strain were used; C57BL/6 mice in solid bars, NOD in polka dots. NOD mice exhibited 
reduced recruitment of total leukocytes, M" and PMN. * p < 0.05; C57BL/6 vs. NOD; 
Student’s t test 






Figure 7- 13 Analysis of MCP-1 levels during CG pleurisy 
Pleurisy was induced with an intra-pleural injection of 0.1ml 1% CG. The mice were 
sacrificed by exsanguination under general anaesthesia, blood was harvested, spun down 
and the serum decanted for analysis. Pleural inflammatory exudate was recovered by pleural 
lavage, cells removed by centrifugation and supernatants decanted for analysis. MCP-1 
levels within the serum and exudate samples were measured by CBA. 6 mice were used per 
time point; C57BL/6 mice in solid lines, NOD in dashed lines. Peak MCP-1 levels in both the 
exudate (A) and serum (B) were significantly lower in the NOD mice. *** p < 0.001, ** p < 
0.01; C57BL/6 vs. NOD; 2-way ANOVA. 





Figure 7- 14 Analysis of KC levels during CG pleurisy 
Pleurisy was induced with an intra-pleural injection of 0.1ml 1% CG. The mice were 
sacrificed by exsanguination under general anaesthesia, blood was harvested, spun down 
and the serum decanted for analysis. Pleural inflammatory exudate was recovered by pleural 
lavage, cells removed by centrifugation and supernatants decanted for analysis. KC levels 
within the serum and exudate samples were measured by ELISA. 6 mice were used per time 
point; C57BL/6 mice in solid lines, NOD in dashed lines. KC levels in the exudate (A) appear 
higher in the NOD mice whereas KC levels in the serum (B) appeared higher in the C57BL/6 
strain significantly lower in the NOD mice. *** p < 0.001, * p < 0.05; C57BL/6 vs. NOD; 2-way 
ANOVA  
* 





24 hour NOD mice C57BL/6 mice 
time point pg/ml (sem) pg/ml (sem) 
 Exudate 
     
MIP-2 41 (10.5) 28 (7.0) 
TNF # 54 (11.7) 42 (4.0) 
IL-10 82 (9.3) 130 (22.8) 
IFN ! 20 (3.3) 22 (6.7) 
     
 Serum 
     
MIP-2 32 (8.1) 66 (8.1) 
TNF # 20 (0.6) 29 (2.6) 
IL-10 30 (17.3) 31 (6.6) 
IFN ! 8 (0.5) 14 (2.0) 
     
 
Table 7- 1 Analysis of cytokine and chemokine levels 24 hours after initiation of 
CG pleurisy 
Pleurisy was induced with an i.pl injection of 0.1ml 1% CG. The mice were sacrificed by 
exsanguination under general anaesthesia, blood was harvested, spun down and the serum 
decanted for analysis. Pleural inflammatory exudate was recovered by pleural lavage, cells 
removed by centrifugation and supernatants decanted for analysis. The levels of chemokines 
and cytokines within the serum and exudates were measured by either ELISA or CBA. 6 
mice were used per time point. No significant differences are evident between NOD and 
C57BL/6 mice 2-way ANOVA.  




7.4 CIRCULATING LEUKOCYTES 
 
7.4.1 Circulating leukocyte numbers are comparable between NOD and 
C57BL/6 mice 
 
Clearly any inflammatory response will be influenced by the numbers of circulating 
leukocytes. It was thus necessary to determine whether the differences in the 
inflammatory responses between NOD and C57BL/6 mice merely reflected lower 
circulating leukocyte levels.  
Blood was obtained by a tail bleed from 6 female NOD mice aged 8 to10 weeks, 
together with 4 aged and sex matched C57BL/6 controls and analysed by flow 
cytometry as described in chapter 2. No difference in the total numbers of circulating 
monocytes was evident between the strains although there was a trend for lower 
levels in NOD mice. NOD mice, however, were noted to have a reduced population 
of circulating GR-1
HI
 monocytes (figure 7.15A). Importantly, no differences were 
seen in the numbers of circulating PMN between strains (figure 7.16).  
Geismann et al (Geissmann et al., 2003) described 2 distinct populations of 
monocytes that can be differentiated by the level of expression of GR-1. GR-1
HI
 
monocytes home to sites of inflammation whilst GR-1
LO
 monocytes differentiate into 
resident M! populations. One possible explanation for the lower circulating numbers 
of GR-1
HI
 monocytes of NOD mice could be that these ‘pro-inflammatory’ 
monocytes are sequestered within areas of pancreatic inflammation (insulitis) thereby 
lowering circulating numbers. The difference in the levels of GR-1
LO
 monocytes 
between NOD and C57BL/6 mice may also be a sufficient explanation for the 
reduced levels of M! recruited to the inflamed peritoneum and pleural cavity in 
NOD mice.  
Young male NOD mice are much less likely to have significant insulitis. Circulating 
leukocyte numbers were therefore determined in 6 male NOD mice aged 5 weeks 
together with age and sex matched C57BL/6 controls. In this case, the NOD mice 
had significantly reduced levels of total circulating monocytes combined with 
significantly fewer numbers of GR-1
HI
 monocytes in their peripheral blood. No 
significant differences were observed in the number of circulating GR-1
LO
 
monocytes (figure 7.15B) or PMN (figure 7.16).  
 






Figure 7- 15 Analysis of circulating monocytes numbers 
Peripheral blood was obtained by tail bleeds and immunolabeled prior to red cell lysis. 
Leukocyte numbers were analysed by flow cytometry. Graph (A) shows data from 8 to 10 
week old female mice; 6 NOD mice and 4 matched C57BL/6 mice. Graph (B) shows data 
from 5 week old male mice; 6 mice per group; C57BL/6 in solid bars, NOD mice in polka dot. 
















































Figure 7- 16 Analysis of circulating PMN numbers per ml of whole blood 
Peripheral blood was harvested by tail bleed and stained prior to red cell lysis. PMN 
numbers were analysed by flow cytometry. No significant differences were seen in the 
circulating numbers of PMN in 2 different experiments. The first experiment used female 
mice aged from 8 to 10 weeks old; 6 NOD mice and 4 matched C57BL/6 mice. The second 
experiment used 5 week old male mice, 6 mice per group. C57BL/6 mice in solid bars, NOD 
mice in polka dot. Data analysed by student’s t test. 




7.5 DELAYED-TYPE HYPERSENSITIVITY MODEL OF PLEURISY 
It was demonstrated that NOD mice exhibited diminished leukocyte recruitment in 
TG peritonitis and CG pleurisy. Markedly reduced M! recruitment was characteristic 
of both models of inflammation in the NOD mouse compared to C57BL/6 mice. 
Although reduced PMN recruitment was clearly part of the phenotype of NOD TG 
peritonitis, it is a little less clear whether the same holds true for CG pleurisy as 
similar peak PMN infiltration as control mice was evident on one occasion (figure 
7.10C) and slightly reduced numbers were evident at the same time point on a second 
occasion (figure 7.12). Diminished levels of MCP-1 were found in NOD mice during 
CG pleurisy in both serum and pleural exudate but no differences in MCP-1 levels 
were identified in the peritoneal lavage fluid during TG peritonitis. Similarly no 
other consistent defects in chemokine or cytokine production were identified in vivo.  
CG and TG were used as inflammatory stimuli principally because resident M! 
within the pleural and peritoneal cavities respectively are critical to the subsequent 
inflammation(Cailhier et al., 2005; Cailhier et al., 2006). If reduced pro-
inflammatory M! function (as evident in vitro) and not defective leukocyte 
migration nor reduced numbers of circulating GR-1
HI
 monocytes were to underlie the 
defective leukocyte recruitment, then it would be reasonable to hypothesise that 
NOD mice would mount a vigorous inflammatory response in a model of 
inflammation that was less dependent on resident M! function. Pleurisy can be 
initiated as part of a delayed hypersensitivity reaction in which CD4
+
 T cells rather 
than resident M! are critical. The model of DTH pleurisy was therefore employed to 
test this hypothesis. 
 
7.5.1 NOD mice exhibit a vigorous inflammatory response during DTH 
pleurisy 
24 male NOD mice aged 6 to 10 weeks, together with age and sex matched C57BL/6 
controls, were divided into 4 groups to give similar time points to the CG pleurisy 
model. Three mice were allocated to the zero time point and 7 mice to each of the 24, 
48 and 72 hour time points. DTH pleurisy was initiated as previously described. In 
brief, all mice were injected intradermally at the base of the tail with 0.1ml 1% 
methylated bovine serum albumin (meth’ BSA) in Complete Freud’s Adjuvant 
(CFA) on day -12.  Mice allocated to the zero time point group were sacrificed on 
day zero whilst all remaining mice were injected with 0.1ml meth’ BSA i.pl and 




sacrificed 24, 48 or 72 hours later as appropriate. Mice were sacrificed by 
exsanguination under general anaesthesia. Pleural inflammatory cells and serum was 
harvested and analysed in a similar fashion to CG pleurisy above. 
Both strains of mice produced a vigorous inflammatory response to the i.pl injection 
of meth’ BSA. NOD mice, however, produced a much greater volume of 
inflammatory exudate (figure 7.17) and recruited greater numbers of leukocytes 
(figure 7.18A). NOD mice appeared slow to initially recruit M!, but the numbers of 
M! recruited by NOD mice exceeded those of the C57BL/6 controls by the 72 hour 
time point (figure 7.18B). Similarly PMN recruitment by NOD mice exceeded that of 
control C57BL/6 mice (figure 7.18C).  
Thus, depending on the stimulus, NOD can generate a vigorous immune response. 
This is perhaps not surprising in a mouse strain that develops autoimmunity with the 
resultant destruction of pancreatic Beta cells. 






Figure 7- 17 Analysis of pleural lavage volumes during DTH pleurisy 
Pleurisy was induced with an intra-pleural injection of 0.1ml methylated BSA 12 days after 
sensitisation. Pleural lavage was performed with 1ml 3.88% sodium citrate. Volumes of fluid 
recovered were accurately weighed to measure the volume. There were 3 mice per group at 
the zero time point with 7 mice per group for all subsequent time points: C57BL/6 mice in 
solid lines, NOD mice in dashed lines. NOD mice produced significantly more inflammatory 
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Figure 7- 18 Analysis of leukocyte recruitment during DTH pleurisy 
Pleurisy was induced with an intra-pleural injection of 0.1ml methylated BSA 12 days after 
sensitisation. Pleural cells were recovered by lavage, immunolabeled and analysed by flow 
cytometry. There were 3 mice per group at the zero time point with 7 mice per group for all 
subsequent time points; C57BL/6 mice in solid lines, NOD mice in dashed lines. NOD mice 
recruited significantly more leukocytes including both PMN and M". *** p < 0.001, ** p < 


















































In this chapter it has been shown: 
 
In M! dependent models of inflammation, NOD mice have a grossly impaired ability 
to mount an inflammatory response with reduced total leukocyte numbers as well as 
M! and PMN infiltration in TG peritonitis and CG pleurisy. Lymphocyte recruitment 
was also less in the NOD mouse during TG peritonitis. 
The pattern of monocyte recruitment, as well as absolute numbers, was abnormal. 
NOD mice exhibited a diminished reduction in mature M! numbers and grossly 
impaired influx of inflammatory monocyte/M!. 
The ratio of DC to M! during CG pleurisy was unaffected suggesting that the 
defective maturation of NOD DC in vitro was not relevant in vivo. 
No gross abnormality was identified in the production of chemokines or cytokines 
during TG peritonitis, although reduced levels of MCP-1 were identified during CG 
pleurisy. 
Circulating levels of GR-1
HI
 monocytes were reduced in the NOD mice. Since 
previous work suggests that these monocytes become inflammatory M! the reduced 
numbers of GR-1
HI
 monocytes could explain, at least in part, the diminished M! 
recruitment. 
The defective inflammatory phenotype in TG peritonitis is independent of idd18, 
suggesting no involvement of the vav3 gene putatively linked to impaired AC 
phagocytosis in NOD M!. 
In DTH pleurisy, an immunological T cell driven and less M! dependent model of 
inflammation, NOD mice are capable of mounting a very vigorous inflammatory 
response with robust leukocyte infiltration. 
 























Chapter 8. Discussion 
  




8.1 MACROPHAGES FROM NOD MICE EXHIBIT DEFECTIVE 
PHAGOCYTOSIS  
An in vitro  phagocytic defect in M! derived from NOD mice was first described by 
O’Brien and colleagues (O'Brien et al., 2002) with further work providing evidence 
of defective AC phagocytosis in vivo (O'Brien et al., 2006). Their seminal studies, 
however, restricted the phagocytic defect to AC, as the phagocytic clearance of 
polystyrene beads was comparable between M! derived from NOD and control 
strains. Defective AC phagocytosis was more pronounced in female mice and a 
diminution of the defect was observed as NOD mice aged (O'Brien et al., 
2002)(O’Brien et al, 2002).  
O’Brien’s group had previously described the wave of apoptosis evident within the 
pancreas during the neo-natal period in various strains of mice as the pancreas is re-
modelled for adult life. Increased numbers of free AC were observed in pancreas of 
NOD mice compared to control strains (Trudeau et al., 2000). As discussed in 
chapter 1.5.2, there is compelling circumstantial evidence linking defective clearance 
of AC to later development of systemic autoimmune diseases such as SLE. O’Brien 
and colleagues argued that the defective clearance of apoptotic beta cells within this 
very narrow time frame in the neonatal period contributed to organ-specific 
autoimmunity, resulting in the development of diabetes in female NOD mice 
(O'Brien et al., 2002). 
 
8.1.1 NOD mice exhibit a phagocytic defect for apoptotic cells and latex 
beads but not IgG opsonised pneumococci in vitro  
This study demonstrated (chapter 3) that the phagocytic defect evident in NOD M! 
in vitro is far more pervasive than originally suggested by O’Brien and colleagues. 
Whilst PM! from young female NOD mice clearly exhibited defective clearance of 
AC, the defective clearance of latex beads was equally evident (chapter 3.2.1). 
Furthermore, in additional studies we clearly demonstrated that the defect was 
evident in PM! and BMDM! from older NOD mice (chapter 3.2.3).  
O’Brien and colleagues in their original paper had noted NOD-derived PM! 
exhibited almost normal phagocytic clearance of apoptotic thymocytes opsonised 
with monoclonal anti-murine anti-CD3 Ig G antibodies (O'Brien et al., 2002). 
Likewise we found the in vitro clearance of pneumococci opsonised with IgG was 




comparable between NOD and C57BL/6 derived M! (chapter 3.2.2). The phagocytic 
defect therefore does not apply to all particles, at least in vitro. 
 
8.1.2 NOD mice exhibit a phagocytic defect for apoptotic cells and latex 
beads in vivo 
 
As discussed in chapter 4, the assays employed by O’Brien and her colleagues to 
assess phagocytic clearance of AC in vivo (O'Brien et al., 2006) were potentially 
flawed. Counting and comparing free AC numbers within thymuses of NOD and 
C57BL/6 mice takes no account of the previously published observations that NOD 
thymocytes are resistant to undergoing apoptosis; a phenotype of NOD mice linked 
to idd 6 (Bergman et al., 2003). Equally, measuring AC phagocytosis by performing 
cytospins of PM! at various time points after an injection of AC into the peritoneal 
cavity fails to appreciate the dynamic nature of peritoneal cell kinetics and the fact 
that PM! localise to the greater omentum or exit the peritoneal cavity following the 
phagocytosis of AC and are therefore not retrievable by peritoneal lavage (Simon 
Watson, PhD thesis, University of Edinburgh). 
We elected to utilize the in vivo phagocytosis assay employed by Phillip Taylor and 
colleagues (Taylor et al., 2000) and adapted by Simon Watson (PhD thesis, 
University of Edinburgh). We concentrated on the number of free AC recovered by 
peritoneal lavage (counted by flow cytometry) at various time points after the 
injection of a known number of AC and made no attempt to assess cytospins. The 
numbers of PM! available to phagocytose AC were also counted at each time point. 
This assay made the assumption that loss of free AC was a surrogate marker for 
phagocytic clearance by PM!.  
This assay demonstrated that NOD and C57BL/6 mice appeared to clear AC with 
equal efficiency from the peritoneal cavity, but NOD mice had considerably more 
PM! in situ than C57BL/6 mice to ingest the administered AC (figure 4.1). 
Mathematically modelling of the data was undertaken by Professor Jonathan Sherrat 
(chapter 4.2.3) and a clear phagocytic defect was unmasked. Interestingly 
mathematical modelling was able to extract additional information from the 
experimental data. For example NOD PM! would take approximately 30 minutes to 
clear an AC compared to 15 minutes for C57BL/6 PM!, at the time point when there 
was 2 million free AC within the peritoneum. Moreover the rate limiting step for the 




NOD PM! appeared to be the ingestion and not the locating and binding of the AC, 
whereas the opposite was true for C57BL/6 PM!. Phagocytosis of latex beads by 
NOD PM! was also reduced in vivo (chapter 4.2.4), confirming the in vitro studies. 
 
8.1.3 The mechanism underlying the phagocytic defect appears 
consistent with dysfunction of the Vav3 gene 
Although phagocytic defects in NOD M! have been identified and published as 
discussed above, the underlying mechanism has remained elusive. Following 
confirmation of the previously published work of O’Brien and colleagues, that NOD 
M! exhibited defective clearance of AC and having extended these findings to other 
particles as discussed above, we set about to dissect the underlying mechanism. 
Initial attempts concentrated on looking for differences between NOD and C57BL/6 
mice in the quantity of mRNA present in comparable M! populations for certain 
receptors known to be involved in phagocytic clearance of AC (table 1.4). The 
quantity of mRNA present was used as a surrogate marker for receptor production. 
BMDM! and PM! from each strain were assessed for a range of receptors and the 
mRNA for each quantified by real time PCR. No consistent differences emerged 
between the two strains for both M! populations assessed (figures 5.1 and 5.2). 
Surface expression of some of these receptors was assessed by flow cytometry and 
compared across the 2 strains. Unfortunately attempts were limited by the avidity 
with which murine antibodies for these receptors bound to PM! (chapter 5.2.2). 
However, as with the mRNA studies above, no clear, pattern emerged.  
These early studies were always ‘fishing expeditions’ dependent on the availability 
of PCR probes and monoclonal antibodies. As additional data accumulated from the 
in vitro phagocytosis assays it became clear the defect was more profound than 
merely affecting the clearance of AC. The mechanism underlying defective 
phagocytosis of a wider range of particles could easily lie within intracellular 
pathways as well as surface receptors.  
The experimental strategy was therefore changed and rather than continue with 
assessing surface receptors or mRNA, it was decided to use NOD congenic strains. 
As discussed in chapter 1.2.2, NOD congenic strains are essentially NOD mice with 
small genetic areas (idd loci) replaced with genetic material from non-autoimmune 
prone strains, usually C57BL/6 mice. As a consequence of switching these small 




chromosomal segments, NOD congenic mice are protected from developing diabetes. 
Since clearance of AC cells by M! in vivo is perhaps more physiologically relevant 
than in vitro data, it was decided to use the peritoneal in vivo assay to compare NOD, 
C57BL/6 and various NOD congenic strains of mice. Linda Wicker at the Cambridge 
Medical Research Institute (CMRI), an international authority on the genetics of 
NOD mice, was consulted and a range of congenic strains made available for this 
purpose. 
NOD mice bred at the CMRI are from the Taconic colony established by Merck in 
the United States of America. NOD mice at the animal facility, Little France, 
Edinburgh were purchased from Charles River, France. The two strains appear subtly 
different in that those from France had consistently higher numbers of resident PM! 
then C57BL/6 mice but cleared similar numbers of AC whilst Taconic NOD mice 
had similar numbers of PM! to control mice and cleared fewer AC. These two NOD 
colonies separated from the original Japanese colony with about 30 back-cross 
generations between them and subtle genetic differences presumably explain this 
difference. 
The in vivo phagocytosis of AC of several NOD congenic strains was compared to 
NOD and C57BL/6 mice. In this manner idd 3, 5, 9, 10 and 18 were assessed for the 
gene or genes underlying defective phagocytosis of AC. The results were quite 
unequivocal (chapter 5.2.3). NOD mice with C57BL/6 genes covering idd 3/10/18 
phagocytosed AC just as rapidly as C57BL/6 mice, whilst NOD mice with a 
combination of C57BL/6 or C57BL/10 genes covering idd 3/10, idd 3/5 or idd 9, 
cleared AC at rates comparable with NOD mice. By implication therefore the NOD 
genes responsible for defective phagocytosis lie within this region on chromosome 3. 
Scrutiny of the gene within idd 18 indicates that Vav3 is the only candidate gene that 
may explain defective phagocytosis (Maier and Wicker, 2005). 
Furthermore the fact that the phagocytic defect localised to a diabetes susceptibility 
locus is further circumstantial evidence linking defective phagocytosis to 
autoimmunity, although not necessarily organ specific. It is possible that the 
phenotype contributes to the autoimmune-permissive genetic background of NOD 
mice rather than autoimmune diabetes per se. 




As a GEF, Vav3 is an interesting candidate gene. It was discussed in chapter 1.4.2 
how GEFs, including those of the Vav family, were recruited to nascent phagosomes 
following ligation of FcR and CR. Interestingly, however, phagocytosis following 
FcR or CR ligation appears to use subtly different intracellular pathways to activate 
actin polymerisation to achieve phagocytosis (Hall et al., 2006). Although GEF were 
necessary to affect actin polymerisation for both pathways, Vav appeared to be 
unnecessary for FcR mediated phagocytosis of particles opsonised with IgG. This 
sits very comfortably indeed with our data that showed no phagocytic defect in vitro 
for pneumococci opsonised with IgG (chapter 3.2.2). There are however a couple of 
points that require further consideration and explanation. 
There are 3 isoforms of Vav within the murine genome; Vav1 is confined to 
haematopoietic cells whereas Vav2 and Vav3 are more ubiquitous. Amy Hall and 
colleagues found that in vitro both Vav1 and Vav3 had to be knocked out before a 
phagocytic defect could be elicited (Hall et al., 2006). However, in vitro work using 
BMDM!, does not always predict in vitro, let alone in vivo findings with resident 
PM!, as clearly demonstrated by further work in this study (chapters 6 and 7). 
Alternatively, additional unknown factors related specifically to NOD M! may 
function in such a way to make the loss of Vav3 more critical. 
Menna Clatworthy and colleagues in Cambridge demonstrated that M! from 
autoimmune prone strains of mice, including NOD mice, express 50% less Fc"R2b 
on their cell surface (Clatworthy and Smith, 2004). Fc"R2b is an inhibitory FcR, and 
cross ligation with an activating Fc"R results in inhibition of phagocytosis. Loss of 
Fc"R2b is therefore associated with increased phagocytosis. As predicted, in their 
experiments C57BL/6 M! derived from Fc"R2b KO mice exhibited a marked 
increase in phagocytosis of opsonised pneumococci compared to wild-type M! 
(Clatworthy and Smith, 2004). Ken Smith’s group in Cambridge have clearly 
demonstrated how the activity of Fc"R2b may control the effective balance between 
phagocytic clearance of bacterial or malarial parasites on the one hand and 
autoimmune diseases such as SLE on the other in both mice and humans (Clatworthy 
and Smith, 2004; Clatworthy et al., 2007; Floto et al., 2005). From this data, NOD 
M! would be expected to exhibit increased phagocytosis of IgG opsonised particles 
such as pneumococci compared to C57BL/6 mice rather than comparable 
phagocytosis. Once again however, these were in vitro experiments and not in vivo. 




Furthermore, they were between Fc"R2b KO and wild-type (C57BL/6) PM! and 
there may be additional factors pertaining to NOD PM! in particular, that explain the 
effects we observed. 
 
8.1.4 Further work 
Additional work is required to prove the link between the phagocytic defect observed 
in NOD-derived M! and idd 18. As discussed above, the data currently available link 
idd 18 to the defect by exclusion: the defect was rescued by C57BL/6 genes across 
idd 3/10/18 but not by control genes across idd 3/10. It is just possible the observed 
phagocytic defect results from multiple genes, some of which may lie in (or be 
influenced by) idd 3 or idd 10 plus idd 18. Further in vivo phagocytosis experiments 
are planned comparing NOD and C57BL/6 mice with two additional NOD congenic 
strains that replace idd 18 and idd 10 individually. If the phagocytosis of AC and 
beads is rescued within the idd 18 NOD congenic strain, whilst it is still evident in 
the idd 10 NOD congenic strain, defective phagocytosis would have been 
conclusively tied to the genes with idd 18 on murine chromosome 3. 
If the link between defective phagocytosis and idd 18 is proven by the strategy 
described above, additional steps could be taken to specifically link the defect in 
NOD M! to Vav3.  
• The definitive experiment would be to rescue the defect by expressing 
C57BL/6-derived Vav3 within NOD M!. This could potentially be 
achieved using viral vectors containing C57BL/6-derived Vav3 to 
transfect NOD M!.  
• Alternatively small interfering RNA (siRNA) technology could be 
employed to knock down Vav3 in C57BL/6 mice in vitro or in vivo, 
with the hypothesis that a similar phagocytic defect as seen with NOD 
mice would then emerge.  
• Western blots could be used to quantitatively measure the expression 
of Vav3 within NOD M! compared to C57BL/6. 
• Over-expression of constituitively active Rac within NOD M! should 
rescue the phagocytic defect if due to defective Vav genes (Hall et al., 
2006). 





8.2 BONE MARROW DERIVED MACROPHAGES AND RESIDENT 
MACROPHAGES FROM NOD MICE EXHIBIT DIVERGENT 
PHENOTYPES IN VITRO 
 
Having examined the phagocytic defect present within NOD-derived M!, it was felt 
important to assess another key aspect of M! function: the ability to orchestrate 
inflammation. The literature appears divided as to whether M! from NOD mice are 
hyper-inflammatory (Sen et al., 2003; Stoffels et al., 2004) or hypo-inflammatory 
(Fan et al., 2004) in their cytokine and chemokine responses to inflammatory stimuli 
in vitro. 
This study addressed the question by comparing different M! populations from NOD 
and C57BL/6 mice to different pro-inflammatory stimuli. BMDM! were compared 
to resident PM! and resident PLM! with the different M! populations being 
obtained from the same mice whenever possible. Different time points were assessed 
(1, 4 and 24 hours) and quiescent chemokine and cytokine responses were measured 
and compared to stimulation with LPS, TG and CG. The latter two substances were 
selected as they were to be used for subsequent in vivo models of peritonitis and 
pleurisy respectively. A mixture of pro-inflammatory (TNF$ and IFN") and anti-
inflammatory (IL-10) cytokines were measured together with IL-6, apparently 
having both pro- and anti-inflammatory properties. MCP-1, an important CC 
chemokine together with KC and MIP-2, key CXC chemokines, were also assessed. 
In this manner it was hoped to get a reasonably ‘full’ picture of how M! from the 
two strains of mice might differ in their response to stimuli. 
Our data suggested BMDM! from NOD mice were much more pro-inflammatory 
than their C57BL/6 counterparts to all three stimuli assessed (figures 6.2 and 6.3 for 
responses to LPS; figures 6.4 and 6.5 for responses to CG; figures 6.6 and 6.7 for 
responses to TG). Levels of pro-inflammatory cytokines and chemokines were higher 
from NOD mice whilst the levels of the important anti-inflammatory cytokine IL-10 
were reduced. As expected, no significant IFN" was detected as it is predominantly 
released by T cells 
Rather surprisingly however, the data implied resident M! populations from the 
same NOD mice were hypo-responsive to inflammatory stimuli. Although the data 
for resident PLM! and PM! were not as consistent as that seen with BMDM! across 




the time courses, the patterns nevertheless appeared consistent enough (see figures 
6.8 through to 6.11 for PLM! and figures 6.12 through to 6.17 for PM!). It could be 
hypothesised that since the resident M! were ex vivo they had possibly a less 
uniform exposure to stimuli during maturation than BMDM! all maturing in the 
same Teflon pot. 
The almost diametrically opposed phenotypes observed between the NOD BMDM! 
and resident M! may go some way to explain differences in the published literature, 
particularly as some groups (Fan et al., 2004) worked predominantly with peritoneal 
M! (albeit TG elicited) whilst others used splenic M! and BMDM! (Sen et al., 
2003).  
The data from this series of experiments also firmly underlines the difficulty of 
extrapolating data from one M! subset to another. BMDM! are frequently chosen to 
represent ‘generic M!’ because of the relative ease in obtaining large numbers of 
them. Our data would argue that whilst useful information can be obtained from 
BMDM!, it must be remembered they are always a model for in vivo M! 
populations and will not necessarily behave in an identical fashion. 
 
8.2.1 Further work 
 
It was mentioned in chapter 5 that BMDM! from NOD mice contained significantly 
more mRNA for CD14 than BMDM! from C57BL/6 mice (figure 5.1), however no 
significant differences in CD14 mRNA levels were identified between PM! from the 
two strains (figure 5.2). Interestingly, reduced surface expression of CD14 was 
perhaps apparent on the surface of NOD PM! (figure 5.3). CD14 functions in 
conjunction with TLR4 as a receptor for LPS. Although the above data does not offer 
an explanation for defective phagocytosis apparent in both BMDM! and PM!, it 
does have the potential to explain a heightened pro-inflammatory response to LPS 
observed by BMDM! but not PM!.  
Further work quantifying CD14 mRNA in resident PLM! and likewise quantifying 
surface expression of CD14 by both BMDM! and PLM! may be helpful. If the 
pattern proves consistent, additional experiments with CD14 blocking antibodies 
would help to clarify the role CD14 may play in the divergent phenotypes observed 
between BMDM! and resident M! from NOD mice. 




Alternatively, relative activity of the NF(B pathways in these population could be 
assessed and compared to C57BL/6 M!. 
 
8.3 NOD MICE EXHIBIT DEFECTIVE RECRUITMENT OF LEUKOCYTES 
IN MACROPHAGE-DEPENDENT MODELS OF INFLAMMATION 
 
Having probed the cytokine and chemokines responses of NOD and C57BL/6 M! to 
LPS, CG and TG in vitro, it was felt important to try and examine the function of 
NOD-derived M! in vivo. TG peritonitis and CG pleurisy were selected as in vivo 
models of inflammation  to assess M! function because the inflammatory response in 
both these models was dependent upon the resident M! population (Cailhier et al., 
2005; Cailhier et al., 2006). In the absence of the resident M! the subsequent 
inflammatory response was extremely muted. 
 The hypothesis suggested by the in vitro data was that since these models were 
reliant on PM! function, reduced acute inflammation would be evident in NOD 
mice. To contrast with these models, the inflammatory response in a model of 
inflammation considered less dependent on resident M! function, DTH pleurisy, was 
also assessed.  
 
8.3.1 NOD mice recruit fewer leukocytes to TG peritonitis 
 
Paul Potter and colleagues from the Hammersmith Hospital originally published that 
SLE-prone strains of mice had abnormal inflammatory responses to TG (Potter et al., 
2003). Hanli Fan then published several similarities between M! from NOD and 
Lupus-prone strains of mice with TG elicited PM! from these strains of mice 
apparently sharing a hypo-responsive cytokine phenotypes (Fan et al., 2004)and 
abnormal Rho activity (Fan et al., 2006) in the presence of AC or the lipid 
component of FBS. Gerben Bouma and colleagues subsequently published that NOD 
mice had an impaired ability to recruit leukocytes to TG peritonitis (Bouma et al., 
2005).  
Experiments in this study corroborated the findings of Gerben Bouma and colleagues 
and demonstrated impaired recruitment of leukocytes in response to TG peritonitis. 
Our data was subtly different insofar as the recruitment deficit we observed was not 
as dramatic. Bouma et al. noted that M! and PMN numbers in NOD mice 
approached 30% and 15%  respectively of those achieved by C57BL/6 control mice 




at 24 hours, we recorded values nearer 50%  for both leukocyte types (see figure 
7.1). Interestingly the cell kinetics we noted bore a striking similarity to those 
described by Paul Potter and colleagues (Potter et al., 2003). It is quite possible these 
differences may reflect differences in NOD colonies as described earlier. 
Since the earlier work of Jean-Francois Cailhier within our group had emphasised the 
fundamental importance of resident PM! in the initiation of TG peritonitis (Cailhier 
et al., 2005), it was decided to examine the cell kinetics of TG peritonitis in the first 
24 hours following TG injection in much greater detail.  
Blood borne monocytes, from which tissue M! are derived, have a low CD11b and 
F4/80 expression as assessed by flow cytometry (see figure 2.27B) compared to 
resident PM! (see figure 2.22). It therefore seems reasonable to assume M! within 
the peritoneum that have CD11b and F4/80 expression profiles closer to monocytes 
are likely to represent recently infiltrated inflammatory monocytes / M!. On the 
basis of this assumption an interesting pattern emerged regarding M! subtypes 
within the peritoneum in the first 24 hours after TG injection. C57BL/6 mice 
promptly ‘lost’ the mature M! phenotype from the peritoneum in a reaction 
reminiscent of the macrophage disappearance reaction (Melnicoff et al., 1989) and a 
rapid influx of infiltrating monocytes / M! was evident. In contrast, NOD mice 
retained the mature M! within the inflammatory cell infiltrate and had a much slower 
recruitment of additional monocytes / M! (figure 7.5).  
In contrast to M! recruitment, which was clearly different between the two strains 
from a very early stage, PMN recruitment in TG peritonitis appears more 
complicated. Recruitment of PMN up to 4 hours was comparable between NOD and 
C57BL/6 mice. C57BL/6 mice continued to increase PMN numbers until they 
appeared to peak at 24 hours whilst, in contrast, NOD mice failed to increase 
peritoneal PMN numbers beyond the 4 hour time point (figure 7.6). 
Thus the data clearly indicated that, as hypothesised and consistent with previously 
published work, leukocyte recruitment in NOD mice was severely impaired in a M!-
dependent model of inflammation, 




8.3.2 NOD mice recruit fewer leukocytes to CG pleurisy 
 
As mentioned above, CG pleurisy is another well-characterised model of in vivo 
inflammation proven to be dependent on the function of the resident M! population 
(Cailhier et al., 2006). As hypothesised the recruitment of leukocytes by NOD mice 
was also diminished in this model of inflammation (figure 7.10A). A subtle 
difference, however, was evident from TG peritonitis. Although monocyte / M! 
recruitment was impaired, PMN recruitment by male mice was remarkably similar 
(figure 7.10 B and C). This pattern however was not consistent and CG pleurisy 
within female NOD mice exhibited reduced recruitment of both M! and PMN 
(figure 7.12). 
 
8.3.3 NOD mice exhibit a vigorous inflammatory response to DTH 
pleurisy 
DTH pleurisy is initiated by pleural antigen presenting cells processing antigen, to 
which the mice had previously been sensitized, and presenting it to CD4
+
 T cells. 
These CD4
+
 cells then release a Th1 profile of chemokines and cytokines to initiate 
the inflammatory response. Although monocytes / M! are recruited and certainly are 
involved in the inflammatory response, the inflammation is predominantly 
considered to be less M! dependent. 
Using this model of inflammation, injecting methylated bovine serum albumin into 
the pleural cavity twelve days after sensitization in the presence of complete Freud’s 
adjuvant, we found that the inflammatory response in NOD mice exceeded that 
observed in the C57BL/6 mice, with increased exudate formation and increased 
numbers of both monocytes / M! and PMN recruited (figures 7.17 and 7.18). 
These observations were important, clearly demonstrating that under certain 
circumstances NOD mice are capable of mounting a robust and exaggerated 
inflammatory response. 
 




8.4 POTENTIAL MECHANISMS FOR IMPAIRED LEUKOCYTE 
RECRUITMENT IN TG PERITONITIS AND CG PLEURISY 
The inflammatory responses observed in TG peritonitis and CG pleurisy were 
therefore entirely consistent with the original hypothesis that predicted a diminished 
inflammatory response in would be observed in NOD mice as a consequence of 
hypo-responsive resident M! populations. The inflammatory response to DTH 
pleurisy was also consistent with the hypothesis that NOD mice would be expected 
to mount robust inflammatory responses in models of inflammation less dependent 
on resident M! function.  
The next step was to try and isolate if possible which precise aspect of NOD resident 
M! function underpinned the defective recruitment of inflammatory leukocytes, and 
to assess other potential explanations for the observations made during TG 
peritonitis, CG pleurisy and DTH pleurisy. 
 
8.4.1 Chemokine and cytokine levels 
As mentioned earlier, production of the important CXC chemokine MIP-2 by 
resident M! had been shown to be critical to subsequent PMN recruitment in these 
inflammatory models (Cailhier et al., 2005; Cailhier et al., 2006). Reduced 
production of MIP-2 by NOD M! was predicted by the in vitro data and therefore 
the first hypothesis to explain the subsequent failure to recruit sufficient PMN in TG 
peritonitis. It was therefore somewhat surprising to observe extremely similar levels 
of MIP-2 measured in the peritoneal lavage fluid from the two strains of mice (figure 
7.7A). Similarly, no differences were in MIP-2 levels were identified in pleural 
exudates from NOD or C57BL/6 mice, although key time points have not yet been 
assessed (table 7.1).  
Could differences in the other chemokines measured explain the reduced 
inflammatory cell infiltrate? Although a few minor differences were identified in 
pleural chemokine levels between NOD and C57BL/6 mice, as discussed in chapter 
7.3.3, they are unlikely to be physiologically important. For example, although KC 
levels in NOD mice were significantly higher at 24 hours than those observed in 
C57BL/6 mice, this observation must be treated with caution since KC levels peak 
much earlier at 3 hours and we do not yet have the data pertinent to this time point. 
Levels of the powerful CC chemokine MCP-1 were low in the pleural exudates from 
NOD mice and represent a tempting explanation for reduced monocyte / M! 




recruitment. However serum levels were similarly low and the exudates-serum 
gradients, down which infiltrating monocytes would travel, were strikingly similar 
(figure 7.13). No differences were identified in peritoneal levels of KC or MCP-1 
(figure 7.7B and figure 7.7C). 
It should be noted however, that the NOD mice had approximately twice as many 
resident PM! or PLM! in situ and also retained them for longer within the serosal 
cavity (at least as far the peritoneum was concerned) to produce the chemokines and 
cytokines measured. It could be argued therefore that the similar levels of 
chemokines and cytokines observed in vivo were compatible with the differences 
identified in chemokine production by resident PM! in vitro.  
Milky spots on the greater omentum are the major site of influx (or efflux) of 
leukocytes from the peritoneal cavity (Cranshaw and Leak, 1990). Similar sites are 
known to occur within pleural cavities (Pereira Ade et al., 1994). If the milky spots 
in NOD and C57BL/6 mice are comprised of similar M! numbers, then it could be 
argued NOD mice might produce less MIP-2 where it ‘really matters’, that is to say 
in the milky spots themselves. However, normal recruitment rates of PMN in the first 
few hours of TG peritonitis are entirely consistent with similar levels of MIP-2 signal 
and suggest an alternative explanation beyond chemokine or cytokine production 
was the cause of the diminished ability of NOD M! to mount a robust response to 
TG peritonitis. 
8.4.1.1 Further work 
Experiments assessing chemokine and cytokine levels in pleural exudates at early 
time points (1 and 3 hours) following CG pleurisy are planned.   
 
8.4.2 Migratory capabilities of NOD leukocytes 
Could impaired migratory capacity of NOD leukocytes explain the diminished 
leukocyte recruitment observed in TG peritonitis and CG pleurisy? Again it is 
difficult to argue that a general impairment of migratory ability underlies the 
recruitment defect if PMN numbers (and therefore rate of PMN migration) are 
similar between the two strains for the first few hours of TG peritonitis and indeed 
increased during DTH pleurisy.  




Nonetheless, Gerben Bouma and colleagues argued day four TG elicited PM! from 
NOD mice demonstrated impaired movement towards MCP-1 in a Boyden chamber 
in vitro (Bouma et al., 2005). However some caution is warranted in the 
interpretation as both their own data and our data would suggest the inflammatory 
processes that had recruited and ‘programmed’ these PM! were very different 
between the two strains of mice.  
On the other hand, since our data suggested the phagocytic defect observed in NOD 
mice localised to Vav3, a GEF known to be involved in actin polymerisation, 
cytoskeletal rearrangement and therefore potentially migration, it was considered 
clearly important to examine whether the impaired recruitment of leukocytes 
localised to the same gene. As shown by figure 7.8, replacing the NOD Vav3 gene 
for C57BL/6 made no difference to the inflammatory response or leukocyte 
recruitment.  
8.4.2.1 Further work 
The migratory abilities of both resident M! (PM! and PLM!) and BMDM! to 
MCP-1 should be assessed in vitro in a Boyden chamber should be assessed, 
avoiding TG elicited PM!. Unfortunately it is extremely difficult to obtain sufficient 
numbers of ex vivo PMN for these experiments and TG elicited PMN are best 
avoided for the same reasons as argued above. 
Conducting in vivo migration tests by injecting chemokines directly into peritoneal 
cavities of NOD and C57BL/6 mice can give data that is difficult to interpret. These 
experiments, as conducted by Bouma et al. do not just assess leukocyte migration but 
are also affected by circulating numbers and the inflammatory response engendered 
by the chemokine itself. 
 
8.4.3 Circulating numbers of NOD leukocytes 
Could circulating leukocyte numbers explain the defective recruitment of 
leukocytes? In a seminal paper Geismann and colleagues (Geissmann et al., 2003) 
(Geismann et al, 2003) demonstrated two subsets of circulating monocytes, 
distinguished by their expression of GR-1. GR-1
HI
 monocytes were rapidly recruited 
into inflamed tissue whereas GR-1
LO
 monocytes remained in the circulation longer 
and matured into resident tissue M!. Our data, in accordance with that of Bouma and 
colleagues, demonstrated reduced numbers of circulating GR-1
HI
 monocytes in naïve 




NOD mice (figure 7.15). This therefore does raise an intriguing explanation for 
reduced monocyte recruitment and is consistent with the initially slower M! 
recruitment seen in DTH pleurisy (figure 7.18).  
Circulating PMN numbers were not significantly different between the two groups of 
mice. It is thought a large reservoir of PMN capable of rapid mobilization to sites of 
inflammation is held within the bone marrow by the chemokine SDF-1 (Martin et al., 
2003). Although there are no data published regarding whether the size of this 
‘reservoir’ varies between different strains of mice, the presence of a smaller 
reservoir within the bone marrow of NOD mice could explain the initial normal 
PMN response we observed in response to TG peritonitis followed by the subsequent 
failure to increase numbers. It is difficult to reconcile this explanation to the 
increased inflammatory response seen in DTH, unless the sensitisation procedure 
itself stimulated NOD mice to somehow increase this pool of PMN within the bone 
marrow. 
8.4.3.1 Further work 
Assessment of PMN numbers within the bone marrow is not as easy as it initially 
sounds. It should be possible to harvest femurs and promptly flush the contents into 
FACS tubes. A single cell suspension could be obtained, washed, stained for GR-1 
and analysed by flow cytometry. Naïve mice from different strains could be 
compared along with mice following an inflammatory stimulus such as TG 
peritonitis. Lower resting numbers PMN in the bone marrow of NOD mice followed 
by depletion would support the hypothesis that the diminished PMN recruitment 
witnessed is merely a reflection of reduced ‘PMN reserve’. The main difficulties 
would be to (a) ensure all PMN from each femur were flushed and counted and (b) 
take into account variations in femur size.  Normalising the data to a control stromal 
cell is has the potential to correct for both these sources of error.  It would also be 
informative to assess the circulating numbers of leukocytes in the two strains of mice 
following sensitisation with complete Freud’s adjuvant. 
 
8.4.4 Complement component C5a 
As discussed in chapter 1.6.4, C5a is a powerful chemotactic agent, principally for 
PMN but also for monocytes. C5a also up-regulates endothelial adhesion molecules. 
Several strains of inbred mice, including FVB, DBA, NZB and NOD are known to 




be completely deficient in C5 due to a two base "TA" deletion near the 5' end of the 
gene (Jackson Laboratories data sheets). Could C5a deficiency underlie the impaired 
recruitment of leukocytes? Although TG peritonitis is thought to be independent of 
complement (White et al., 2002) and CG pleurisy is thought to be more reliant on 
complement, in reality inflammation in vivo is unlikely to be so clear-cut. As 
described in chapter 1, the complement system plays an integral part of the whole 
inflammatory process, triggered by surfaces of pathogens, antibodies and AC. 
Olga Stein and colleagues examined TG peritonitis in a range of strains of mice and 
noted reduced recruitment in four of them: 129/sv, FVB, NZB and A/J (Stein et al., 
2006). Strikingly, two of these strains (FVB and NZB) are C5 deficient as mentioned 
above, making C5 deficiency an attractive mechanism for the underlying defective 
recruitment of leukocytes in these models. 
Bouma and colleagues tried to address this very issue by demonstrating the defect 
persisted even when C5a alone was used as the inflammatory stimulus in either 
peritonitis or an air-pouch model of inflammation. The problem with this approach is 
that it does not get around the fact that an inflammatory response initiated by C5a 
would be expected to generate further C5a production in C5 sufficient mice and 
hence enhanced leukocyte recruitment. Therefore although similar levels of C5a 
were used to initiate the inflammation, subsequent C5a deficiency may still underlie 
the poor inflammatory response in NOD mice. A similar argument could be used to 
explain why other chemokines and cytokines used in isolation elicited a diminished 
inflammatory response in NOD mice. 
DTH pleurisy offers some evidence C5a deficiency is not the root cause of the 
reduced inflammatory response in NOD mice to TG peritonitis and CG pleurisy. 
Although, as stated earlier, this model is primarily an immunologically driven 
response, driven by Th1 CD4
+
 cells, it is most unlikely that complement activation 
would not take place in the ensuing inflammation with apoptotic PMN and local 
tissue damage etc. However, in this setting at least, C5a deficiency does not appear to 
dampen the immune response and it is quite possible other small complement 
components such as C3a and C4a (that have similar but weaker actions to C5a) fulfil 
the functions of C5a in these mice.  




8.4.5 Further work 
 
Additional work is requires to prove the hypothesis that the observed hypo-
inflammatory responses seen in NOD mice with TG peritonitis and CG pleurisy are 
indeed due to the hypo-responsive phenotypes of the PM! and PLM! respectively.  
One interesting way would be to use M! depletion models. Richard Lang’s group 
generated transgenic mice expressing human diphtheria toxin receptor under the 
CD11b promoter in FVB mice (CD11b-DTR), it has been convincingly demonstrated 
that PM! ablation results following intraperitoneal injection of toxin (Cailhier et al, 
2005). By depleting resident PM! as above, followed by adoptive transfer of either 
NOD or C57BL/6 PM! into the depleted FVB mice immediately prior to initiating 
CG pleurisy (or TG peritonitis), it should be possible to test the hypothesis directly. 
Two main assumptions are made in this experiment, (a) NOD and C57BL/6 MHC 
genes would be equally pro-inflammatory in FVB mice and (b) that within a 24 hour 
time frame M! from both strains of mice would not be rejected.  Controls would be 
required but the experiment would be testing the pro-inflammatory capacity of NOD 
and C57BL/6 M! in comparable in vivo environments. 
 






The first aim of this thesis was to confirm or refute the phagocytic defect observed in 
M! derived from NOD mice. As discussed above, a phagocytic defect in NOD mice 
was confirmed both in vitro and in vivo. The extent of the phagocytic defect was 
extended beyond that originally published (O’Brien et al, 2002) to include AC, latex 
beads and un-opsonized pneumococci. Pneumococci opsonized with IgG were 
phagocytosed in vitro without apparent difficulty. Work with NOD congenic strains 
has identified a prime candidate gene underlying this defect, namely Vav3, a 
Guanidine Exchange Factor. Published work has implicated Vav3 in the down-
stream signalling events following phagocytosis via CR but not FcR. Because the 
phagocytic defect appears to localise to a diabetes susceptibility locus this offers 
additional circumstantial evidence linking defective phagocytosis to autoimmunity. 
The second aim of the thesis was to probe the apparent contradictory nature of the 
inflammatory phenotype of NOD-derived M!, both in vitro and in vivo. Intriguingly, 
the phenotypes of BMDM! and resident PM! or PLM! in vitro appeared 
diametrically opposed. BMDM! were hyper-responsive to inflammatory stimuli 
whilst the resident M! were hypo-responsive. Trying to assess how these phenotypes 
may influence inflammation in vivo is much more complicated. Although, as 
predicted, hypo-inflammatory responses were witnessed in two M!-dependent 
models of inflammation (TG peritonitis and CG pleurisy), the expected explanation 
of decreased chemokine production was not evident. In vivo models are by their very 
nature much more complicated and the migratory abilities of leukocytes, circulating 
numbers and inherent differences in other factors such as the anaphalactin C5a could 
all play a contributory role. More work, as outlined above, is required to answer 
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